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resumo 
 
 
Anualmente, em todo o mundo, existem 25 milhões de casos de doenças transmitidas por alimentos 
fazendo com que a segurança alimentar seja um tópico de grande importância. Apesar do esforço 
considerável para melhorar a segurança alimentar, a incidência de intoxicações e infeções transmitidas por 
alimentos é ainda bastante elevada. Staphylococcus aureus é uma bactéria patogénica oportunista que possui 
a capacidade de crescer em vários tipos de alimentos, bem como a capacidade de produzir um grande número 
de fatores de virulência, incluindo enterotoxinas, as quais são responsáveis pela intoxicação alimentar 
estafilocócica. Esta é uma das doenças alimentares mais predominante a nível mundial. 
Com o aumento da procura de alimentos mais seguros, têm sido desenvolvidas novas tecnologias para a 
sua preservação. Entre essas tecnologias encontra-se o processamento por alta pressão (PAP), que é um 
método não térmico que possibilita a inativação ou o controlo de microrganismos patogénicos e de 
microrganismos responsáveis pela deterioração dos alimentos, ao mesmo tempo que mantém as 
propriedades dos alimentos. A deteção rápida e específica de microrganismos patogénicos (ou de 
microrganismos que podem provocar deterioração de alimentos) tornou-se cada vez mais importante na 
indústria alimentar. Atualmente, para detetar e identificar bactérias são utilizados métodos tradicionais 
baseados em testes bioquímicos e/ou serológicos e também em métodos moleculares baseados em análise 
de DNA ou RNA. No entanto, estes métodos são dispendiosos, demorados e/ou laboriosos. 
Consequentemente, é necessário desenvolver novos métodos alternativos como por exemplo, com base na 
metabolómica microbiana, que pode ser explorada como ferramenta para deteção de microrganismos na 
indústria alimentar. A metabolómica microbiana utiliza os metabolitos libertados pelos microrganismos, 
podendo permitir não apenas a deteção e distinção de espécies microbianas mas também das suas estirpes.  
Um dos objetivos deste trabalho foi avaliar a eficácia do tratamento por PAP, na inativação de estirpes não 
enterotóxicas e enterotóxicas de S. aureus. Deste modo, foi 1) avaliada a eficácia dos diferentes tratamentos 
(diversas pressões e tempos de pressurização); 2) avaliado o impacto dos tratamentos nos fatores de 
virulência, na capacidade de fermentação do manitol e na suscetibilidade à meticilina; 3) avaliado o 
desenvolvimento de resistência após vários ciclos sucessivos de PAP, e 4) avaliada a capacidade de 
recuperação da viabilidade após 14 dias de tratamento. Neste trabalho também se caracterizou o 
exometaboloma volátil de S. aureus e avaliou o seu potencial para distinguir as estirpes enterotóxicas de não 
enterotóxica. Assim, 1) o perfil do exometaboloma volátil de S. aureus foi caracterizado utilizando uma técnica 
avançada de cromatografia em fase gasosa; 2) o perfil de S. aureus foi analisado no total, avaliando a 
presença de compostos específicos já descritos para esta espécie bem como a sua origem metabólica; 3) 
aplicou-se um método de análise estatística multivariada, de forma a obter um conjunto de compostos voláteis 
de forma a distinguir as diferentes estirpes, nomeadamente distinguir as estirpes enterotóxicas das não 
enterotóxicas; e 4) este conjunto de compostos voláteis foi analisado em detalhe de forma a compreender as 
diferenças entre estirpes e assim justificar a sua distinção. 
Os resultados da inativação por PAP mostraram maior barotolerância da estirpe não enterotóxica (ATCC 
6538), não sendo esta completamente inativada a 600 MPa durante 30 minutos (mantendo uma viabilidade 
de aproximadamente 4.0 log UFC.mL-1). Utilizando estas condições de tratamento, as duas estirpes 
enterotóxicas (2153 MA e 2065 MA) foram completamente inativadas. Tanto a estirpe ATCC 6538 como a 
estirpe 2153 MA (com uma enterotoxina) suportaram 10 ciclos de pressurização sucessivos, contrariamente 
à estirpe 2065 MA (com três enterotoxinas) que foi totalmente inativada ao fim de 4 ciclos, com um decréscimo 
de 9.2 log UFC.mL-1. O tratamento por PAP não afetou os fatores de virulência testados, nem a capacidade 
de fermentação do manitol e a suscetibilidade à meticilina de nenhuma das estirpes. Nenhuma das estirpes 
foi capaz de recuperar a viabilidade após 14 dias de incubação, em nenhum dos 10 ciclos de tratamento. 
O estudo do exometaboloma volátil de S. aureus permitiu detetar 240 compostos, pertencentes a 10 famílias 
químicas, tendo como principal origem metabólica a degradação de aminoácidos, o metabolismo do piruvato 
e o stresse oxidativo. A análise em detalhe do exometaboloma volátil permitiu selecionar 10 compostos 
voláteis que têm sidomais frequentemente reportados noutros estudos sobre o exometaboloma volátil de S. 
aureus. Após análise estatística multivariada, foi possível distinguir as estirpes testadas com base no número 
(ou na ausência) de enterotoxinas. As estirpes ATCC 6538 e 2153 MA são mais similares entre si, 
encontrando-se separadas da estirpe 2065 MA. Esta distinção deve-se ao facto desta última estirpe produzir 
maiores concentrações de compostos voláteis resultantes da degradação de aminoácidos de cadeia 
ramificada, enquanto a estirpe ATCC 6538 produz maiores concentrações de compostos voláteis resultantes 
da degradação da metionina. 
Em conclusão, os resultados deste estudo mostraram que o tratamento por PAP é eficaz para controlar 
estirpes enterotóxicas de S. aureus, não permitindo o desenvolvimento de resistência nem a recuperação da 
viabilidade após tratamentos sucessivos. Embora os fatores de virulência não tenham sido afetados pelo 
tratamento por PAP, as estirpes enterotóxicas foram mais facilmente inativadas quando comparadas com a 
estirpe não enterotóxica. Concluiu-se ainda que o exometaboloma volátil de S. aureus é bastante complexo 
e que através do estudo do exometaboloma é possível distinguir estirpes enterotóxicas de estirpes não 
enterotóxicas. Foi possível selecionar um conjunto de 10 compostos que poderão potencialmente vir a ser 
utilizados como biomarcadores da presença de S. aureus. 
 keywords Staphylococcus aureus, High pressure processing, Enterotoxins, Staphylococcal food poisoning, 
Resistance, Recovery, Inactivation, Reduction effectivness, Microbial metabolomics, Volatile 
exometabolome, Exometabolome microbial volatile organic compounds. 
abstract 
 
With 25 million cases of foodborne diseases occurring annually worldwide, food safety is a major 
concern. Despite considerable efforts to improve food safety, outbreaks of foodborne diseases due to 
the presence of pathogenic microorganisms, such as Staphylococcus aureus, are well described in the 
literature. S. aureus is a well-adapted opportunistic pathogen, which is able to grow in numerous types 
of food, producing an extensive number virulence factors, including enterotoxins, which are responsible 
for staphylococcal food poisoning. This type of food poisoning is one of the most prevalent foodborne 
diseases in the world.  
With an increased demand for safer food, new food preservation technologies have been developed. 
Among these technologies is high pressure processing (HPP), which is a non-thermal food preservation 
method that enables the inactivation or control of pathogenic microorganisms and microorganisms 
responsible for food spoilage, maintaining food properties. 
The quick and specific detection of pathogenic microorganisms (or of microorganisms responsible for 
food spoilage) has become increasingly important in the food industry. Usually the detection, and 
identification of bacteria is performed using traditional methods based on biochemical and/or serological 
tests and also on molecular methods based on DNA or RNA analysis. However, these methods are 
costly, time consuming and laborious. Consequently, it is necessary to develop new alternative methods, 
such as those based on microbial metabolomics, which can be used as a tool to detect microorganisms 
in the food industry. Microbial metabolomics uses the metabolites released by microorganisms, being 
able to allow not only the detection and distinction of microbial species, but also the distinction of their 
strains. One of the objectives of this work was to evaluate the efficacy of HPP treatment for the 
inactivation of non-enterotoxic and enterotoxic S. aureus strains. Thus, to accomplish this objective, 1) 
the effectiveness of different treatments (different pressures and holding times were evaluated); 2) the 
impact of the treatments on virulence factors, fermentation of mannitol and methicillin susceptibility was 
evaluated; 3) the development of resistance along several successive HPP cycles was evaluated, and 
4) the recovery capacity after 14 days of treatment was also assessed. Other objective of this study was 
to characterize the volatile exometabolome of S. aureus and evaluate its potential to distinguish the 
enterotoxic strains from the non-enterotoxic strain. For this purpose, 1) the profile of the volatile 
exometabolome of S. aureus was characterized using an advanced gas chromatography technique; 2) 
the S. aureus profile was analyzed as a whole and evaluated the presence of specific compounds 
already described for this species as well as its metabolic origin; 3) a multivariate statistical analysis 
method was applied in order to obtain a set of volatile compounds responsible for the distinction of the 
three strains used; and 4) these set of volatile compounds were analyzed in detail in order to explain 
the differences between strains, thus justifying their separation. 
The results of inactivation by HPP showed a higher barotolerance of the non-enterotoxic strain (ATCC 
6538), not being completely inactivated at 600 MPa for 30 minutes (maintaining a viability of 
approximately 4 Log CFU.mL-1). The two enterotoxic strains (2153 MA and 2065 MA) were completely 
inactivated using these treatment conditions. Both strains ATCC 6538 and 2153 MA (with an 
enterotoxin) were able to withstand 10 successive pressurization cycles, whereas the strain 2065 MA 
(with three enterotoxins) was completely inactivated after 4 cycles, with a decrease of 9.2 log CFU.mL-
1. The HPP treatment did not affect none of the tested virulence factors, the mannitol fermentation ability 
and methicillin susceptibility of any of the strains. Moreover, none of the strains were able to recover 
their viability after 14 days of incubation in any of the treatment cycles. 
The study of the volatile exometabolome of S. aureus allowed the detection of 240 volatile organic 
compounds, belonging to 10 chemical families, having as main metabolic origins the degradation of 
amino acids, the metabolism of pyruvate and oxidative stress. It was also possible to find 10 of the most 
reported volatile compounds in studies concerning the volatile exometabolome of S. aureus. The  
detailed analysis of the volatile exometabolome allowed selecting 10 volatile compounds that have been 
reported more frequently in other studies concerning the volatile exometaboloma of S. aureus. The 
multivariate statistical analysis, allowed to distinguish the strains based on the number (or absence) of 
enterotoxins. The strains ATCC 6538 and 2153 MA are more similar to each other, being separated 
from the strain 2065 MA. This distinction is due to the latter strain has larger amounts of volatile 
compounds, resulting from the degradation of branched-chain amino acids, while the strain ATCC 6538 
showed higher amounts of volatile compounds with origin in the degradation of methionine. 
In conclusion, the results showed that HPP is effective in the control of S. aureus, not allowing the 
development of resistance or recovery of viability after successive treatments. Although the virulence 
factors were not affected by HPP treatment, the enterotoxic strains were more easily inactivated than 
the non-enterotoxic strain. It was also concluded that the volatile exometabolome of S. aureus is quite 
complex and that the exometabolome analysis allows to distinguish enterotoxic strains from non-
enterotoxic strains. It was possible to select a set of 10 compounds that can be potentially used as 
biomarkers of S. aureus. 
 
  
 
 
 
 
 
 
 
 
 
“The saddest aspect of life right now is that science gathers knowledge 
faster than society gathers wisdom.” 
 
Isaac Asimov 
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Thesis outline and objectives 
Thesis outline 
Gastrointestinal diseases are responsible for 25 million infections each year, with 
diarrheal diseases as the second leading cause of death in the world (1). In fact, foodborne 
diseases, along with waterborne diseases, are responsible for the death of approximately 1.8 
million people every year, most of whom are children, and accountable for economic losses in 
food industry, health systems, tourism and also for the consumer (2). Sets of norms and rules 
have been developed over the years, in order to guarantee safe food for the consumer. Although 
food contamination with foodborne pathogens might be avoided through the development and 
implementation of such procedures, food preservation methods are extremely important to 
control food contamination by pathogenic microorganisms and also to control microorganisms 
responsible for food deterioration. These methods have been used since antiquity and include 
heating, salting, freezing, drying, freeze-drying, irradiation, fermentation, canning, the addition 
of antimicrobials and chemicals and more recently, ionization radiation, pulsed electric fields, 
ultra-violet (UV) decontamination, pulsed high intensity light, high intensity laser, pulsed white 
light and high pressure processing (HPP) (3). Nowadays HPP progressively appears as a 
commercially viable alternative food preservation method in order to answer consumer demand 
for safes but also fresher and nutritious food (4,5). 
Despite considerable efforts to improve food safety, foodborne diseases outbreaks linked 
to the presence of pathogenic bacteria at harmful levels in food has been well documented, 
highlighting the need for technological interventions in order to address food safety risk posed 
by these pathogens in the final food products. Among them, is Staphylococcus aureus, which is 
responsible for one of the main foodborne diseases, staphylococcal food poisoning (SFP) (6). S. 
aureus is an opportunistic pathogen, able to grow in many types of food, that produces a wide 
number virulence factors and is able to develop continuously resistance features, turning it into 
a well succeed foodborne pathogen (7). Furthermore, S. aureus is well known for quickly 
developing resistance to antibiotics, from penicillin to methicillin-resistant S. aureus (MRSA) 
strains, passing through vancomycin-intermediate S. aureus (VISA) strains to community 
acquired MRSA, until vancomcyin-resistant S. aureus (VRSA) strains (8), thus being 
melodramatically called a superbug by non-scientific (and also some scientific) press, which is 
mainly a multidrug resistant bacteria (9,10) 
Although many efforts concerning the prevention of S. aureus in foodstuff, either by 
respecting the norms or using food preservation methods, there is still a high probability that 
food might be contaminated by this pathogen. The conventional methods for the detection of 
non-enterotoxic and enterotoxic strains of S. aureus both in foodstuff and in clinical samples, 
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are time consuming and not always sensitive, thus the need for a method which is able to 
distinguish the two types of strains as quickly as possible, either MRSA from MSSA, VISA from 
VRSA or even enterotoxic from non-enterotoxic strains, arises. Microbial metabolomics, using 
microbial volatile organic compounds (MVOC) or, as it will be referred over this document, 
volatiles, resorting to headspace (HS) solid phase microextraction (SPME) combined with 
comprehensive two-dimensional gas chromatography with time of flight mass spectrometry 
detection (HS-SPME/GC × GC-ToFMS) (11,12), has the potential to achieve such a distinction. 
In order to reduce the risk of SFP, it is essential to develop alternative food processing 
methods, such as HPP, and an alternative S. aureus detection/distinction method, such as HS-
SPME/GC × GC-ToFMS. 
The present PhD thesis is organized in six chapters, according to the organizational 
sequence illustrated in Figure 1. 
 
Figure i -PhD thesis workflow: from the introduction, to the work performed with HPP, to the assessment of the volatile 
exometabolome until the integration of the work performed with concluding remarks and future work. 
Chapter 1 presents an in-depth literature review of S. aureus, SFP and HPP. The first part 
of this chapter describes the characteristics of S. aureus, its importance as an etiological 
foodborne opportunistic pathogen, the many diseases it causes, including the description of SFP 
and the chemical and genetic features of enterotoxins (SE). The second part describes HPP as an 
alternative food preservation method with the development of the factors conditioning the 
effectiveness of HPP in S. aureus. This chapter was published in the journal Innovative Food 
Science & Emerging Technologies with the DOI: 10.1016/j.ifset.2016.06.008 
Chapter 2 offers an insight into the world of volatile microbial metabolomics of S. aureus. 
This chapter makes a small introduction to concepts related with metabolomics, focusing mostly 
on the concept of microbial metabolomics. Furthermore, it takes a look into the 30 year old 
picture of S. aureus volatile metabolome, including the volatiles reported over the years as well 
as their metabolic origin. Finally, with the data achieved from beholding such picture, a 
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suggestion of a possible volatile pattern of biomarkers that characterizes S. aureus is done. This 
chapter is under preparation to be submitted for publication. 
Chapter 3 evaluates the efficiency of different HPP treatments in the inactivation of the 
three S. aureus strains (one non-enterotoxic and two enterotoxic) and assesses the impact of 
HPP on virulence factors. The results revealed that the non-enterotoxic strain was more 
baroresistant than the two enterotoxic strains and that none of the tested virulence factors was 
affected by HPP. Factors that probably explain these results are presented. This chapter was 
published in the journal Food Control with the following DOI: 10.1016/j.foodcont.2015.04.022 
Chapter 4 reports the development of resistance and the recovery of viability of the three 
previously used S. aureus strains after several cycles of HPP. The strains were submitted to ten 
consecutive HPP cycles using the survivors of the previous cycle, and their viability was assessed 
in every cycle. Furthermore, to evaluate if the strains were able to recover from the HPP cycles, 
colonies were counted up to fourteen days. The results revealed that two of the strains were 
able to survive over the ten cycles while one was completely inactivated in the fourth cycle. The 
results also showed that none of the strains was able to recover from the HPP treatment even 
after fourteen days. This chapter was published in the journal Food Microbiology with the 
following DOI: 10.1016/j.fm.2014.09.016 
Chapter 5 aimed to profile the volatile exometabolome of the same S. aureus strains and 
to detect if differences between the non-enterotoxic strain and the enterotoxic strains existed. 
The exometabolome profile comprised 240 volatiles belonging to several chemical families, 
which were putatively identified, making this study the first ever reporting such a high number 
of volatiles for S. aureus. The volatiles found had mainly origin in amino acid (AA) degradation 
pathways and were also linked to oxidative stress. Furthermore, using variable importance in 
projection (VIP), achieved from partial least square discriminant analysis (PLS-DA), it was 
possible to create a hierarchical heatmap cluster (HHC) showing the distinction between strains 
accordingly to the number of SE. This chapter is also under preparation for submission. 
Chapter 6 integrates the key points of this work and highlights the main conclusions of 
both HPP in S. aureus and its volatile exometabolome, as well as the limitations of this work. In 
line with these conclusions, perspectives for future work, since S. aureus is such a major 
opportunistic pathogen with much research needed not only in the area of food microbiology 
but also in clinical microbiology, in order to answer the many pendent questions.
 12 
 
Thesis outline and objectives 
Objectives 
The main objective of this PhD thesis was to apply HPP treatments into three different 
strains of S. aureus (one non-enterotoxic, one with one SE and one with three SE) and, by using 
microbial metabolomics, to characterize the volatile exometabolome of the same strains. Under 
this framework, the particular objectives can be summarized as: 
• To evaluate the impact of HPP of different treatments on non-enterotoxic and 
enterotoxic strains of S. aureus. 
•  To assess the effect of HPP treatments on non-enterotoxic and enterotoxic strains of S. 
aureus virulence factors. The ability to ferment mannitol and susceptibility to methicillin were 
also evaluated.  
• To evaluate the endurance of non-enterotoxic and enterotoxic strains of S. aureus to 
consecutive cycles of HPP treatments and to determine if these strains recover their viability. 
• To footprint the non-enterotoxic and enterotoxic strains of S. aureus through their 
volatile exometabolome, using a metabolomics-based strategy employing HS-SPME/GC × GC-
ToFMS. 
• To detect, via the volatile exometabolome, if the non-enterotoxic strain of S. aureus can 
be distinguished from and enterotoxic strains of S. aureus. 
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CHAPTER 1. Introduction 
 
A review on the inactivation of Staphylococcus aureus by high pressure 
processing 
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Adapted from: 
I Baptista, SM Rocha, Â Cunha, JA Saraiva, A Almeida, Inactivation of Staphylococcus aureus by high pressure 
processing: An overview. Innovative Food Science & Emerging Technologies, 2016, 36, 128–14 
 15 
 
Chapter 1 
Context 
Food safety is a major concern for consumers, food industry, health systems and 
governments, with 25 million foodborne diseases occurring annually worldwide (1). S. aureus, is 
an extremely versatile opportunistic pathogen being responsible for SFP due to its enterotoxic 
strains (7). With increasing demands for safer food, new food preservation technologies are 
increasingly gaining interest. In the last two decades, HPP appeared as an alternative non-
thermal food preservation method promoting inactivation of some spoilage and pathogenic 
microorganisms, while maintaining food characteristics (4,5).  
 
Figure 1.1 - Literature survey of published research articles using a search query in the field topic with the keywords 
“Staphylococcus aureus” for Staphylococcus aureus publications (dark grey line; secondary y axis), “high pressure 
processing” or “high hydrostatic pressure” for HPP publications (light grey bars) and “high pressure processing” or 
“high hydrostatic pressure” in combination with “Staphylococcus aureus” for Staphylococcus aureus inactivation by 
HPP publications (black bars) in topic; from 1985 to 2014 via Web of Science™. 
HPP has been tested in several studies to inactivate this bacterium, and results show that 
S. aureus is one of the most barotolerant species to HPP. This bacterial species has been 
extensively studied from 1985 to 2014 (Figure 1.1), with the number of publications being above 
7.000 per year in the last decade. Although the number of publications for HPP alone (Figure 
1.1) is not as high as the number of publications for S. aureus alone, there is a significant amount 
of knowledge concerning the effects of HPP on food matrices, food components (such as 
proteins, enzymes and lipids) and on the inactivation of microorganisms and their ability to cope 
with high pressures, with the number of publications above 200 per year since 2012. However, 
there are specifically 57 publications concerning the effect of HPP on S. aureus (Figure 1.1), with 
 16 
 
Chapter 1 
highest number of publications in 2012 (7 publications). Thus, this knowledge should not only 
be increased but also expanded to the food industry in order to establish effective HPP protocols 
for the inactivation of several strains of S. aureus and to different food matrices. 
In this chapter, S. aureus biology will be approached as well as the principles of HPP. 
Factors that modulate HPP efficiency will be revised, firstly based on the state-of-the art 
described for bacteria in general and afterwards, when studies exist, for S. aureus specifically.  
1.1. Staphylococcus aureus 
Staphylococci are Gram-positive bacteria widely distributed in the environment, which 
can reside on the skin and mucosal surfaces of humans and other animals (13). The genus 
Staphylococcus contains at least 49 species, several of which are not only clinically significant 
but are also important for the food industry, agriculture and economy (14). The most pathogenic 
of these species is S. aureus (15). S. aureus is an exceptionally well adapted opportunistic 
pathogen that can survive under different conditions, with no particular nutritional or 
environmental requirements (16–18). This microorganism is able to withstand several months 
on items and surfaces and is capable to cause a large range of diseases in humans and animals 
(19–21).  
Over the years, S. aureus infections have highly increased in individuals, being currently 
one of the main causes of human bacterial infections worldwide, with MRSA strains emerging 
as important etiological agents of infection not only inside (hospital acquired MRSA) but also 
outside of healthcare settings (community-associated MRSA) and even in a large diversity of 
animals (8,22–27). More recently animals have been pointed as important sources of human 
infections with MRSA strains (28–31) and the ability for these strains to colonize humans and for 
human S. aureus strains to colonize animals have been described (22,32–34). In fact, the 
presence of MRSA strains in meat products has been reported recently (35,36). 
S. aureus possesses several characteristics such as its quorum sensing mechanisms and 
virulence factors (Table 1.1) that enable it to cause a large range of diseases (36–38). It produces 
a vast diversity of exoproteins (such as hemolysins, nucleases, proteases, lipases, hyaluronidase 
and collagenase) which grant the ability to colonize host tissues and also other exoproteins that 
contribute to its capacity to cause disease and inhibit the host immune responses (such as toxic 
shock syndrome toxin-1, SE, exfoliative toxins and leukocidin) (39,40). The genes encoding these 
virulence factors are regulated in a coordinated mode, revealing the strategy of this pathogen 
to initially establish itself in the host and, afterwards, to cause the disease (41). 
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1.1.1. Staphylococcus aureus as an etiological opportunistic pathogen 
S. aureus is a ubiquitous commensal symbiont and colonizer of both humans and animals 
(16,25). In humans, the anterior nares of the nose are the main ecological niches of S. aureus  
Table 1.1 - Staphylococcus aureus virulence factors and their function in colonizing and evading the immune responses 
of the host (42–47).  
Virulence factor Putative function 
Cell surface factors 
Microbial surface components recognizing adhesive matrix 
molecules (MSCRAMMs) 
Family of proteins on the basis of structural similarities and a common mechanism for ligand 
binding, which is mediated by two adjacent subdomains containing IgG-like folds 
Staphylococcal protein A Interference with optimization and phagocytosis, through the binding to Fc portion of the 
immunoglobulin 
Fibronectin-binding proteins Promotes bacterial attachment to fibronectin and to plasma clots, the adhesion to extracellular 
matrix and supports the invasion 
Collagen-binding protein Promotes the adherence to collagenous tissues and cartilage and prevents the classical pathway 
of complement activation 
Clumping factor proteins Adhesion to immobilized fibrinogen, immune evasion by binding soluble fibrinogen, degradation 
of C3b, adhesion to desquamated epithelial cells and nasal colonization 
Serine–aspartate repeat protein Involved in immune invasion and very likely in nasal colonization and promotes the degradation 
of C3b 
Bone sialoprotein-binding protein Promotes the adhesion to extracellular matrix 
Capsular polysaccharides Promotes the reduction of phagocytosis, bacterial colonization and its persistence on mucosal 
surfaces 
Staphyloxanthin Carotenoid pigment that confers protection against reactive oxygen species (ROS) such as O2
-, 
H2O2 and HOCl generated by host neutrophils 
Near iron transporter (NEAT) motif proteins Promote haem capture from haemoglobin and help bacteria to survive in the host, where iron is 
restricted 
Iron-regulated surface protein Promotes haem uptake and iron acquisition, the adhesion to desquamated epithelial cells, the 
resistance to lactoferrin, the Invasion of non-phagocytic cells and  accelerates the degradation of 
C3b 
Protein A Promotes the inhibition of opsonophagocytosis, B cell superantigen, inflammation, endovascular 
infection and  endocarditis 
S. aureus surface protein G and plasmin-sensitive surface protein Promotes the adhesion to desquamated epithelial cells and the formation of biofilm 
Adenosine synthase A Promotes the survival inside neutrophils  
S. aureus surface protein X Promotes biofilm formation, cell aggregation and squamous cell adhesion  
Serine-rich adhesin for platelets Promotes endocarditis and endovascular infection  
S. aureus surface protein C Promotes primary attachment and accumulation phases of biofilm formation  
Biofilm-associated protein (present only in bovine strains) Promotes biofilm formation, prevents invasion of mammary gland epithelial cells and promotes 
aggregation on epithelial cell surfaces.  
Secreted factors 
Superantigens Promote the proliferation of large quantities of T cells causing a massive cytokine release, 
interfering with the host immune system by aiming the innate and adaptive responses 
Staphylococcal enterotoxins Induces emesis and gastroenteritis 
Toxic shock syndrome toxin-1 Acts on the vascular system by causing inflammation, fever, and shock. 
Cytolytic toxins Promote the development of β-barrel pores in the plasma membrane and cause leakage of the 
cell’s content and lysis of the target cell 
α-hemolysin Is inserted into in the eukaryotic membrane and oligomerizes into a β-barrel that forms a pore 
causing osmotic cytolysis (is mainly cytolytic to human platelets and monocytes) 
β-hemolysin Promotes hydrolyzation of sphingomyelin of the host cell plasma membrane, producing 
phosphocholine and ceramide 
γ-hemolysin Promotes lysis in both erythrocytes and leukocytes due to the formation of pore, by binding to the 
cell surface 
Leucocidins E/D and M/F-PV Promotes lysis in leukocytes due to its pore forming activity 
Panton-Valentine Leucocidin Promotes lysis in leukocytes due to its pore forming activity 
Catalase Promotes the inactivation of toxic hydrogen peroxide and free radicals produced inside phagocytic 
cells 
Coagulase Extracellular protein that stimulates the conversion of fibrinogen to fibrin, causing the formation 
of clots in mammalian plasma 
Lipases Promote lipid digestion, allowing it to grow on skin surfaces and cutaneous oil glands and biofilm 
formation 
Proteases Promotes the inactivation of host-derived inhibitors, modulate bacterial adhesion and cell surface 
proteins, acquire nutrients and spread through tissues 
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Nucleases Promotes the degradation nucleic acid of the host, the evasion of neutrophil extracellular traps, the 
inhibition of biofilm formation through the cleavage of extracellular DNA and the prevention of 
biofilm initiation 
Hyaluronidase Promotes the hydrolyzes of hyaluronic acid, helping the spread through the tissues 
Lecithinase Promotes the hydrolyzes of lecithin (phospholipid), causing cell lyses 
Saphylokinase Activates plasminogen, facilitating the dissolution of the fibrin clot and interacts with the human 
neutrophil peptides (α—defensins) enhancing bacterial resistance to phagocytosis 
Staphylococcal complement inhibitor Binds to the C3 convertases, inhibiting their activity on the bacterial surface, thus preventing 
phagocytosis 
Extracellular fibrinogen-binding protein Binds to fibrinogen, interferes with platelet aggregation and also binds to C3b, preventing it to 
bind to activator surfaces thus inhibiting the complement-mediated lysis and opsonophagocytosis 
Chemotaxis inhibitory protein of S. aureus Promotes the inhibition of neutrophil and monocyte chemotaxis 
S. aureus formyl peptide receptor-like 1 Inhibitor Binds directly to the formyl peptide receptor-like 1 promoting the inhibition of specific ligands 
acting as an antagonist 
Extracellular adherence protein Inhibits neutrophil recruitment by interacting directly with the host adhesive proteins intercellular 
adhesion  molecule 1, fibrinogen or vitronectin 
(colonization mainly happens due to the hands when these touch contaminated surfaces or, in 
a much lower frequency, directly through the air) although other sites, such as the skin, perineal 
area, pharynx, gastrointestinal tract, vagina and the axillae might also be colonized (21,48). 
There are two types of S. aureus nasal carriers in humans: persistent carriers (20% of 
individuals) and intermittent carriers (nearly 60% of individuals) (49,50); with the remaining 
percentage being non carriers (21). However, the reason why some individuals are non-carriers 
while others are persistent carriers still remains unclear (40), but studies point towards a set of 
factors belonging to both host and bacteria (25).Nasal carriage depends on a wide assortment 
of features that depend not only on availability and usage of bacterial colonization factors but 
also of the susceptibility, resistance and other features of the host such as genetics, sex, age, 
hormonal status (in women) and anatomic alterations of the nares (25,48). An interesting fact is 
that the population structures of nasal S. aureus are very similar all over the world (25). Nasal 
carriage is associated with most S. aureus infections, being the frequency of infections for 
carriers higher (although less severe) than for non-carriers, with S. aureus diseases in this last 
group caused mainly by the ingestion of contaminated food with enterotoxic strains of S. aureus. 
In fact, S. aureus has successfully colonized millions of humans (25). Furthermore, it has been 
described that a commensal strain can turn into a pathogenic strain through a change of state, 
rather than the existence of two separate strains, and this “new” strain will face an extremely 
severe host defense system (17,51). 
When the host's body suffers some sort of disorder, S. aureus might become pathogenic 
(16,25). As a result, this bacteria is able to cause a wide range of infections in humans and other 
animals, including folliculitis, furunculosis, boils, impetigo, cellulitis, sepsis, deep abscesses, 
necrotizing pneumonia, osteomyelitis, infective endocarditis, urinary tract infections and 
infections of the central nervous system, and also toxic shock syndrome and SFP (21,25,41). 
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1.1.2. Staphylococcus aureus as a foodborne pathogen 
SFP is caused by huge growth of S. aureus strains that are capable of producing SE (52). 
However, SFP is not directly caused by staphylococcal cells but by its SE (7), making this 
foodborne disease a food poisoning rather than a foodborne infection (like the ones caused by 
Salmonella spp.). 
S. aureus has the ability to grow in an extensive array of temperatures, pH and NaCl 
concentrations, which allows its growth in many different sorts of foods, such meat (mainly 
poultry) and meat products, milk and dairy products, fermented food, vegetables, fish products, 
salted food products (e.g., ham), egg products, bakery products, sandwich fillings, among others 
(18,50,53). A main concern related with meat is the fact that most raw poultry meat (both fresh 
and frozen) are significantly contaminated with S. aureus (54,55) since the majority of poultry 
processing lines contains “endemic strains” (18). Usually, SFP occurs when the number of S. 
aureus colony forming units per gram of food (CFU·g−1) is higher than 105, though, depending on 
the conditions and strain, this number can be lower (56). Food involved in SFP differ greatly from 
country to country (57).  
Although SFP is usually a self-limiting disease, approximately 10% of the cases require 
hospitalization. Consequently, SFP represents a significant social burden due to hospital 
expenses, loss of patient working days and their productivity, and also the cost of disposing of 
contaminated food (18).  
According to Hennekinne et al. (2010) (58), there are five conditions to induce SPF:  
i. The existence of a source that contains S. aureus strains able of producing SE; 
ii. Transfer of enterotoxic S. aureus from the source to the food; 
iii. Food with favorable characteristics for the growth of enterotoxic S. aureus and generation of 
SE; 
iv. Favorable temperature and enough time for the growth of the enterotoxic S. aureus and 
generation of its SE; and 
v. Ingestion of food containing the necessary amount of SE to cause symptoms. 
Since S. aureus does not compete with indigenous flora of raw foods, food contamination 
is mainly due to poor handling, allowing enterotoxic S. aureus to enter the food chain while 
processing food products and/or after improper storage (53,59). On a smaller scale, enterotoxic 
S. aureus can be transferred to food by air and dust (53). To avoid SFP, prevention must pass 
through strict microbiological food control, which compromises hand and environmental 
hygiene, identification and isolation of carriers, and proper antibiotic therapy of food handlers 
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(50). Swabs from the nasopharynx and/or skin lesions of food handlers should be taken when 
SFP is suspected (2). The isolation of enterotoxic strains of S. aureus from humans vary between 
40 and 60% (60), making the contaminations of food by food handlers a major problem. 
Even though SFP is the third most important foodborne disease present all over the world, 
its true incidence can be underestimated due to several factors that can go from unreported 
outbreaks, minor outbreaks, misdiagnosis of the illness (which is symptomatically similar to 
other types of food poisoning, such as the one caused by Bacillus cereus), improper sample 
collection and laboratory examination, lack of seeking assistance by the affected subjects and 
the lack of routine surveillance for the detection of S. aureus and its SE in food or the detection 
of SE in stools (6,18,53,61,62). 
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Table 1.2 - Staphylococcal food poisoning outbreaks reported in the literature. 
Country, City Period Setting of Outbreak Suspected source SE 
Number of 
diseased 
Reference 
Malasya, Kapar 1983 School canteen Foodhandler - 48 (63) 
USAa 1986 School Chocolate milk SEA 850 (64) 
USA, Starkville February to April 1989 Several cafeterias Canned mushrooms SEA 99 (65) 
USA, Texas 1992 Elementary school’ canteens Deboned chicken salad - 1 362 (66) 
Brazil, Minas Gerais 1998 Catholic priest’s ordination 
ceremony 
Chicken, roasted beef, rice and beans SEA 4000 (67) 
Japan, Osaka Prefecture June to July 2000 Households Powdered skim milk SEA, SEH 13 420 (68,69) 
Saudi Arabia, AI-Madinah, AI-
Monawarah 
March 2003 Catered buffet Chicken and rice - 492 (70) 
Norwaya December 2003 Kindergarten Mashed potato made with raw milk SEH 8 (71) 
Japan, Shiga Prefecture 2005 Restaurant Grilled salmon - 862 (72) 
USA, Kansas December 2005 Catered buffet at a company Smoked sausage SEA 138 (73) 
Austria, Eisenstadt September 2006 School canteen Foodhandler - 113 (74) 
Republic of Paraguay, San Lorenzo, 
Asunción and Ciudad del Este 
March 2007 Households Milk SEC, SED 400 (75) 
Germany, Baden-Württemberg June 2008 Catered buffet lunch at a 
wedding party 
Pancakes filled with minced chicken SEA 150 (76) 
Franceb October to November 
2009 
Households Cheese SEE 23 (77) 
USA, Illinois December 2010 Bakery Cakes and desserts SEA, SEB, 
SEC, SED 
100 (78) 
Australia, Sydney June 2012 Catered buffet dinner at an 
elite sporting event 
Chicken stir-fry or fried rice - 22 (79) 
USAa July 2012 Military Unit Lunch Party - - 35 (80) 
India, Mysore December 2012 Nursing hostel Kerala matta rice - 171 (81) 
Germany, Freiburg April 2013 Christening party Ice cream SEA 13 (62) 
a Distict or city not revealed. 
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b Several french departments (Pas de Calais, Nord, Somme, Aisne, Savoie and Gard) 
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SFP outbreaks (Table 1.2) vary in number and can comprise as few as 8 subjects or as 
many as more than 10 000. In 2012, 346 cases of SFP were reported to the European Union, 
corresponding to 6.4% of foodborne outbreaks, with mixed food being responsible for 31.4% of 
the outbreaks, followed by cheeses which were associated with 20% of the outbreaks (82). In 
the same year, 5 cases of SFP were reported in the United States, corresponding to 1% of 
foodborne outbreaks (80), with 55% of outbreaks attributed to meat and poultry dishes (6). In 
Australia, between 2000 and 2012, 14 cases of SFP were reported, with 29% of outbreaks 
associated with catered food (79). 
1.1.3. Staphylococcal enterotoxins  
SE are a family of serological well defined monomeric proteins (220–240 amino acids) 
belonging to the pyrogenic toxic superantigen family, with low molecular weight (26–30 kDa) 
and well conserved structures, that are water and saline solution soluble, and that are mostly 
produced by several coagulase producing S. aureus strains, which are capable of producing more 
than one SE (18,83,84). SE possess important properties such as the capacity to induce emesis 
and gastroenteritis, in addition to their superantigenecity (85). They are not only able to resist 
to heat and acidity, but are also stable in vast range of pH and can resist to the inactivation by 
gastrointestinal proteases and other proteolytic enzymes (e.g., pepsin, trypsin, rennin and 
papain) (57,86). In practice, these properties mean that even though S. aureus can be completely 
inactivated during food processing or through food preservation methods, the biological activity 
of SE remains unaffected (86). Moreover, S. aureus can produce SE in a wide range of 
temperature, pH, NaCl concentrations and water activity (87). 
There are twenty one SE or SE-like (SEl; related SE with no emetic activity or that have not 
been tested yet) superantigens, SEA, SEB, SEC, SED, SEE, SEG, SEH, SEI, SElJ, SElK, SElL, SElM, 
SElN, SElO, SElP, SElQ, SER, SES, SET, SElU and SElV (88,89). 
Currently, SEA is the serotype most frequently involved in SFP (80%), followed by SEB 
(10%) (50,86,87). SE can also cause toxic shock-like syndrome, being involved in allergic and 
autoimmune diseases (53,57,90). Moreover, SEB in particular, can be used as a potential 
biological warfare weapon (50,91). 
There is a direct proportionality between the toxicity of a SE and the quantity ingested of 
that SE (92).For example, the amount of SEA necessary to cause SFP is 100 ng (93). However, the 
amount of SE needed to induce SFP depends also of the individual susceptibility to the SE, its 
weight and its health condition, the type of food, and also the SE type (50,94). Furthermore, the 
linearity between the number of S. aureus CFU.g−1 and the production of SE present in a sample 
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might be disassociated and attention must be paid to the different environments in which cells 
are growing, because they can affect the SE production (87). 
Some strains of enterotoxic S. aureus isolated from food are also MRSA (95–98). However, 
although the number of foodstuff containing MRSA strains has become higher over the years, 
there is still no evidence that MRSA strains are foodborne (36). 
1.2. High pressure processing 
Nowadays, consumers demand not only convenient and ready-to eat food but also search 
natural food products with an extended shelflife and high quality, that are less processed, 
preservative free, with low salt, sugar or fat contents and healthier (4,87,99). Along with these 
requirements, the increased awareness of the risk of foodborne diseases forced the food 
industry to develop new non-thermal alternative food processing techniques such as ionization 
radiation, pulsed electric fields, UV decontamination, pulsed high intensity light, high intensity 
laser, pulsed white light, high pressure processing, among others (3,87,99,100). 
HPP is a fairly new non-thermal food preservation technique that inactivates foodborne 
pathogens responsible for foodborne diseases and food spoilage by subjecting foods to 
pressures between 400 and 600 MPa, with or without heat (101), with minimal effect on taste, 
texture and nutritional characteristics (102–104). This technology also has the advantage of 
being applied to pre-packaged food products, highly preventing post-processing contamination 
(105). HPP was adopted by the food industry from the manufacturing of ceramics, artificial 
diamonds, superalloys and sheet metal forming (106). 
Although HPP was first described to inactivate bacteria in 1895 by Royer (107) and by Hite 
and in 1899 (108), it was only in the 1990's that this technology began to be applied to the food 
industry (109). Nowadays, HPP is applied all over the world in a extensive variety of food 
products (99,103,110). 
Over the last twenty years, considerable research has been performed and the efficacy of 
HPP has been proved by extending food shelf life and improving food safety. Many works have 
been done with vegetative cells of bacteria, mainly with several strains of Escherichia coli, 
Listeria monocytogenes, Listeria innocua, Salmonella spp., Vibrio parahemolyticus and S. aureus, 
which are important foodborne pathogens (111–113). Some works have also been done with 
bacterial endospores, which are pressure-resistant, with special interest to the ones performed 
with spores of Clostridium botulinum, Clostridium perfrigens and B. cereus, which are also 
important foodborne pathogens (114). Yeasts and molds (Byssochlamys fulva, Byssochlamys 
nivea, Talaromyces avellaneus and Saccharomyces cerevisiae) inactivation by HPP has also been 
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studied (105,115–117). The inactivation of viruses through HPP is not as studied as the 
inactivation of bacteria, however there are some published studies with Hepatitis A virus, 
Poliovirus, Norovirus and human Rotavirus (118–121). 
The efficacy of HPP depends on many different factors such as the type of microorganism 
(spores are the most resistant and are in general, followed by gram-positive vegetative cells, 
which are followed by gram-negative vegetative bacteria, whereas molds and yeasts are more 
sensitive), on the bacterial shape (rods are more sensitive than cocci) and the growth of the 
culture (122,123).  
The main advantages of this technology are (99,106):  
i. The processing of food at ambient or low temperature;  
ii. Instant transmittance of pressure throughout the system (independently of the size or shape); 
iii. Microbial death without the need of heat and chemical preservatives/additives, improving 
food quality and shelf life;  
iv. Creation of ingredients with new functional properties;  
v. Maintenance of flavoring characteristics and nutritional components; and  
vi. Being an environmental friendly process, requiring only electric energy and it does not 
generates waste products.  
Nonetheless, as in all technologies, there are some practical challenges in the applicability 
of HPP to food safety, such as the high cost of HPP equipments. Furthermore, there is also a lack 
of information concerning the effect of HPP on toxins, allergens and nutrients (99). 
HPP stands on three basic principles (102,104,110): 
i. Le Chatelier's principle, which states that the application of pressure shifts the system 
equilibrium toward the state occupying the smallest volume and, thus, any phenomenon 
accompanied by a decrease in volume will be enhanced by an increase in pressure and vice 
versa;  
ii. Principle of microscopic ordering, which states that at constant temperature, an increase in 
pressure will increase the degrees of ordering of molecules of a given substance; and 
iii. Isostatic principle, which states that pressure is transmitted quasi-instantaneously and 
uniformly throughout the sample volume independently of the size and geometry of the 
product, meaning that during HPP treatments all parts of the food will experience similar 
pressure, with pressure and temperature exerting antagonistic forces on molecular structure 
and chemical reactions. 
The pressurization of liquid or solid foods at room temperature is usually accompanied by 
a moderate temperature increase, termed adiabatic heating, which is of approximately 3 °C per 
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100 MPa in foods with high water content or 8–9 °C in foods with high fat content (103,110). 
HPP treatments can be applied in a cyclic or continuous mode. The pressure, time and 
temperature applied are dependent of the type of product and of the expected result. 
Temperatures above or below ambient temperature increase the efficiency of HPP treatments 
for microbial inactivation (99,103,105).  
1.2.1. Factors conditioning the effectiveness of HPP in Staphylococcus aureus 
As mentioned, the efficiency of HPP depends on the type of microorganism and also on 
the bacterial shape (122,124). In the following sections, the parameters that modulate HPP 
efficiency will be discussed, firstly based on the state-of-the art for bacteria and after specifically 
for S. aureus, depending on the bibliography available. Although there is a lack of studies for S. 
aureus concerning some factors, they will be approached using other bacterial species due to its 
importance. Furthermore, when pertinent, comparison between S. aureus and other bacteria 
will be made. In addition, HPP inactivation kinetics will also be approached, since even though 
several HPP studies for S. aureus reported a first-order inactivation kinetics, other studies 
showed the need of nonlinear models to adequately fit decay curves of S. aureus. 
 
Figure 1.2 - Effect of HPP on Staphyococcus aureus cell structures and biomolecules; adapted from Oger & Jebbar, 
2010 (125). A: membrane phospholipids; B: protein translation on ribosomes; C: protein folding (PDB ID: 2FNP 
(126)); D: multimeric protein; E: staphylococcal enterotoxin (PDB ID: 1ESF (127)). Membrane phospholipids are 
extremely sensitive to increasing pressures, passing from the liquid-crystalline phase into a gel state. At pressures above 
345 MPa, conformational changes occur in Staphylococcus aureus ribosomes which will have consequences in protein 
translation. Although the effects of HPP on protein conformation are conditioned by the type of protein, at pressures 
above 300 MPa the effects are usually irreversible. Staphylococcus enterotoxins (SE) are extremely baroresistant 
proteins, suffering no conformational changes at pressures up to 800 MPa. 
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1.2.1.1. Cell structures and biomolecules  
The inactivation of bacteria by HPP is a multi-target approach (Figure 1.2), causing 
changes in cell membranes (with special attention given to the membrane phospholipids phase 
transitions), cell wall, ribosomes, proteins, lipids and enzyme-mediated cellular functions (128). 
Thus, as HPP targets more than one cellular structure and/or function, cell death is the result of 
a combination of damages in different parts of the cell (129,130). 
i) External cell structure (cell membrane and cell wall) 
The cell membrane is the most pressure sensitive cellular component and is considered 
the main target of HPP inactivation in microorganisms. It is accepted that the cause of cell death 
is mainly due to the leakage of intracellular constituents through the permeabilized cell 
membrane (106,131). Nevertheless, it has been shown that bacteria can restore their 
membrane after pressure application if that pressure is not severe enough to affect irreversibly 
the membrane, as seen in E. coli (132). Lower fluidity of the bacterial cell membrane (Figure 1.2) 
causes an increase in HPP sensitivity (106). HPP effects on cell membranes will consequently 
alter cell permeability, transport systems, loss of osmotic responsiveness, organelle disruption 
and the ability to maintain intracellular pH (128). During compression, the phospholipids from 
bacterial membranes are compressed (130) and cell membrane proteins are degraded, which 
will consequently have negative effects in the membrane function (133). These effects are the 
main cause of sub-lethal injury created by HPP in microorganisms, which prevents them to grow 
on selective media and/or requires longer periods of time to recover (124). 
Due to differences in the cell wall structure, Gram-negative bacteria are more sensitive to 
HPP than Gram-positive bacteria (133). This fact relies on the higher complexity of Gram-
negative cell wall structure which consist of an inner and outer membrane with a thin layer of 
peptidoglycan stuck between (134). On the other hand, cell walls of Gram-positive bacteria are 
more elementary, consisting solely of a thick peptidoglycan outer layer (which represents 90% 
of the cell wall) (134). It has been shown that S. aureus cell membranes damage by HPP is not 
easy. This was shown using scanning electron microscopy (SEM) to examine cell morphological 
changes and it was observed that S. aureus cells without HPP treatment exhibited a smooth and 
uniform aspect opposed to loss of cell surface smoothness, irregularities and fractures when 
pressurized at 300 MPa or few invaginations when pressurized at 350 MPa and, only when this 
pressure is combined with CO2, severe cell shrinking occurred, suggesting cell membrane 
damage (135,136). 
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This is supported by the results of propidium iodide (PI) staining that showed an increase 
in S. aureus 1.2465 cell membrane permeability from 5% to 69%, using a combination of 350 
MPa and a concentration of 3.8 NL.L-1 of dissolved CO2, however, no cell disruption was observed 
(Table 1.3) (136). 
Using acridine orange, it was seen that almost all S. aureus ATCC 25923 cells were stained 
orange due to little membrane permeabilization and only at pressures above 404 MPa 
fluorescence decreased slightly (137). Using Live/DEAD Baclight Bacterial Viability kit and 
fluorescent microscopy to assess membrane integrity of S. aureus cells pressurized between 200 
to 400 MPa, the number of red cells (dead cells or cells with damaged cell membrane) increased 
with increasing pressures but remained very close to the number of green cells (live cells or cells 
with intact cell membrane), which decreased slightly even at 400 MPa (135). However, with 
increasing pressures from 200 to 400 MPa, changes in membrane properties were caused: 
disruption or increase in membrane permeability, loss of membrane integrity, denaturation of 
membrane-bound proteins, and pressure-induced phase transition of membrane lipid bilayer 
which led to a subsequent increase in S. aureus cell volume at pressures mainly above 400 MPa 
(138–140). Furthermore, due to the phase transition of membrane lipids at temperatures above 
35 °C bacterial cells become more sensitive (141). 
ii) Ribosomes and cytoskeleton 
Another important target site are the ribosomes (Figure 1.2). Generally, HPP causes 
subunit dissociation in microorganism ribosomes, limiting cell viability (142,143) by inhibiting 
protein synthesis (124,144). In fact, cell death and ribosome injury are closely related events 
(143). Using differential scanning calorimetry (a technique that can be used to evaluate the 
effect of pressure on ribosome denaturation), a correlation between the ribosome-associated 
enthalpy and the loss of cell viability due to pressure treatment (50–250 MPa) was found in E. 
coli cells (143). Comparing the thermograms of unpressurized S. aureus cells with the 
thermograms of pressurized cells at 345 MPa, differences were detected through changes in 
specific peaks (shift to lower temperatures in pressurized cells), which suggest denaturation of 
the ribosome due to pressure treatment (145). 
iii) Other structural and morphological cell changes  
Other morphological and structural changes in microorganisms' cell include the 
detachment of the membrane from the cell wall, the elongation of the cell, the compression of 
gas vacuoles and the condensation of nuclear material (105,129). 
 29 
 
Chapter 1 
S. aureus cells suffered an increase in their volume at pressures above 400 MPa due to 
changes in membrane properties (Table 1.4) (140). Under transmission electron microscope 
(TEM) untreated cells displayed intact cell wall, cell membrane, homogeneous cell cytoplasm 
and electron-transparent regions of nucleoids (Table 1.4) (92). After HPP, at pressures above 
500 MPa, instead of a cell membrane with a single-thick-layer presentation, a double-track 
bilayer structure appeared, the cytoplasmatic material became aggregated, the nucleoids region 
gained a fibrous appearance and became enlarged and the interior regions became compacted 
(92). At lower pressures, the membrane and cell wall preserved its distinct aspect but, at higher 
pressures, the peptidoglycan layer collapsed and pieces of the outer layer seem to be loosened 
(92). 
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Table 1.3 - Efficiency of HPP inactivation of Staphylococcus aureus strains (studies performed using combined effects). 
Study Matrix HPP treatment range HPP Complement Strain Inactivation Range Reference 
1% peptone solution 207 – 345 MPa/ 5 – 10 min/ 25 – 50 °C ST 
485 0.40 – 6.03a 
(146) 
765 0.59 – 8.04a 
Citric acid 
345 MPa/ 5 min/ 35 °C 
pH 4.5 
485 3.47a 
765 4.00a 
pH 5.5 
485 1.78a 
765 2.97a 
pH 6.5 
485 1.58a 
765 2.16a 
Lactic acid 
pH 4.5 
485 4.22a 
765 5.00a 
pH 5.5 
485 2.16a 
765 3.10a 
pH 6.5 
485 1.70a 
765 2.40a 
Pasteurized milk 
345 MPa/ 5 min/ 50 °C 
ST 
485 8.34 
(147) 
765 8.30 
Pasteurized orange juice 
ST 
485 5.50 
765 8.30 
Nisin plus pediocin AcH 
485 8.34 
765 8.30 
Skimmed milk 150 – 300 MPa/ 30 min/ 25 °C ST ATCC 6538 0.50 –  6.00ab (148) 
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Lacticin 3147 2.2 –  6.00ab 
Potassium phosphate buffer 400 MPa/ 15 min/ 20 °C 
ST 
LMMBM14 
3.20ab 
(149)  
Nisin 4.30ab 
Bovine lactoferrin 4.10ab 
Pepsin hydrolysate of lactoferrin 2.80ab 
Lactoferricin 3.10ab 
Pasteurized milk 
345 MPa/ 5 min/ 50 °C 
ST 
485 5.50a 
(111) 
765 8.30a 
Nisin plus pediocin AcH 
485 8.34a 
765 8.30a 
Cream of chicken soup 
ST 
485 5.70a 
765 8.20a 
Nisin plus pediocin AcH 
485 8.30a 
765 8.20a 
Sodium chloride solution 
(0.9% w/v) 
200 MPa/ 60 min/ -20, - 10, -5, 0,  5 and 30 °C 
Without pre-incubation and without 
chloramphenicol 
IFO 13276 
1.60 – 4.70ab 
(150) 
Without pre-incubation and with 
chloramphenicol 
1.50 – 4.90ab 
With pre-incubation without chloramphenicol 1.60 – 2.70ab 
With pre-incubation with chloramphenicol 1.30 – 2.95ab 
Potassium phosphate buffer 250 MPa/ 15 min/ 25 °C 
ST 
ATCC 27661 
0.9a 
(151) 
Hen egg white lysozyme 0.8a 
Goose egg white lysozyme 0.2a 
Cauliflower lysozyme 0.5a 
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Mutanolysin from Streptomyces globisporus 0.1a 
Bacteriophage λ lysozyme 0.5a 
Bacteriophage T4 lysozyme 0a 
Fuet (fermented traditional 
sausage) 
400 MPa/ 10 min/ 17 °C 
ST CTC1008, 
CTC1019 and 
CTC1021c 
0.5dg 
(152) 
Enterocins A and B 0dg 
Phosphate-buffered saline 
193 MPa/ 4x10 min/ -20 °C 
ST 
ATCC25923 
0.70 – 1.10a 
(153) 
Lysozyme 0.90a 
Nisin 0.60 – 0.80a 
McIlvaine citrate-phosphate 
buffer 
ST 0a 
Nisin 0a 
McIlvaine citrate-phosphate 
buffer 193 MPa/ 35+5+10 minh/ -20 °C 
pH 3.5 
ATCC25923 
1.70ab 
(154) 
pH 4.0 1.30ab 
pH 5.0 1.10ab 
pH 6.0 1.00ab 
pH 7.0 0.60ab 
Apple Juice ST 1.30ab 
Fuet (fermented traditional 
sausage) 
400 MPa/ 10 min/ 17 °C 
ST CTC1008, 
CTC1019 and 
CTC1021c 
0.39df 
(155) 
Enterocin AS-48 0.39df 
Luria Bertani 350 MPa/ 10 min/ 30 °C 
ST 
1.2465 
0.90a 
(136) 
CO2 7.90a 
Rice pudding 500 MPa/ 5 min/ 22 °C 
ST 
CCUG 31966, 
CCUG 35601 and 
CCUG 41879c 
2.90d 
(156) Nisin 3.77d 
Enterocin AS-48 3.30 –3.50d 
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Clove oil 1.80d 
Cinnamon oil 1.30d 
Pasteurized milk 400 MPa/ 5 min/ 10 °C 
ST 
Sa9 
0.5ab 
(157) 
Bacteriophages (phiIPLA35 and phiIPLA88) 0.6ab 
ST – HPP single treatment (without complements)  
a log CFU.mL-1 
b Exact values not given; values obtained by estimation using the data reported on graphic 
c Cocktail of strains 
d log CFU.g-1 
f Counts performed 7 days after pressurization 
g Counts performed 1 day after pressurization 
h Total time (35 min of compression plus 5 min of holding time plus 10 min of decompression 
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iv) Proteins  
Generally, HPP can cause a wide range of effects on proteins that can go from minor 
conformational effects to the loss of native folding (Figure 1.2), dissociation of monomers in 
multimeric proteins (Figure 1.2), or even precipitation and aggregation, which depends on the 
protein type and processing conditions being usually reversible at pressures between 100 and 
300 MPa and irreversible at pressures higher than 300MPa (99,158). Protein covalent bonds are 
not affected by HPP, but non-covalent bonds (ionic, hydrophobic and hydrogen bonds) are 
affected (103,130). For example, primary structure is minimally affected by HPP (128). However, 
proteins will suffer changes in their secondary, tertiary and quaternary structures, which will 
affect membrane proteins and some enzymes (99,128). 
Due to protein denaturation, the inactivation of key enzymes is to some extent 
responsible for the inhibitory effects of HPP on microorganisms (124). The way to which 
enzymes are affected is, however, not linear and bacterial enzymes diverge greatly in their 
capability to resist pressure (105). Changes in the active centers of enzymes are mainly due to a 
change in their conformation (unfolding and, more difficultly, denaturation), which might be 
irreversible (134). 
Denaturation of monomeric proteins, such as S. aureus SE may occur at extreme pressures 
but, generally, they do not show any changes in proteolysis (99,144). The effect of HPP on 
monomeric proteins is of special importance for S. aureus since SE appear to be highly 
piezotolerant monomeric proteins (83,84,159). Using enzyme immunoassays (EIA) to monitor 
the reactivity of suspensions of SEA to SEE it was observed that HPP treatments up to 800 MPa 
had no effect on the reactivity of SE at temperatures of 5 and 20 °C (159). Only at 80 °C a 
decrease in SE reactivity was observed (159). On the other hand, after pressurization at 600 
MPa, SEA suspension was still able to induce a proliferative activity on rat thymocytes and, by 
increasing the temperature from 20 °C to 45 °C, the proliferative response to SEA by T-cells was 
significantly induced (ρ < 0.05) when compared to unpressurized SEA and SEA pressurized at 20 
°C (160). Although the effect of HPP on proteic virulence factors is of high importance, studies 
are still scarce. 
v) Lipids 
Lipid systems are extremely sensitive biological constituents to HPP (161), due to their 
hydrophobic nature (162). In biological membranes, lipids are the backbone, appearing as a 
lamellar phospholipid bilayer matrix (163). HPP affects membrane phospholipids by reducing 
the curl and straightening acyl chains, causing lateral shrinkage and an increase in its thickness 
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(Figure 1.2) (164). During compression, above 27 MPa, the phospholipids from the membranes 
are compressed, favoring the passage from the liquid-crystalline phase into a gel state (Figure 
1.2) and, during decompression, the dual layer conformation is lost allowing the development 
of pores which will cause cytoplasmic leakage (130,131). Random movements of the 
phospholipid acyl chains caused by HPP cause water molecules to infiltrate between the 
hydrophilic phospholipid head groups and into the bilayers (165). 
In S. aureus IFO 13276, barotolerance increases when cells are able to adapt to lower 
temperatures (150), and also in bacteria with high unsaturated and saturated fatty acids ratio in 
membranes (164). 
vi) Nucleic acids 
Although no papers were found describing the effects of HPP in S. aureus nucleic acids, it 
is important to discuss the effect of HPP in nucleic acids. Nucleic acids are exceptionally resistant 
to HPP denaturation and their structure can remain undamaged at pressures up to 1000 MPa 
(124,166). Deoxyribonucleic acid (DNA) is extremely stable due to α-helical structures which are 
supported by hydrogen bonds (124,128). However, because enzymes are affected by HPP, DNA 
replication and transcription mechanisms, as well as protein translation, are inhibited (167). 
Another effect of HPP, although indirect, is the exposure of DNA to endonucleases that under 
normal circumstances would not be in contact with DNA (168). Nonetheless, the effects of HPP 
on DNA are exceptionally complex. An increase in pressure causes the release of counter ions, 
disrupts stacking interactions, increases the resistance of double-stranded helix (due to the 
stabilization of DNA hydrogen bonds) which leads to the denaturation into single strands and 
induces the transition of double helices from the B to Z form (165). 
1.2.1.2. Bacterial strain dependence  
Sensitivity to HPP is also dependent of the strains of a species (133,169). S. aureus follows 
this rule and different strains exhibit different degrees of resistance to HPP, with some strains 
able to present different D values (time in minutes necessary to kill 90% of the microbial 
population at determined temperature and pressure) under the same HPP conditions, such as 
the difference between the strain 485, which has a D value of 2.55 min, and the strain 765, which 
has a D value of 0.62 min (Table 1.4) (141), being the former strain more resistant than the latter 
(Table 1.3 and Table 1.4) (112,141,147). 
These differences, which can be more or less higher, can be the result of inherent 
characteristics of each strain such as the carotenoids produced by S. aureus which function as 
antioxidants, protecting S. aureus against oxidative stress and stabilizing the membrane during 
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infection and pathogenesis (170–172). Different S. aureus strains produce different quantities 
of carotenoids which seem to be important for the resistance to HPP, as observed on a number 
of studies in which authors were able to relate differences in carotenoid content with HPP 
resistance,
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Table 1.4 - Efficiency of HPP inactivation of Staphylococcus aureus strains (studies performed using only HPP). 
Study Matrix HPP treatment range Strain Inactivation Range Da and zb values Reference 
Pork slurry 101 – 608 MPa/ 10 min/ 25 °C ATCC 25923 0.10 – 6.30fg - (137) 
Whole cow’s milk 50 – 350 MPa/ 4 – 12 min/ 20 °C ATCC 27690 0.10 – 8.61dg 
D200 MPa/20 °C – 211.8 
D350 MPa/20 °C – 15.0 
D300 MPa/20 °C – 3.7 
D350 MPa/20 °C – 2.56 
(173) 
1% Peptone Solution 345 MPa/ 5 – 15 min/ 25 – 50 °C 
315 0.90d - 
(141) 
485 0.70 – 8.11d D50°C -2.55 
565 1.12d - 
582 7.80d - 
743 0.86d - 
765 1.51 – 2.70d D50°C - 0.62 
778 0.70d - 
Ovine milk (6 % fat) 200 – 500 MPa/ 5 – 15 min / 2, 10, 25, 50 °C CECT 534 0.10 – 7.30dg 
D450 MPa/2 °C – 20 
D450 MPa/25 °C – 16.7 
(174)) 
Ringer Solution 
400 – 500 MPa/ 15 min/ 4, 25, 50 °C CECT 534 
3.30 – 7.50dg - 
(175) 
Ovine milk (0, 6, 50% fat) 0.50 – 7.10dg - 
Cheddar cheese slurries 100 – 800 MPa/ 20 min/ 10, 20, 30°C 
ATCC 6538 
0 – 3.00dg 
D300 MPa/20 °C – 38 
D350 MPa/20 °C – 33 
D400 MPa/20 °C – 20 
Z - 359 (176) 
Miniature cheeses 
100 – 500 MPa/ 20 min/ 20°C 
0 – 4.3dg - 
Phosphate buffer 0.1 – 7.0dg - 
TSBY 345 MPa/ 10 min/ 35 °C 
485 2.50d - 
(112) 
765 3.10d - 
TSB 150 – 550 MPa/ 1x15, 3x5, 5x3, 7x2 min/ 20 °C 
ATCC 6538 
0 – 8.9d - 
(177) Sturgeon caviar 
450 – 500 MPa/ 1x15, 3x5 min/ 20°C 
3.50f - 
Trout caviar 3.66f - 
UHT whole milk 
600 MPa/ 4 min/ 4 – 45 °C 
ATCC 12600 
4.00 – 4.30d - 
(178) 600 MPa/ 8 min/ 4 – 45 °C 5.70 – 8.40d - 
600 MPa/ 10 min/ 4 – 45 °C 7.40 – 8.30d - 
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Apple juice 
250 – 350MPa/ 5 – 30 min/ 
30 –40°C 
485 
1.40 – 8.2d - 
(179) 
Orange juice 0.94 – 8.2d - 
Apricot juice 1.26 – 8.2d - 
Sour cherry juice 0.56 – 8.2d - 
Tryptone saline solution 
500 MPa/ 30 – 90 min/ 20 – 25 °C 
c 
1.27 – 5.28d - 
(180)) 
500 MPa/ 30+60, 60+90, 30+60+90 min/ 20 – 25 °C 6.86 – 8.28d - 
0.1% peptone water 200 to 400 MPa/ 5 min/ 40 °C 485 0.07 - 3.24d - (140) 
Human milk 
500 MPa/ 6x0.5, 3x10, 6x5, 2x30, 3x30 min/ 20 – 25 
°C 
ATCC 6538 0 – 6.63d 
DTSA – 4.88 
DBPA – 5.72 
(181) 
ATCC 6538 6d 
DTSA – 5.23 
DBPA – 5.37 
0.1% peptone solution 
ATCC 25923 6d 
DTSA – 5.85 
DBPA – 5.08 
ATCC 25923 6d 
DTSA – 5.85 
DBPA – 5.08 
Sliced cooked ham 
600 MPa/ 6 min/ 31 °C 
CTC1008, CTC1019 and 
CTC1021h 
1.1f - 
(182) Sliced dry cured ham 0.5f - 
Marinated beef loin 2.7f - 
Whole liquid egg 200 – 400 MPa/ 3 – 15 min/ c c 0.92 – 2.63d - (183) 
Sterile raw milk 100 – 500 MPa/ 10 – 50 min/ 25°C ATCC 29213 5.04dg – 7.84dg - (92) 
Sodium Phosphate 
500 MPa/ 8 min/ c SH 1000 
0.43 – 3.8d - 
(184) 
DMG (sodium 3,3-dimethyl glutarate) 0.48  – 4.2d - 
4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid (HEPES) 
1.25dg - 
MOPS (morpholinepropanesulfonic acid) 0.45g – 0.65dg - 
Tris Buffer 0.40g – 1.0dg - 
Non-food emulsion model 500 MPa/ 10 min/ 20 °C ATCC 6538 6.39d - (185) 
Marinated and dehydrated beef strips 550 MPa/ 2 x 1 min/ 22 °C ATCC 25923 8d 
DTSA – 2.12 
DBPA – 2.45 
(186) 
a Decimal reduction time (time in minutes necessary to kill 90% of the microbial population at a certain temperature and pressure) 
b Pressure increase required to accomplish an 1 log cycle reduction in the D value 
 39 
 
Chapter 1 
c Absent information 
d log CFU.mL-1 
f log CFU.g-1 
g Exact values not given; values obtained by estimation using the data reported on graphic  
h Cocktail of strains 
i log CFU per strip 
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i.e., strains with higher carotenoid content are more resistant than strains with lower carotenoid 
content (Table 1.4) (187). 
Other factors include the sigma B (σB) factor (recognized as an important factor for the 
resistance of S. aureus to heat, pulsed electric fields treatments, as well as to chemical agents). 
It controls the carotenoid production along with other detoxifying products such as catalases, 
as seen when comparing the Newton strain (which contains the σB factor) with its isogenic 
mutant (without the σB factor), being the shoulder duration (time during which the membrane 
is able to maintain its integrity and functionality) of the first one much higher than the last one 
(187,188). 
1.1.2.4. Influence of matrices 
The effectiveness of HPP is also dependent on the composition and properties of the 
matrix, with pH and water activity (aw) being of high importance (105,122). Concerning the 
properties of the study matrix, it is reported that some food elements such as proteins, 
carbohydrates, and cations can have a protective effect on microbial cells, which makes the 
inactivation data obtained in studies performed in buffers or medium culture not directly suited 
to be extrapolated to real food situations (105,128).  
Several studies have been done in order to compare different study matrices to determine 
their effect on the efficiency of the inactivation of S. aureus by HPP. In fact, it is possible to see 
that some food matrices have indeed a protective effect whilst others aid the effects of HPP. For 
example, the baroprotective effect of milk and other dairy products is widely recognized. In a 
study performed with S. aureus strain CECT 534 in Ringer solution and ovine milk containing 
several percentages of fat content (0, 6 and 50%), it was clear that inactivation rates were higher 
in Ringer solution, followed by 0% fat ovine milk, 6% and 50% fat ovine milk (Table 1.4) (175). In 
this study, it was possible to observe the baroprotective effect of milk not only due to its fat 
content but also due to the presence of calcium ions and protein content (175,189–191). This 
baroprotective effect was also seen in S. aureus CECT 534 (Table 1.4) which was more sensitive 
in phosphate buffer than in miniature Cheddar cheese and cheese slurry system (176). However, 
when S. aureus inactivation by HPP was tested in human milk, the baroprotective effect was 
absent and D values were slightly or considerably inferior (e.g. D values for ATCC 6538 were 4.88 
min for human milk and 5.23 min for 0.1% peptone solution), depending on the strain, most 
likely due to the fact that human milk is known to have many antimicrobial elements that acted 
as a synergistic effect (181).  
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The baroprotective effect of matrices with low aw (130) was observed in a study done with 
sliced cooked ham, sliced dry cured ham and marinated beef loin, given that the highest 
inactivation of a S. aureus cocktail (strains CTC1008, CTC1019 and CTC1021) resulting in higher 
inactivation in beef loin, followed by sliced cooked ham and finally, dry cured ham had the 
lowest inactivation (Table 1.4) (182). These results correlate with the different aw of these 
products (marinated beef loin > sliced cooked ham > sliced dry cured ham). Moreover, when 
comparing a ham model system with phosphate buffer it was observed that D values were 
higher for the food model, being these values of 18.6 and 7 min, respectively, for 450 MPa (192). 
Studies also show that HPP inactivation is dependent of the study matrix pH. This is clear 
when the inactivation of a relatively resistant strain of S. aureus 485 was tested in different fruit 
juices (Table 1.4) and results show that the lowest inactivation occurred in apricot juice (pH 3.80; 
5.00 log CFU·mL−1), followed by orange (pH 3.76; 5.37 log CFU·mL−1) juice and, the highest 
inactivation was obtained for sour cherry juice (pH 3.30; 5.70 log CFU·mL−1) (179). However, the 
baroprotective effect of food matrix is not evident when, under the same HPP conditions, the 
inactivation of S. aureus ATCC 6538 is tested in samples of sturgeon caviar, trout caviar and in 
tryptic soy broth (TSB). Results showed that the three different matrices did not affect the 
efficacy of HPP, with total inactivation for TSB and almost full inactivation for both caviar 
samples, making this technology suitable for the treatment of caviar (177).  
The choice of the buffer used in HPP assays is also of high importance. This is seen in a 
study using five different buffers (two anionic, two zwitterionic and one cationic) with results 
(Table 1.4) showing that the inactivation of S. aureus SH1000 in zwitterionic buffers and cationic 
buffer (reduction of between 0.4 and 1.4 CFU·mL−1) was much lower than that of the cationic 
buffers (reduction of between 3.8 and 4.2 log CFU·mL−1), most likely due to the fact that the last 
one is more pressure sensitive (with HPP causing a pH decrease) and the first ones are pressure 
stable (184).  
The results show that not only HPP can be quite effective inactivating S. aureus in low fat 
products, in products with acidic pH and with high water activity but also that the study matrix 
holds a strong influence in its effectiveness. Nonetheless, in order to apply HPP to food products 
not yet studied, new studies must be performed. 
1.1.2.3. Microbial growth phase 
The efficacy of HPP depends on the growth of the culture, with cells in the exponential 
phase more sensitive than cells in the stationary phase (122,124,176). In fact, bacterial cells in 
the exponential phase exhibit longer shoulders than cells in the stationary phase (187). For S. 
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aureus cells, the σB factor is likely to be involved in the differences of resistance in stationary 
and exponential phases since this factor, which is responsible for the control of 251 genes 
including stress resistance genes, is mainly expressed in the beginning of the stationary phase 
(187). This is supported by comparing the duration of the shoulder of S. aureus Newton strain 
and its isogenic mutant without the sigB operon (IK 184), showing that the deletion of the σB 
factor decreased significantly the shoulder length (187). Nonetheless, within the same strain, 
the extension of the effect of HPP is not only dependent of the growth phase but also by HPP 
processing parameters. 
1.1.2.5. HPP processing parameters 
i) Pressure value 
The effectiveness of HPP in the inactivation of bacteria depends highly on the pressures 
used (130). Under the same temperature and pressurization times, increasing pressures usually 
in- crease microbial inactivation, as it is observed in most studies with S. aureus (Table 1.4). As 
consequence, D values decrease with increasing pressures, such as D values obtained for a 
barotolerant strain of S. aureus in a ham model, which decreased from 18.6 min at 450 MPa to 
1.3 min at 660 MPa (192). In S. aureus 485, both average cell volume and average cell view area 
also increased with increasing pressures (Table 1.4) (140). Furthermore, for the same S. aureus 
strain, at pressures up to 250MPa cells did not exhibit significant changes in their surface and 
shape but, at pressures higher than 300 MPa, cell surface lost its smoothness and became 
irregular and fractured (135). 
ii) Temperature 
Processing temperature conditions the efficiency of HPP in bacteria. At temperatures 
between 20 and 35 °C, S. aureus 585 cells are not as sensitive to HPP as they are above 35 °C, as 
a result of the phase transition of membrane lipids (146). Bacterial cells previously subjected to 
other stress conditions such as sub-lethal heat or cold shock (due to the increase on the 
percentage of polyunsaturated fatty acids in cell membranes become more resistant to 
pressure, as studies with E. coli (129). For S. aureus IFO 13276 (Table 1.4), this is also valid since 
by adapting itself to low temperature it increased, as a consequence, its barotolerance (150). 
Maintaining the same pressure and pressurization time, higher inactivation is achieved by raising 
temperature (Table 1.3 and Table 1.4), meaning that D values become lower as it was the case 
of S. aureus CECT 534 (Table 1.4), at 450 MPa, with D values decreasing from 20 min at 2 °C to 
16.7 min at 25 °C (174). A similar behavior was observed in the case of a barotolerant strain of 
S. aureus, at 400 MPa, with D values decreasing from 2.15 min at 45 °C to 1 min at 50 °C (193). 
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Nonetheless, at 600MPa, using low pressurization times, increasing HPP temperatures seems to 
have limited effect as seen on S. aureus ATCC 12600 (Table 1.4), for which reductions were very 
similar for 4 °C, 21 °C and 45 °C using 4 min and, only at pressurization times of 8 min, the 
temperature effect became visible (178). 
iii) Holding time 
HPP efficacy also depends highly on the holding time (130), i.e., using higher holding times 
usually increases the efficiency of the process. Inactivation values for S. aureus CECT 534 (Table 
1.4) using pressures of 500 MPa at 25 °C increased from approximately 1.7 log CFU·mL−1 at 
holding times of 5 min, to approximately 2.2 log CFU·mL−1 at holding times of 10 min, and to 
approximately 3.2 log CFU·mL−1 at holding times of 15 min (174). The increase in inactivation 
with increasing holding times is widely de- scribed in other studies (Table 1.3 and Table 1.4). 
However, in some studies, differences between S. aureus inactivation is not always significant 
by increasing holding time, such as the results achieved for liquid whole egg, in which at 370 
MPa (Table 1.4), results showed an inactivation of 2.34 log CFU·mL−1 at 5 min and of 2.47 log 
CFU·mL−1 at 15 min (183).  
Pressure can be applied either in a continuous way or using cycles (pulsed HPP treatment), 
with this last approach resulting in higher inactivation. This is the case for S. aureus ATCC 6538 
(Table 1.4) which showed an inactivation of 1.9 log CFU·mL−1 when it was pressurized at a 
continuous holding time of 15 min, while the inactivation increased to 2.2 log CFU·mL−1 when 3 
cycles of 5 min are applied and to 4.15 log CFU·mL−1 when 5 cycles of 3 min are applied (177). 
The same pattern was described in another study (Table 1.4), using a pressure of 500 MPa, with 
a reduction of 4.28 log CFU·mL−1 for 60 min and, using 2 cycles of 30 min, the reduction increased 
to 5.89 log CFU·mL−1, while using 6 cycles of 5 min or 3 cycles of 10 min, inactivation was higher 
than 6 log CFU·mL−1 (180). 
iv) Compression and decompression rates 
Results achieved from studies relating to compression and decompression rates are 
scarce and conflicting (194). In microbial cells and spores, slow compressions might be able to 
cause stress responses turning HPP much more efficiently and fast decompressions might lead 
to higher inactivation due to a fast adiabatic expansion of water (114,195). In S. aureus and E. 
coli the combination of fast compression and slow decompression is reported to cause higher 
inactivation rates when compared to the opposite (194,195). However, it has also been 
described for L. innocua that inactivation rates are not affected by using either combinations 
(i.e., fast compression with slow decompression and slow compression with fast decompression) 
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over the other (196). For S. aureus ATCC 6538, inactivation in skimmed milk and tris buffer was 
more effective using fast compression (33MPa/s) with medium decompression (28 MPa/s) 
(mainly due to mechanical injuries that occurred during pressure change in fast compression 
and in slower decompression due to the extension of the process time after pressurization since 
cells were already more sensitive because of pressure holding time) and in orange juice the 
inactivation was effective independently of the combinations used (194). In E. coli, the high 
effectiveness of fast compression seems to be related to the adiabatic heating during 
compression while the high effectiveness of slow decompression seems to be associated with 
the extension of processing time (194). 
1.1.2.6. Antimicrobials 
In order to increase HPP efficiency, antimicrobials such as bacteriocins, lysozyme, chitosan 
or essential oils can be used in combination with HPP (130). Depending on the antimicrobial 
used, the synergistic effect can be inexistent, small or high. In S. aureus ATCC 6538 (Table 1.3), 
the use of only HPP treatment at pressure 250 of MPa caused a reduction of 2.2 log CFU·mL−1 in 
skimmed milk but, by using the same pressure along with lacticin 3147, full inactivation (> 6 log 
kill) was achieved (148). In S. aureus LMMBM14 (Table 1.3), the synergistic effect between HPP 
and nisin and between HPP and bovine lactoferrin was observed, with one extra log of 
inactivation when compared to HPP alone, but there was no synergistic effect using pepsin 
hydrolysate of lactoferrin or lactoferricin with HPP (149). The use of HPP with a cocktail of two 
bacteriocins (nisin and pediocin AcH) caused full inactivation of S. aureus 485 (Table 1.3) in 
chicken soup cream compared to an inactivation of 5.7 log CFU·mL−1 using only HPP (111). The 
enterocin AS-48 shows no synergistic effect when used in a S. aureus multi-strain cocktail (CTC 
1008, CTC 1019 and CTC 1021) inoculated in a fuet (fermented traditional sausage) (Table 1.3) 
(155). Using lysozyme as an antimicrobial (Table 1.3), only hen egg white lysozyme seems to 
have a small synergistic effect in S. aureus ATCC 27661, when compared to the synergistic effect 
of goose egg white lysozyme, or with cauliflower lysozyme, or with mutanolysin from 
Streptomyces globisporus, bacteriophage λ lysozyme and bacteriophage T4 lysozyme (151).  
Nonetheless, the synergistic effect seems not only dependent of HPP conditions but also 
of the strains used and study matrices. This was observed when the synergistic effect of nisin 
was tested (193 MPa for 4×10 min at -20°C) in S. aureus ATCC 25923 and results show that in 
phosphate-buffered saline (pH 7.0) nisin in combination with HPP was unable to cause 
bactericidal effect on ATCC 25923 cells (Table 1.3), however there was a synergistic effect in 
McIlvaine citrate-phosphate buffer (pH 5.0) (154). 
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Oils such as clove oil and cinnamon oil (Table 1.3) are also described as possessing 
synergistic effect, causing an increase in HPP inactivation when compared to HPP treatment 
alone (156).  
Bacteriophages (Table 1.3) can also be used and, although no synergistic effect was 
detected after HPP treatment in S. aureus Sa9, after 48 h the combination of HPP with the phage 
cocktail led to complete inactivation (approximately 9 log CFU·mL−1), most likely due the fact 
that HPP sub-lethally injures the cells of S. aureus which become easier to be infected by the 
bacteriophages (157). 
1.1.2.7. Staphylococcus aureus resistance to HPP  
Food preservation methods apply one or more environmental stresses in foodborne 
bacteria in order to avoid or slow its growth (197). As response, stressed foodborne bacteria can 
react by adapting phenotypically or genotypically (197). Phenotypically, when wild type colonies 
of S. aureus were compared with colonies of a baroresistant sub-population (obtained by 
subjecting the original bacterial suspension to HPP treatments), these mutants presented a 
weak growth, small sized colonies, weak agglutination reactions, weak coagulation with small 
clumps, defective production of staphyloxanthin, identical hemolysis to wild type, higher 
susceptibility to tested antibiotics and diminished capability to invade the Caco-2 human colon 
adenocarcinoma cells, but possess, however, increased thermotolerance and barotolerance 
(reductions lower than 0.8 to 2.8 log CFU·mL−1 when compared to the wild type) (198). 
Genotypically, protection against the effects of HPP can be granted by mutations in regulators 
that are responsible for the repression of specific groups of stress-response genes (199). The S. 
aureus σB factor is a regulator responsible for the expression of several genes, at least 251, 
encoding virulence factors and stress-response proteins, and its activity is maximum in the 
stationary phase of growth (200,201). In S. aureus, the deletion of the sigB gene (IK 184 strain), 
which encodes σB, causes a reduction in the resistance to HPP when compared to the parental 
strain (Newton strain) (187). Hence, since S. aureus has the ability to adapt both phenotypically 
and genotypically, these fitness characteristic might be the reason why this species is highly 
resistant to HHP. 
1.1.2.8. Recovery of damaged cells 
HPP causes death to a cell when the damages inflicted surpass the capability to repair its 
damages (130). However, HPP may not always fully inactivate bacteria and might only cause 
injuries to the cells (202). Bacteria can recover from injuries under certain conditions which 
makes this ability extremely important from the food safety point of view since the recovery of 
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bacteria during storage has been described in several studies. For example, L. monocytogenes 
treated by HPP increases the expression of genes related to the repair mechanisms of DNA, 
protein complexes of transcription and translation, the septal ring, the system of general 
translocase system, flagella assemblage and chemotaxis, and lipid and peptidoglycan 
biosynthetic pathways (203).  
The ability to repair the damages in bacterial cells after HPP is very important to avoid an 
overestimation of HPP inactivation (202). Usually, assessing the recovery of S. aureus after HPP 
involves the use of non-selective media [such as tryptone soya agar (TSA) or brain heart infusion 
(BHI)] and selective [such as media supplemented with NaCl or Baird-Parker agar (BPA)].After 
HPP, S. aureus cells, and other bacterial cells, can present 3 possible states (202): 
i. Active cells - colonies are formed on both non-selective and selective agar; 
ii. Primary injury - structural damages like cell wall and/or cell membrane injury; colonies 
are formed on non-selective agar but not on selective agar, however they can grow much 
more slowly in this last medium; 
iii. Secondary injury - metabolic injuries; no colonies are form in either non-selective or 
selective agar, however, colonies might appear after a long period of storage first on non-
selective agar and later on selective agar.  
From pressures between 350 and 550 MPa, S. aureus is thought to suffer secondary injury 
after HPP treatments, which poses the need for studies to be done over longer periods of time 
in order to detect the possible repair of secondary injured cells to primary injured or to active 
cells (202). D values might be different when the recovery is done in selective and non-selective 
and, depending of the study matrix, these values might be higher in the selective media or the 
other way around. This is observed when the same barotolerant strain of S. aureus is pressurized 
in a food model at 450 MPa, with D values of 26.4 min for the selective media (BPA) and of 18.6 
min for the non-selective media (BHI agar), while the opposite occurs in phosphate buffer (20.2 
and 21.2 min for BPA and BHI agar, respectively) at 350MPa (192,193). 
Given that HPP inactivation effectiveness also depends on the study matrix, the recovery 
of cells is also dependent of the study matrix as it can be observed that when HPP is performed 
in sterilized skimmed milk, orange juice and tris buffer solution, S. aureus ATCC 6538 cells can 
recover or at least maintain some viability when stored at 4 °C for 15 days in all tested matrices 
except in orange juice in which no viability was observed after 7 days of storage, most likely due 
to the acidity of the matrix (204). When using meat products as study matrix, after an initial 
inactivation caused by HPP, levels of a cocktail of S. aureus strains were able to remain constant 
during 120 days of storage at 4 °C in beef loin and in dry ham, however, in cooked ham, levels 
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decreased over storage and counts were lower than 1 log CFU.g−1 at the end of the 120 days 
(182). In a non-food emulsion model, S. aureus ATCC 6538 were unable to recover after being 
fully inactivated by HPP past 180 days of storage at room temperature (185).  
The recovery of S. aureus is also dependent of the strain and of the conditions in which 
they recover, since some strains that are able to grow under non-stressful conditions are unable 
to grow under stressful (such as in BHI with different concentrations of NaCl, NaNO2, or 
potassium lactate and in BHI at different levels of acidity), conditions whilst others that are able 
to grow under non-stressful conditions are also able to grow under stressful conditions (205). S. 
aureus 485 and 765 are able to recover in chicken soup cream with a cocktail of two bacteriocins 
(nisin and pediocin AcH) after a 5 day storage at 25 °C, even though full inactivation had been 
achieved after HPP treatment, and at the day 9 of storage levels of viability were higher than 
the unpressurized sample (111). In cooked ham with nisin and nisin plus potassium lactate 
treatment levels of S. aureus decreased differently (ρ < 0.05) over 90 days storage after HPP 
treatment, showing that cells were not only unable to recover but also that the effect of the 
antimicrobials was effective during the whole storage period (113). In fact, nisin (Table 1.3) is 
reported to avoid the recovery of a cocktail of S. aureus strains while in storage (113,156,206). 
1.1.2.9. HPP inactivation kinetics 
The study of HPP inactivation of microbial cells and spores has produced survival curves 
that were modelled by mathematical functions aiming to describe adequately and accurately 
the inactivation kinetics (207).Although these models have been previously mainly used in 
thermal inactivation they have been adapted for HPP inactivation. Therefore, this subject will be 
interchangeably approached giving priority to HPP inactivation kinetics of S. aureus when 
information is available. By applying accurate inactivation kinetics, both the bactericidal effect 
of HPP and the implementation of safe processing conditions become possible (135,206,208), 
while a thorough knowledge of inactivation kinetics would ideally assure a decisive application 
of HPP (187).  
Kinetic models are mainly used to mathematically quantify microbial inactivation data 
achieved in HPP experiments (usually isothermal), using different processing parameters such 
as pressure, temperature and/or time (110).When microorganisms are exposed to HPP, or to 
other lethal food processing technologies, the concentration of survivors decreases with 
increasing processing parameters (209). Most often, the inactivation of microorganisms follows 
first-order kinetics (also known as the log-linear model), which means that, over time, all cells 
would have the same sensitivity and probability of dying over pressure treatments (135,209–
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211). In a simple explanation, for cells treated with HPP, the logarithm of the surviving cells is 
plotted against time, producing a straight line (209). From this model one can calculate the D 
value, which is the time, usually in minutes, needed to decrease the number of microorganisms' 
cells by a factor of 10 (usually indicates as one log or decimal reduction of the number of 
microorganisms) and it is used as a measure of the microorganism resistance to HPP (209). From 
the temperature dependence of D value the “z-value”, which is the temperature interval at 
which D value will decrease or increase by a factor of 10, can be determined (212). However, 
although first-order kinetics adequately describes many cases of thermal and HPP 
microorganisms’ inactivation, the many exceptions to this model rendered it to be an exception 
rather than the rule. Consequently, over the last 25 years, nonlinear models for inactivation data 
appeared as a preferable alternative (187,207,210,211,213–215).  
The use of nonlinear models is the result of important deviations from linearity due to the 
display of curves with a shoulder (downward concavity), tailing (upward concavity) and sigmoid 
shape (it begins with an upward concavity and finishes with a downward concavity or vice versa) 
(216). The shoulder phenomenon is the period in the beginning of the survival curve in which no 
measurable inactivation takes place after pressure application (217). The tailing phenomenon 
can be described as the stabilization at the end of a survival curve after an initial linear decrease 
due to the existence of a pressure resistant population in a culture, by the effects of 
experimental conditions, or cell-age distribution (110,218). When in rare cases both phenomena 
occur, survival curves with sigmoid profiles appear (187).  
In fact, the complexity of effects of HPP treatments in microbial cells makes HPP 
inactivation difficult to follow first-order kinetics. Nowadays, it is accepted that nonlinear 
inactivation kinetics models explain the majority of pressure inactivation curves (207). The most 
commonly used nonlinear models in HPP inactivation kinetics include the Weibull (219), 
modified Gompertz (220), log-logistic (221), and the Baranyi (222) models. The use of these 
models assumes the existence of differences in the survival time due to differences in individual 
cells (209) and yields several independent parameters that allow the characterization of shapes 
as well as the response of the cells in relation to time (207). Even though first-order kinetics is 
not always followed, there are numerous studies where D and z values are calculated by using 
first-order kinetics models (211). This is true for many published papers concerning S. aureus 
inactivation by HPP (Table 1.4) and so, in this section only papers which refer and/or compare 
other models will be approached.  
Chen (2007) (210) fitted the inactivation data of S. aureus (strain 210) in UHT whole milk 
at two different conditions (21.5 °C/600 MPa and 50 °C/500 MPa) with linear, Weibull, and log-
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logistic models and computed their mean square error (MSE; smaller values of MSE indicate a 
better fit of the model to the data) values were computed. For the condition 21.5 °C/600 MPa 
the log-logistic model (MSE=0.3) allowed a more accurate description of the inactivation of S. 
aureus, followed by the Weibull model (MSE = 0.7). For the condition 50 °C/500 MPa both the 
log-logistic model and the Weibull model allowed an adequate description of the inactivation of 
S. aureus with a MSE value of 0.2. For both conditions, the linear model presented higher MSE 
values (1.7 for 21.5 °C/600 MPa and 2.4 for 50 °C/500 MPa), showing that this model should not 
be used to describe S. aureus inactivation under these conditions. Cebrián et al. (2010) (187) 
studied HPP inactivation kinetics of eight S. aureus strains under different conditions (pressures 
between 350 and 600 MPa and holding times up to 60min) and fitted the Baranyi model to the 
inactivation curves, since the study aimed to analyze different phases of inactivation (shoulders, 
log-linear phase of inactivation and tails). The Baranyi model allowed the authors to describe 
accurately these phases and consequently to separately correlate each phenomenon with the 
mechanisms of inactivation. In the study of Tassou et al. (2007) (192), HPP inactivation kinetics 
of a HPP resistant strain of S. aureus was examined in different matrices (phosphate buffer and 
ham model system). Although the log-linear model was applied to determine D and z values, the 
Baranyi's model was fitted to the ratio log10(N/N0) for the estimation of the death rate constant, 
the standard error of fit and the correlation coefficients. The authors observed an apparent first-
order kinetic behavior for both matrices, but the inactivation data was better described by the 
Baranyi's model. Guan et al. (2006) (178) studied HPP inactivation kinetics in S. aureus (ATCC 
12600) at different process temperatures in UHT whole milk. By examining the survival curves 
they observed that the linear model was unsuitable to describe the obtained survival curves and 
so they fitted the data to three nonlinear models (Weibull, log-logistic and modified Gompertz) 
and computed their MSE. The modified Gompertz model was more appropriate to describe the 
inactivation of S. aureus at processing temperatures of 4 and 21° C, while the Weibull model was 
more appropriate at 45 °C. The Weibull model was also successfully applied to describe the 
survival curves of S. aureus (strain 485) in carrot juice and in peptone water (216). In the study 
of Viazis et al. (2008) (181), HPP inactivation kinetics was assessed in two S. aureus strains (ATCC 
6538 and ATCC 25923) in human milk and in peptone water. For the strain ATCC 6538 first-order 
inactivation kinetics was observed. However, due to tailing phenomenon observed for the strain 
ATCC 25923, the investigators fitted the data to the Weibull model, thus demonstrating a much 
higher fit compared with the linear model initially applied. Yao et al. (2015) (206) also achieved 
a good fit of data to the Weibull model for HPP inactivation kinetics in S. aureus (CGMCC 1.1861, 
ATCC 6538) independently of the initial inoculum levels and of the matrix (saline solution or 
meat slurry). Furthermore, the analysis of the shape factors (n) values (a Weibull model 
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parameter), indicated that the survival curves of S. aureus fitted with Weibull model were 
concave upward or tailing (n < 1). 
Hence, although first-order kinetics has been applied to many HPP inactivation kinetics of 
S. aureus, this model, is not always the most adequate. Data should always be fitted to adequate 
and accurate models, so that safer processing conditions can be estimated and assured, thus 
preventing risks by food sub-processing or unnecessary food over-processing, which leads to 
undesirable food quality losses. 
1.3. Concluding remarks 
S. aureus HPP inactivation efficiency depends on several factors resembling a cascade of 
effects rather than being dependent of only one specific factor. Similarly, the inactivation of S. 
aureus, like that of other microorganisms, is a multi-target process. The integrity of cell 
structures (cell membrane, cell wall, ribosomes) and of biomolecules (i.e., proteins and lipids), 
is affected by HPP treatment. Monomeric proteins such as SE are hardly affected by HPP, but 
strains of S. aureus with SE are more efficiently inactivated than those without SE. This resistance 
of SE to HPP is extremely important from the food safety point of view because even though cell 
death can occur SE properties remain unchanged or are enhanced if processing temperature is 
not high. However, if HPP is promptly applied, SE producing cells will be efficiently inactivated 
and will not be able to produce toxins.  
When HPP only causes secondary injuries (metabolic injuries), recovery is dependent on 
the matrix and processing conditions used. Matrices such as Ringer solution and phosphate 
buffer cause higher HPP inactivation than more complex ones, which emphasizes the 
significance of using real food in HPP studies to avoid misestimating inactivation. Furthermore, 
because first-order kinetics is not always verified, and moreover pseudo first-order kinetics can 
occur, misleading an adequate fit, HPP inactivation data should always be carefully fitted into 
accurate and suitable kinetic models in order to properly estimate and assure safer processing 
conditions.  
Barotolerance, adaptability to HPP and the ability to recover from HPP are major 
problems from the food safety point of view. Inactivation of S. aureus remains an uncharted 
territory with much more work to be done in order to understand its behaviour in response to 
HPP. 
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Context 
For approximately three billion years the planet Earth has been the home of the most 
diverse group that ever lived, microorganisms (223). Spreading over three domains (Archaea, 
Bacteria and Eukarya) and possessing a huge population size, microorganisms occupy very 
distinct ecological niches. Due to their large genetic diversity their metabolism is also extremely 
diverse. In a simple way, microbial metabolomics is the study of the metabolism of 
microorganisms under a given set of conditions (224). In this chapter, a thirty year old portrait 
of the volatile metabolome of S. aureus will be presented. 
2.1. Concepts and strategies 
To understand the volatile exometabolome of S. aureus, some concepts need to be 
defined as well as its assessment strategies, including the collection methods, detection 
methods and most commonly applied statistical methods. Hence, these themes will be 
approached in the next subsections. 
2.1.1. Metabolome, metabolomics and microbial metabolomics 
The metabolome, was defined for the first time by Oliver et al. (1998), as the 
comprehensive set of metabolites found in a biological cell, tissue, organ or organism, 
representing the end products of cellular processes, which changes accordingly to the 
physiology, development or pathological state of the cell, tissue, organ or organism (225). 
Metabolites are small molecules that offer information related to the cellular state since they 
are chemically dependent of the metabolism, serving thus as an imprint of the biochemical 
activity of the cell, tissue, organ or organism (226). 
 
Figure 2.1 - Cell representation of the four “omics sciences” that constitute the Systems Biology discipline: genomics 
(DNA), transcriptomics (mRNA), proteomics (proteins) and metabolomics (metabolites). 
Metabolomics, along with genomics, transcriptomics and proteomics, (Figure 2.1), is part 
of discipline of a larger discipline called Systems Biology (227). Metabolomics is the study of the 
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metabolome of a cell, tissue, organ or organism under a given set of conditions, i.e., 
metabolomics is the comprehensive analysis in which all the metabolites (or only a part) are 
identified and/or quantified (228).  
Microbial metabolomics studies the complete array (or just a specific part) of metabolites 
belonging to a microorganism and monitors the end result of interactions between its 
development process and the environment, thus providing a precise picture of the real 
physiological state of a microbial cell (224). Although microorganisms are generally simple, 
giving the advantage of being perfect models to develop, apply and validate metabolomic tools, 
making  easier to integrate metabolomic data with the remaining “omics”, microbial 
metabolomics is not an easy field due to the diversity of microbial sort of cells and the existence 
of three different matrices: intracellular space, extracellular space and the culture headspace, 
which are quite difficult to distinguish, making the dive in microbial metabolomics a difficult task 
(229). Furthermore, it is believed that the number of microbial metabolites discovered until now 
is much smaller than the reality (230), especially when only a small fraction (approximately 1%) 
of microorganisms is known, with the remaining 99% belong to the “microbial dark matter” 
(231). 
Microbial metabolomics evaluates the role of microorganisms in disease (of human and 
other animals and plants), bioremediation, compound degradation and the interaction (positive 
or negative) with other organisms (232–236). Furthermore, it gives a picture of the physiological 
state of amicroorganism when this is subjected to specific external factor (such as the presence 
of an antibiotic, the growth in different culture medium, the growth phase and the 
presence/absence of different nutrients) (237–239). Another important application of microbial 
metabolomics is  the discrimination of microbial species and strains, detection of silent gene 
mutations and in the production of biofuels (12,239–247). 
Some microbial metabolites are volatile, granting specific odors to microorganisms (248). 
These metabolites, also known as microbial volatile organic compounds (MVOC) or simply 
volatiles (for easy reading), are produced by microorganisms as by-products of primary and 
secondary metabolisms (240,249), and are characterized by their low molecular weight 
(between 100 and 500 Da), high vapor pressures, low boiling points and lipophilic nature 
(250,251). Volatiles can be fatty acids, hydrocarbons, alcohols, aldehydes, ketones, terpenes, 
norisoprenoids, nitrogen and sulfur compounds (250). Volatiles have the advantage of being 
extracted directly from the headspace of the sample without other chemical processes or 
culturing (252). 
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Even though the potential of microbial metabolomics is enormous, there are some 
technical hurdles that still prevent its efficient applicability, such as the effective quenching of 
cell metabolism when sampling is combined with the separation of intra- and extracellular 
metabolites, the low ratio between microbial cell biomass and extracellular medium, the lack of 
standard and robust protocols that can be applied in different microorganisms and under 
different experimental conditions, the inexistence of a unique analytical method able to detect 
and identify the whole metabolome of a cell, the identification of microbial secondary 
metabolites, the characterization of new ones and finally their association with specific 
metabolic pathways is still slow process (229). Furthermore, because metabolomic analysis 
express the significance of changes in metabolite abundances (even the non-existence), it must 
be guaranteed that the intensity of each metabolite can be directly matched to the intensity of 
the metabolite in question in another sample, which can be, for example, a blank medium 
control (negative control) (228). 
2.1.2. Strategies to study microbial metabolomics 
Other than the primary concepts, it is highly important to define the aim of the study, 
since it will influence sampling, sample processing and analytical techniques (253). This means 
that there is the need to define a strategy before beginning the study. Thus, in light of the aim 
of the study, different strategies can be used (254,255): 
i. Metabolite target analysis – Identification and quantitative analysis of predefined metabolites 
of interest concentrations, disregarding the remaining peaks existent in the sample. 
ii. Metabolic profiling – Identification and approximate quantitative analysis of a set of 
metabolites linked by identical physical and chemical properties or connected to metabolic 
pathways. 
iii. Metabolic fingerprinting – The analysis of samples is made without identification and 
quantification of metabolites. This is a quick method used to determine similarities and/or 
differences between samples, which can be determined visually or via chemometric 
techniques. It is usually referred to the analysis of endometabolome (metabolites located inside 
the cell). This is a fast strategy and ideally appropriated for fast evaluations.  
iv. Metabolic footprinting – The analysis of samples is made outside the cell, in the metabolites 
expelled from the microorganism (exometabolome) into the culture medium or another 
specimen (food or clinical samples). With this analysis, significant information for functional 
genomics and strain characterization becomes available and it can also deliver a crucial 
understanding to cell communication mechanisms. Furthermore, it can provide information 
concerning the intracellular metabolic status and support the interpretation of metabolic 
networks and flux. 
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Microbial metabolomics can use several technologies, either individually or combined, 
depending on the aim of the study and the type of sample. In microbial metabolomic analysis, 
samples can be either cell pellets (endometabolome, usually mentioned as metabolic fingerprint 
analysis) or extracellular culture medium (exometabolome, usually referred as metabolic 
footprint analysis) (256). Obtaining the latter is generally quite simple, with filtration and/or 
rapid centrifugation being enough (256,257). However, to acquire the first, a step of quenching 
is necessary, mainly due to the short half-lives of intracellular metabolites, which currently poses 
as a problem in microbial metabolomics, with research papers dedicated on comparing several 
quenching and also extraction methods, with quenching procedures strongly dependent of the 
microorganism, meaning for example that procedures developed for bacteria might not be 
directly transferred for yeast (256,258–261).  
Because the work concerning microbial metabolomics in this thesis is dedicated only to 
the volatile exometabolome of Staphylococcus aureus (Chapter 5), the aspects related to 
quenching will not be further developed. 
In order to collect S. aureus volatiles, SPME has proven to be an extremely efficient 
method in capturing volatiles of different origins (262,263). SPME has the advantage of not using 
solvents, being inexpensive and quite simple to use, incorporating in a single step the extraction 
and concentration of volatiles and needing only a small sample volume (252,262). This method 
involves the absorption or adsorption of the volatiles onto a pre-coated fiber, like 
divinilbenzene/carboxen/polydimethylsiloxane (DVB/CAR/PDMS), which is exposed in HS above 
the sample continuing for a determined amount of time and, afterwards, there is the release of 
the volatiles from the SPME fiber into an injection port (252,262,264). 
Once the S. aureus volatiles have been collected in the SPME fiber, the next step is to 
analyze those metabolites. This step can be achieved using several analytical platforms that use 
nuclear magnetic resonance (NMR) and mass spectrometry (MS), for which the resolution, 
sensitivity and selectivity can be improved when coupled to gas chromatograpy (GC) or liquid 
chromatography (LC) (254).  
In order to improve the lack of accuracy in metabolite quantification due to peak 
distortion, comprehensive two-dimensional gas chromatography (GC×GC) appeared as an 
alternative method with higher separation efficiencies reducing the problem of co-eluting 
metabolites and improving their quantification, having also the advantage of improving 
detectability (less co-elution and sharper peaks), and increasing identity assignment (265). For 
GC×GC time-of-flight mass analyzers coupled with MS (ToFMS), high spectral acquisition rates 
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while granting an elevated number of data points with a high mass resolution and high mass 
accuracy is provided. The GC×GC technique uses two columns, usually a nonpolar and a polar 
column, which are linked through a modulator, i.e., two different GC columns in stationary phase 
are linked via an on-column injector, the modulator, which transfers consecutively effluent from 
the first dimension into the second dimension (266,267). The use of GC×GC-ToFMS has been 
applied in microbial metabolomics with success (12,257,267). 
There are many analytical platforms being used in S. aureus metabolomics, such as 
selected-ion flow-tube mass spectrometry (SIFT-MS) (243), secondary electrospray ionization 
mass spectrometry (SESI-MS) (268), proton-transfer-reaction mass spectrometry (PTR-MS) 
(269), gas chromatography with flame ionization detector (GC-FID) (270) and electronic nose (e-
nose) (271). 
 
Figure 2.2 - Data processing and interpretation of a metabolomics experiment (272). 
After the data is acquired from GC×GC-ToFMS equipment and in order to extract the 
required information, data processing and data analysis need to be applied. In Figure 2.2 are the 
guidelines of data processing and interpretation of a metabolomics experiment according to the 
metabolomics standards initiative (MSI) (272–274). 
Concerning data processing, there are several statistical analysis methods used for 
metabolomics. This is usually performed in order to understand and give sense of data 
generated. Multivariate analysis is the most commonly used in metabolomics, with principal 
component analysis (PCA) and partial least squares discriminant analysis (PLS-DA) being the two 
most applied statistical methods (275). PCA is an unsupervised statistical analysis, which 
preserves as much of the variance from the original data using the lower dimensionality (usually 
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two or three dimensions) output data as possible (276). PCA enables the visual assessment of 
the samples, which are distributed in the principal component (PC) space, using score plots 
(275). On the other hand, PLS-DA is supervised statistical analysis used to improve the separation 
between groups (275). Another common statistical analysis is hierarchical clustering, which also 
provides a visual judgement by dividing the observed datasets into subgroups, placing samples 
with similar metabolic profiles closer, i.e., in the same subgroup (275,277). 
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Figure 2.3 - Diagram representing how Staphylococcus aureus metabolomic studies are linked by shared volatiles. These same studies also have volatiles that are unique. Transparent nodes with 
reference numbers represent studies; black lines connect the studies between each other through the coloured nodes, which represent unique or shared volatiles (for color legend see Table A2.2, 
from Annexes) described for S. aureus in those studies.
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2.2. Exploring Staphylococcus aureus volatile metabolome and related 
pathways 
From 1986 to 2016, forty five studies were published either concerning the volatile 
metabolome of S. aureus or mention specific S. aureus volatiles as part of the study or attempted 
to detect S. aureus through its volatiles. In total, there are one hundred and fifty volatiles (Table 
A2.2, Annexes) described for S. aureus, spread over thirty three studies which reported the 
existence of volatiles, with the remaining twelve studies reporting only m/z (mass-to-charge 
ratio) patterns or m/z.  
In Figure 2.3, it can be seen how these studies are not only intertwined through common 
reported volatiles but also possess their own unique described volatiles. While in some of the 
studies (Figure 2.3) the volatiles reported are almost the same as in other studies, like some sort 
of good Mona Lisa forgeries with some made by the same artists (243,270,278–281), in others 
the Mona Lisa forgeries are not as good, i.e., a considerable amount of unique volatiles is 
reported (282,283). Thus, all studies, in their own methodological approach, aim to find volatiles 
there are characteristic of S. aureus or its strains in order to compare them with other species 
or other S. aureus strains; or find volatiles when the aim is to see the impact of some factor (lack 
of glucose or oxygen during growth, use of antibiotics, among others) on S. aureus metabolome. 
In the end, most studies have a “higher purpose”, which involves the application of volatiles or 
volatile fingerprints to detect and identify microorganisms (species and/or strains) in diseases in 
a faster and non-invasive way than the conventional microbiological methods. 
There are two ways to address these studies. The first way divides the studies into two: 
those which identified S. aureus volatiles and those which fingerprinted S. aureus. The second 
way, also divides the studies into two different groups: the first concerning in vitro studies and 
the second concerning clinical studies, including proof of concept studies. Thus, at in vitro 
studies, are the studies that use different culture media, growth conditions or techniques to find 
fingerprints or footprints. The clinical studies, including proof of concept studies, are studies on 
which sterile clinical specimens are inoculated with cultures of microorganisms to find specific 
volatiles or volatile fingerprints that allow the identification of a species and/or strains and also 
studies with the objective of achieving an initial evaluation of a method used to detect volatiles 
to find the etiological agent of diseases such as pneumonia, sinusitis, and even bacteremia in 
clinical samples. This approach seems to be the most logical and it is the one followed in the 
next sub-sections. It is important to mention that whenever a study makes reference to a 
pathway in the origin of volatiles, this information will be given. 
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2.2.1. In vitro studies 
The studies belonging to this group encompass the bulk of S. aureus volatile metabolomic 
studies. These are studies made using different culture media such as BHI, tryptic soy broth 
(TSB), dextrose broth (DB), nutrient broth (NB), mannitol-salt agar (MSA), blood agar (BA), 
chemically defined medium (CDM), among others. Within this group the volatiles of S. aureus 
come from different strains, some belonging to the American Type Culture Collection (ATCC), 
others to the National Collection of Type Cultures (NCTC) or even strains isolated from clinical 
specimens. Although this group comprises twenty eight studies, the vast majority did not 
address any metabolic pathways or the ones that mention mostly belong to studies done with 
1H-NMR. However, volatiles reported in these studies are very few and are practically the same 
between them, which makes the pathway described the same, i.e., pyruvate metabolism. 
i. Microbial metabolomics to study Staphylococcus aureus antibiotic resistance 
Perhaps not yet the subject of an increased attention, is the use of microbial 
metabolomics to understand how antibiotics affect S. aureus metabolism. Knowing the origin of 
volatiles (and the non-volatile metabolites) is indicative of the pathway (and the site in the cell) 
in which a determined antibiotic will find its target. This is particularly important for S. aureus, 
since this bacterium has developed resistance to many antibiotics over the years (Figure 2.4), 
making it of Priority 2 (high; where Priority 1 is critical and Priority 3 is medium) for the World 
Health Organization, in terms of research, discovery and development of new antibiotics (9). 
 
Figure 2.4 - Timeline of Staphylococcus aureus development of resistance to antibiotics (8,27). 
In a study, performed to assess the effects of triphenylbismuthdichloride (used as an 
antimicrobial agent to coat catheters) on the volatile exometabolome of S. aureus (Sa113) 
acetate, ethanol and 2,3-butanediol were reported (284). The accumulation of these volatiles 
(and other non-volatile metabolites), which increased with increasing concentrations of 
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triphenylbismuthdichloride, suggested that this antimicrobial agent directed pyruvate into 
alternative pathways, although the mechanism of action remained unknown, indicating that 
triphenylbismuthdichloride affected pyruvate catabolism (284). 
An interesting study also concerning antibiotics was performed with the aim of finding a 
volatile that could be used as a marker of bacterial growth as a fast method to test the 
effectiveness of an antibiotic (285). The growth of two S. aureus strains (ATCC 29213 and ATCC 
43300, sensitive and resistant to oxacillin, respectively) with oxacillin, was tested. Methanethiol 
was found to be directly correlated to bacterial growth, which the authors classified as a valid 
maker gas for bacterial growth, which decreased with higher concentrations of the tested 
antibiotics (285).  
ii. Microbial metabolomics to distinguish Staphylococcus aureus from other bacterial 
species 
Most studies analyzed in the in vitro subsection have the objective of distinguishing S. 
aureus from other bacterial species. 
In 1986, one study stood out for being pioneering, and is perhaps one of the most cited 
works concerning the study of bacterial volatiles (270). This study compared several clinical 
isolated strains of S. aureus, Pseudomonas aeruginosa, Proteus miriabilis and Klebsiella 
pneumoniae. Sixteen volatiles were described for S. aureus strains using both GC-FID and GC-
MS. In fact GC-MS added four volatiles to the ones found by CG-FID. In the reported volatiles, S. 
aureus strains produced a distinctive profile that consisted of 2-methyl-1-propanol, 3-methyl-1-
butanol and 3-hydroxy-2-butanone, with this last volatile being unique for S. aureus (270).  
Another study aimed to distinguishing S. aureus ATCC 25923 from other bacterial species 
(P. aeruginosa, E. coli and Salmonella typhimurium) (286). The spectra of each bacterial species 
were qualitatively unique, possessing distinctive features that could be used to discriminate the 
tested bacterial species, based only on their volatile profiles (286). Thirteen volatiles were 
reported in total, of which eleven volatiles (Table A2.2, Annexes) were detected for S. aureus, 
from which nine volatiles were shared with other studies, such as 3-methyl-1-butanol, ethanol 
and acetic acid, while others, such as acetonitrile and pyrimidine, were detected only in this 
study (286).  
Other studies were also able to positively discriminate S. aureus from other bacterial 
species. This is the case in which S. aureus DSM 13661 was distinguished from other fourteen 
bacterial species using the volatiles acquired via multi capillary column-ion mobility 
spectrometry (MCC-IMS) (with GC-MS confirmation) (287), or by using fingerprints obtained for 
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S. aureus (ATCC 25923) and three other Gram-positive bacteria, differences between spectra 
were found (288), and even differences between S. aureus ATCC 25923 from S. typhimurium and 
eleven strains of E. coli O157:H7, independently of the media culture used (meat extract 
medium; vegetable extract medium and apple extract medium) were also found (289). 
An interesting study comparing mainly long-chain alcohols and other volatiles emitted 
from twenty four foodborne Gram positive (including S. aureus ATCC 12600) and Gram negative 
bacteria concluded that the first group of bacteria produced a lower number of long-chain 
alcohols, as well as other volatiles, than the latter (290). Furthermore, it was also reported that 
for Gram positive bacteria a more frequent detection of polysulfides (especially dimethyl 
disulfide) was found (290). Concerning specifically the S. aureus strain studied, there was a lack 
of production of long-chain alcohols and only two volatiles were reported: 2-tridecenone 
(volatile uniquely reported in this study) and dimethyl disulfide (volatile commonly reported not 
only for S. aureus but also for other bacteria) (290). 
iii. Microbial metabolomics to distinguish Staphylococcus aureus strains 
Some studies aimed to distinguish between S. aureus strains. One of those studies aimed 
to detect differences between one MSSA (ATCC 29213) and one MRSA (NRS 382) strains, using 
two different types of SPME fibers (282). Differences between the two strains were able to be 
detect, especially if the SPME exposure time was of 8 h (versus 10 min every hour for a total of 
ten hours) (282). This study reported 46 volatiles (Table A2.2, Annexes) in total, including 
commonly found S. aureus volatiles, like 3-methyl-1-butanol, 3-methylbutanal, ethanol, acetic 
acid, 3-methylbutanoic acid and acetaldehyde or unique volatiles including the halogenated 
compounds N,N-dimethylsulfamoyl chloride and 2,4,6-triphenyl-1,3,5-tripropylborazine, 
decanal, 2-methyl-3-hexanol among many others (282). Actually, this study stands out in Figure 
2.3, on the top left, not only for being linked to many shared colored nodes but also for having 
many unique colored nodes.  
A singular study is the one of Chippendale and co-workers, which used clinical isolates of 
S. aureus (four isolates), Streptococcus pneumoniae and Haemophilus influenza, to follow the 
development of major volatiles over an increasing period of time (24, 48 and 72 hours) and, by 
using the concentrations of those volatiles, were able to distinguish two strains of S. aureus 
unknown to the authors until the analysis of the PCA done to S. aureus and also by analyzing the 
concentration of the volatiles detected (243). First, using PCA as multivariate analysis of samples, 
it was possible to see that S. aureus cultures were clearly different from the medium culture 
(BHI supplemented with lysed horse blood) but, concerning incubation time, no individual 
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clusters were observed based on the concentration of the volatiles detected (243). The surprise 
was seen in the same PCA, which showed two different clusters of S. aureus (one at the positive 
PC1 and the second in the positive PC1 and negative PC2) revealing the presence of two groups 
that comprised distinct metabolic activities, which the authors attributed to probable 
genotypical or phenotypical differences (243). In this study, eight major volatiles were reported 
for S. aureus. Another remarkable fact, was the intake of ammonia from the medium culture in 
the first 24 h and, afterwards, its elevated emission, surpassing the concentration of this volatile 
in the medium culture, most likely produced to raise the external pH (243,291). Furthermore, 2-
propanone, which is usually reported as part of the volatiles emitted by this species (Table A2.2, 
Annexes) was detected in the HS of S. aureus cultures, but none of the two groups produced this 
volatile (243). A distinctive feature of these groups is that one produced higher amounts of 
methanol, acetaldehyde, ethanol and propanol, and while this same group produced increasing 
concentrations of pentanal from 48 to 72 h, the other group was only able to produce higher 
concentrations than the medium culture of this volatile at 72 h. An important aspect of this study 
is that through the concentration of the volatiles detected and the PCA, it was possible to see 
the presence of two distinct groups of S. aureus. 
iv. Microbial metabolomics combining both the distinction of bacterial species and strains  
Here we can find at least two important studies. The first compared eleven strains 
belonging to eight bacterial species, including the strains NCTC 6571 and ATCC 8325 of S. aureus 
(292). The authors used only volatiles released which were significantly higher than the negative 
controls (blank media culture). Analyzing the resultant twenty three volatiles, significant 
differences, both qualitatively and quantitatively, were found between species and strains (292). 
The second study compared eight strains of four species of bacteria, including three S. aureus 
strains, of which the first was only described as a clinical isolate, the second strain was a MSSA 
and the third strain was a MRSA (293). Twenty five volatiles comprised the dataset analyzed, 
which was used to compare different strains, and their abundance was compared with the 
medium control (blank media culture). Using the first three components of PCA it was possible 
to explain 26.5% of the total variance, showing a separation between the medium control and 
the four studied microorganisms, with S. aureus being characterized by the release of high levels 
of 2-propanone, dimethylsulfide and dimethyltrisulfide (293). Concerning the MSSA and the 
MRSA strains, it was possible to observe that they were quite similar between each other and, 
only after the use of a PLS-DA with cross model validation, differences between the two strains 
were found using the eight volatiles most dissimilar and descriptive to compare both strains 
(293). Thus, the MRSA strain was characterized by high abundances of seven of the volatiles 
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while the MSSA was characterized by the remaining one, which was a halogenated compound 
(1,1,2,2-tetrachloroethane) (293). Along with this volatile, two other volatiles containing 
chlorine (trichloroacetic acid and 1,4-dichloroacetic acid) were found in the headspace of the 
strains of S. aureus which, according to the authors, was described for the first time for S. aureus 
(293). 
 
v. Microbial metabolomics studies comparing different Staphylococcus aureus growth 
conditions  
Volatiles reported in these studies mainly compare S. aureus growth conditions, such as 
the presence or absence of oxygen, the lack of a substrate or of an enzyme, the type of culture 
medium, the type of SPME fiber used to collect volatiles from the HS, the type of GC columns, 
among others. 
Concerning the growth of S. aureus (ATCC 6538) under aerobic and anaerobic conditions, 
using 1H-NMR, fourteen volatiles were reported showing that the presence/absence of oxygen 
had influence on volatiles coming from pyruvate metabolism, namely through ethanol and 3-
hydroxy-2-butanone (294). Also the lack of an enzyme such, as formyl transferase, was able to 
influence pyruvate metabolism (295). 
Another sort of study, done with the strain NCTC 6571, aimed to test three different SPME 
fibers, two different GC columns and three different growth media (240). In total eighteen 
conditions were tested and eight volatiles were detected in one or more conditions. The volatile 
3-methyl-1-butanol was detected in seventeen of the conditions being more an exception than 
a rule, since the remaining seven volatiles appeared in much less conditions (240).This means 
that variations in methodologies (different SPME fibers, different growth media and different 
GC columns) influenced the volatiles detected (240).  
In other study in order to evaluate how different conditions influence the volatiles 
produced by six bacterial species and by a total of twenty one strains, including four strains of 
S. aureus, obtained from routine samples were used (296). Using three different media culture, 
accordingly to the species tested: MacConkey agar for E. coli, Klebsiella spp., Citrobacter spp., 
and P. aeruginosa; MSA for S. aureus and pylori agar for Helicobacter pylori, it was found that 
the volatiles detected for all species belonged to different chemical families: acids, alcohols, 
hydrocarbons and ketones (296). The total concentration of those volatiles per species was 
assessed and the results showed that S. aureus produced lesser concentration of volatiles when 
compared to the other species, with the exception of H. pylori (296). Based on the spectra of the 
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several species, the authors concluded that the species were unequivocally different from each 
other, with some masses being unique of each species (296). However, one can wonder if the 
differences found on the volatile concentrations and the spectra of the different species were 
not the result of using different media culture, one for the Gram-negative bacteria (except H. 
pylori), another for S. aureus and another for H. pylori. The different media culture used have 
different composition, which will influence the pathways used by the different bacteria, which 
in turn will influence the volatiles released. Thus the “explicit” differences between bacterial 
species can be questioned. 
In another study, the volatiles released by S. aureus (a clinical isolated strain) grown in 
NB, BHI and DB were assessed (269). By subtracting the background mass spectra of the negative 
culture media controls, it was possible to stay only with the volatiles released from the growth 
of the cultures in the different media culture (269). The authors concluded that the types, but 
not the concentrations, of volatiles released by S. aureus were not dependent of the growth 
broth (269). Nonetheless, the authors also reported that the time evolution and intensity of the 
volatiles detected as well as the growth of the culture were highly dependent of the growth 
medium (269), which is expected due to the different composition of the media which will 
influence the time in which the maximum concentration of volatiles will occur since their 
concentration is dependent of the growth phase of the bacterium. In fact, even the lack of 
glucose has influence in the central pathways of S. aureus, with a decrease in the release of the 
larger part of metabolites associated with those pathways (297). 
Consequently, based on the results of Lechner et al., 2005 (296) and of O'Hara and 
Mayhew, 2009 (269), a gap can be found in the studies of the volatile fraction of microbial 
metabolomics. It seems to lack a study which compares the volatiles released from a bacterium, 
such as S. aureus, when it grows in different media, and that also compares it with other bacteria 
grown at the same time and in the same media, using growth curves in addition to the detection 
of volatiles. Preferably, this study should be done using a combination of analytical techniques 
to cover as many metabolites as possible (volatiles and non-volatiles) and as many pathways as 
possible. 
Finally it is important to mention the studies performed with an electric nose (e-nose) 
which aim to identify different bacterial species through volatile patterns as a potential method 
of non-invasive detection of infections (271,298–301). 
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2.2.2. Clinical and proof-of-concept studies  
In this subsection are presented some examples of studies performed for S. aureus, that 
use inoculated sterile clinical specimens to find volatiles or volatile fingerprints. In general, most 
proof-of concept studies dwelling with microbial metabolomics, namely the volatile fraction, 
usually have a prior phase in which the method is tested with pure cultures in samples of healthy 
specimen donors and, only afterwards, the method is tested in specimens of unhealthy donors. 
i. Microbial metabolomics to study the volatiles released by Staphylococcus aureus 
inoculated in blood 
Two studies aimed to detect volatiles released by S. aureus inoculated in blood, using 
BacT/ALERT® media bottles. The first described and quantified the volatiles released at two 
collection times (6 and 24 h) by five bacterial species, including the strain ATCC 25923 of S. 
aureus, in BacT/ALERT®FA media bottles, using SIFT-MS (302). Nine volatiles which were most 
likely to be bacterial growth markers, were quantified in both collection times. S. aureus was 
characterized by the production of acetaldehyde, ethanol, ammonia, methanethiol and 
dimethylsulfide (302). In this study the pattern of ammonia concentration variation was similar 
to that obtained in the study of Chippendale et al., 2014 (243). The concentration of ammonia 
was lower than that in the culture medium at 6 h and increased at 24 h, attaining a higher 
concentration than that in the culture medium (302). The authors found that the profile of S. 
aureus (and the other bacteria) was similar in both collection times, meaning that by using SIFT-
MS, the identification could be done at 6 h (302). 
The second study aimed to compare the effectiveness of SIFT-MS with the BacT/ALERT 
automated blood culture system, using two inoculation concentrations (5 and 100 CFU.mL-1) in 
two types of BacT/ALERT® media bottles (FA and SN) and two collection times (8 and 24 h) for 
the quantification of growth indicative volatiles. For S. aureus, it was possible to detect bacterial 
growth much earlier using by SIFT-MS than the BacT/ALERT® system, between 5 h and 7 h earlier, 
using both inoculation concentrations and both types of media bottles (280). 
ii. Microbial metabolomics to study Staphylococcus aureus antibiotic resistance 
Also using the same bacteria as the two previous studies and using two different types of 
BacT/ALERT® media bottles (FA and SA), this study aimed to assess not only bacterial growth but 
also to evaluate antibiotic susceptibility through changes in the concentration of the volatiles 
detected (281). Using the concentration of the nine volatiles previously identified (302), S. 
aureus released high concentrations of ethanol, 2-propanone, acetaldehyde, acetic acid, 
ammonia and dimethyl sulfide (281). When the effect of flucloxacillin was tested below and 
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above minimum inhibitory concentration (MIC), the production of ammonia and dimethyl 
sulfide was inhibited at 6 h. At 22 h, aminoacetophenone, ethanol and formaldehyde were 
inhibited by flucloxacillin above its MIC, while below it MIC no inhibition of these volatiles was 
observed (281). The authors showed that like in the previous study (302), SIFT-MS can detect 
the volatiles characteristic of bacterial growth at 6 h in both types of media bottles and, that by 
using volatiles, it is possible to determine antibiotic susceptibility at 22 h (281).  
iii. Microbial metabolomics in the detection Staphylococcus aureus in respiratory proof-
of-concept studies  
In proof-of-concept studies there are many that aim to find in microbial metabolomics a 
quicker and non-invasive method to detect the pathogen responsible for a determined 
respiratory disease. Thus, by using volatiles released by respiratory pathogenic bacteria, of 
which S. aureus is part, it is possible to make a diagnosis fitting the criteria above mentioned 
(236,268,279,283,303–308).  
One of these studies uses the volatiles released by six pathogenic bacteria responsible for 
sinusitis, in order to detect their growth in both culture media and in infected sinus-mucus (304). 
In the first part of the study, the volatiles released by the six bacteria were assessed after growth 
in blood or chocolate agar. Furthermore, these authors also studied the blanks of both mediums 
and of the petri dish, which had different volatiles not related to the bacteria-released volatiles 
(304). S. aureus produced 8 volatiles from which 3-methylbutanoic acid was the most abundant 
and characteristic (304). Volatile analysis from sinus mucus collected from twelve patients 
showed that for one of the patients the flora was dominated by S. aureus, and at least for 
another, S. aureus would be present due to the presence of the volatile 3-hydroxy-2-butanone, 
although the authors described this volatile as not being that abundant in the pure cultures 
(304). The authors conclude that these results are positive for the creation of e-nose specific 
sensors for non-invasive examination of suspected sinusitis (304). Furthermore, due to 
differences in the abundances of some volatiles or even the appearance/disappearance of 
others when comparing bacteria grown in media culture and in sinus mucus, the important role 
of growth substrate and environment is shown (304).  
Also, one of these studies compares the volatiles released from two bacterial species (S. 
aureus and P. aeruginosa) responsible for ventilator associated pneumonia (VAP) (303). This 
study stands out not only for the number of volatiles described, of particular interest for S. 
aureus, but also for attributing the pathways in the origin of some of the volatiles detected. S. 
aureus released 32 volatiles (Table A2.2, Annexes), belonging to different chemical families, 
including 3-methylbutanoic acid, 3-methyl-1-butanol and 3-methylbutanal, which have their 
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origin in the amino acid leucine (Figure 2.6) or volatiles such as acetic acid ethanol, acetaldehyde, 
and 3-hydroxy-2-butanone, which have their origin in pyruvate metabolism (Figure 2.6). Because 
some volatiles appear 1.5 to 3 hours after inoculation of bacteria and most do not appear in the 
exhaled breath of healthy volunteers (smokers and non-smokers), the monitoring of volatile 
breath markers of the tested bacteria, as well as other VAP causing microorganisms, can allow 
the non-invasive detection, and possibly the identification, earlier than conventional 
microbiological methods. Using this study as well as other studies performed using different 
microorganisms, these authors used the volatiles detected for a non-invasive detection of the 
used pathogens, including S. aureus, in the lower respiratory tract for the diagnosis of VAP. S. 
aureus was detected in 22.7% of the patients, with twelve of the previously detected volatiles 
being detected in the end-tidal air of VAP patients (279). 
A noteworthy study was done with the aim of using volatiles for the detection of common 
etiological pathogens as a non-invasive and quick method for the analysis of breath in cystic 
fibrosis patients (307). In a first phase, human cells were used for the in vitro study, which were 
inoculated with the tested pathogens, including S. aureus DSM 20231, and volatiles were 
assessed. In a second phase, in vivo detection of volatiles were assessed in the breath of cystic 
fibrosis patients. In both phases, volatiles were achieved through SPME and analyzed by GC-MS. 
Although no identification of the volatiles was done for none of the tested pathogens, the 
authors were able to see differences between the microorganisms tested but they concluded 
that the use of volatiles for a non-invasive method, although having a great potential, still need 
to be improved (307). 
iv. Microbial metabolomics in the detection Staphylococcus aureus in different specimens 
in proof-of-concept studies  
Proof-of-concept studies were also done using other specimens. A major study was 
performed with the objective of testing a quick chromatographic method (GC-FID) to detect 
volatile fatty acids (VFA) in anaerobic blood cultures (309). To achieve this objective, 
BacT/ALERT®FAN media bottles (for anaerobic bacteria) were inoculated with cultures 
containing suspensions of twenty six bacterial species (including S. aureus) in sterile human 
blood. The two VFA identified for S. aureus were acetic acid and 3-methylbutanoic acid (309). A 
total of 288 (out of 375) clinical blood cultures were microbiologically positive (309). After being 
submitted to routine microbiological examination, GC-FID was used to detect VFA present. 
Results showed that 202 blood cultures had a single bacterial species, and of those only 9 had S. 
aureus, which released the two previously found VFA, although 3-methylbutanoic acid was only 
occasionally found (309). The authors concluded that using the combination of microbiologically 
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positive clinical blood cultures grown in anaerobic media bottles, the aerobic bacteria could be 
distinguished by genus and that the presence of 2-methylpropanoic acid, butanoic acid, 4-
methylpentanoic acid and hexanoic acid was typical for anaerobic bacteria (309). However, the 
main conclusion of this study is not so directed for S. aureus but for the ability of GC-FID to 
detect 11.2% of anaerobes from negative blood cultures undetected by routine microbiological 
examination (309). The same kind of study was also performed for clinical exudates of different 
origin and results for S. aureus were the same as in the previous studies, with the same VFA 
being detected (310). Nonetheless, a higher percentage of clinical exudates (20.5%) was 
detected with GC-FID based on distinct VFA profiles which were reported as negative by 
cultivation (310). 
Using another specimen, is a study that uses routine microbiological methods and 
volatiles to test samples of milk from cows with clinical mastitis (311). Milk was first tested using 
routine microbiological methods, and afterwards, if one of the main etiological agents (including 
S. aureus) of mastitis were found, samples were submitted to GC-MS, in order to analyze their 
volatiles. From the mastitis etiological agents found in the samples, S. aureus was the pathogen 
which produced more volatiles (nineteen in total), being distinguished from the remaining 
species mainly due to 3-methyl-1-butanol, 2-methylbutanal, 3-methylbutanal, ethyl 2-
methylbutanoate, ethyl 3-methylbutanoate, 2-butanone and 3-hydroxy-2-butanone (311). 
Using the volatiles produced by the analyzed bacteria, the authors found that they were 
different depending on the species. However, they were only able to distinguish S. aureus, 
coagulase-negative staphylococci and E. coli from the two remaining species of Enterococcus 
spp. (311). 
Finally, in order to detect common urinary tract infection pathogens, including S. aureus 
NCTC 7447, volatiles from inoculated sterile urine were studied using SIFT-MS (312). In urine, S. 
aureus was only able to produce four volatiles, including large quantities of ammonia (312). As 
mentioned before, this production was most likely raise the low extracellular pH (291). In this 
study it was not possible to completely discriminate between the inoculated microorganisms 
(312). 
2.3. Potential Staphylococcus aureus volatile biomarkers 
From the studies presented in the previous section, most of them aimed 1) to detect the 
volatiles of S. aureus or its spectra and second 2) to be identify S. aureus in different types of 
samples. Besides, in other studies it has been searched for a pattern of biomarkers that enables 
a quick identification of S. aureus and other species. These studies reported that by using the 
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volatile metabolites the detection time of S. aureus in a sample could be significantly lower than 
that of the conventional methods. Furthermore, if a biomarker could be found for MSSA or 
MRSA strains or even for enterotoxic and non-enterotoxic strains, it would be a great detection 
innovation. 
An ideal biomarker must meet several criteria: should be readily available, should be 
highly sensitive and specific, should vary promptly in response to a specific condition; should 
provide a deeper understanding about the microorganism; and it should be useful in different 
areas (313,314). Besides identifying S. aureus as an etiological agent, biomarkers can potentially 
be used to answer an array of different objectives: to detect S. aureus in food samples or in the 
environment, especially in hospitals, can be used to see how S. aureus interacts with other 
microorganisms and with their hosts, allowing to detect differences between colonization and 
disease, among many others (232–247,315). 
Ideally, volatiles with the potential to serve as biomarkers must be reported 
independently of the growth conditions. Thus, it is important to summarize which are the most 
reported volatiles of S. aureus (Figure 2.5), being more likely linked to the metabolism of this 
bacterium and not the result of a specific condition or belong to the growth media artefacts or 
even to the container in which the research is done. In Figure 2.5, it is possible to see that the 
volatiles that are most frequently detected for S. aureus include ethanol, 3-hydroxy-2-butanone, 
2-propanone, acetic acid, 3-methyl-1-butanol, 3-methylbutanoic acid, dimethyl disulfide, 
methanethiol, acetaldehyde and 3-methylbutanal (Table A2.2, Annexes). On the other hand, 
also in Figure 2.5 can be seen that most of the volatiles which are closer to the center, were only 
reported in one (light blue) or two studies (light lilac), such as 2-(3-acetoxy-4,4,14-
trimethylandrost-8-en-17-yl)-propanoic acid, 2,4,7,9-tetramethyldec-5-yne-4,7-diol, 3-
phenylfuran, styrene, 2-octanone, 2,6,10,14-tetramethylhexadecane, among many others 
(Table A2.2, Annexes). 
It is, however, important to give up the concept of a biomarker and embrace the concept 
of a pattern of biomarkers. For example, based on Figure 2.5, it could be suggested the use of 
ethanol as a biomarker for S. aureus. However, this would be inapropriate, because ethanol is a 
volatile produced by other microorganisms (248). There are, however, some volatiles derived 
from the catabolism of leucine 3-methyl-1-butanol, 3-methylbutanal, 3-methylbutanoic acid 
that are commonly reported as associated with S. aureus specifically (Table A2.2, Annexes). 
Another commonly reported volatile of S. aureus is 3-hydroxy-2-butanone and also 
methanethiol and dimethyl disulfide (Table A2.2, Annexes). In fact, the combination of these 
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volatiles can be a pattern of biomarkers for S. aureus. However, more work needs to be 
performed in order to validate this or any biomarker pattern. 
 
Figure 2.5 - Diagram illustrating the frequency of appearance of volatiles of Staphylococcus aureus by published 
papers (Table A2.2, Annexes). The volatiles nearer the centre with smaller letters and thinner lines are volatiles that 
appear with less frequency in papers. As volatiles move away from the centre and letters get bigger with thicker lines, 
the higher is the frequency in which they appear in papers. Volatiles with the same colours appear in the same frequency 
as each other. 
In order to validate a possible biomarker, it is important to know its metabolic origin. All 
the above mentioned as the most reported volatiles are known to come from specific pathways 
such as pyruvate metabolism, diacetyl pathway, leucine catabolism, methionine catabolism, or 
derive indirectly from these pathways (Figure 2.6). However, not all pathways have been 
described for S. aureus and, in most research papers, the pathways are transposed from other 
microorganism for which the pathway was studied. Concerning S. aureus, the pathways 
described for the commonly reported volatiles have not yet been studied. One example of a 
commonly described pathway in microorganisms in general is the β-oxidation of fatty acids 
which is in the origin of methyl ketones. Although 2-pentanone or 2-heptanone, are reported in 
4 and 3 studies, respectively, they do not originated in the β-oxidation of fatty acids pathway, 
because the phylum Firmicutes does not possess this pathway and an alternative pathway 
remains yet to be found (96). 
The selection and identification of patterns of biomarkers will be the first step toward 
developing and optimizing diagnostic tools that specifically detect the presence of S. aureus that 
are cheaper than the analytical platforms available and that will be able to detect in minutes 
and without a specialized technician to interpret the results (293,316). Specific patterns can be 
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recognizable by e-noses as in situ diagnostic tool which can be “custom made”, through the 
development of specific and sensitive sensors, to detect a pattern of biomarkers, improving the 
detection of S. aureus in different sort of matrices, from clinical specimens to foodstuff 
(316,317).  
2.4. Concluding remarks 
From the studies concerning the volatile fraction of S. aureus metabolome, it is possible 
to realize that the knowledge obtained from 1986 to 2016 is still small, especially when 
compared to other organisms such as S. cerevisiae, E. coli, among others. However, it is possible 
to see that using patterns of some volatiles along with their concentration allow the distinction 
of S. aureus from other bacterial species. 
Most of the studies concerning the volatile exometabolome of S. aureus mentioned only 
few volatiles (one or two) while others reported as many as forty six volatiles. In these studies it 
is stated that the volatiles of S. aureus have low carbon numbers. However, analyzing Table A2.2 
(Annexes) it is possible to see that S. aureus volatiles can have from one to fifty nine carbons.  
Furthermore it was patent in some studies the importance of including a control of the 
used medium (blank culture medium), which can be removed/subtracted to the 
areas/concentrations of the volatiles in order to have a dataset which is composed only of 
volatiles that are significantly different from those of the control medium and, thus, have a huge 
probability of belonging to the metabolome of S. aureus instead of the used culture medium. 
Moreover, the results of these studies also showed that the volatiles produced are strongly 
conditioned by the used conditions: type of media culture, type of SPME fibers, type of GC 
columns, time of volatile extraction, the method of dataset selection and the design of the 
research. It will be important to have more studies using the same experimental conditions in 
order to define a selective metabolomic profile for S. aureus detection/identification. 
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Figure 2.6 - Metabolic map of potential biomarkers in bold for Staphylococcus aureus represented as a subway map: different color lines correspond to different pathways, small circles (stations) 
correspond to metabolites (volatile or non-volatile), and big circles (stations with connection with another line) correspond to metabolites that are the starting point to another pathway or metabolites. 
Colored metabolite’s name and size appear in more than seven papers (303,318–322). 
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It is also essential to know the origin of the most reported volatiles. Thus, a complete 
substantiated metabolomic map specific for this such problematic bacterium is yet needed. 
Transposing pathways from other bacteria is not enough. It is most likely that the central 
pathways, like glycolysis, pyruvate metabolism and degradation of AA can be equal or similar 
between bacterial species, or, as seen, can be more or less active in some species rather than 
others. However, as it can be inferred from Table A2.2 (Annexes), indole, which is a typical 
volatile of E. coli, H. influenzae, K. oxytoca, is not produced by S. aureus because this bacterium 
does not possess the enzyme tryptophanase. In fact, when biochemical identification tests are 
performed for S. aureus it is always stated that “S. aureus is indole negative” (323). Although 
this is not necessarily linear, especially when the discovery of many S. aureus strains even 
allowed the discovery of non-mannitol fermentative strains and even catalase negative strains, 
there are perhaps some strains which can be indole positive. This is also similar to the case of 
the production of methyl ketones via β-oxidation of fatty acids, which S. aureus does not possess 
(324). 
Finally, the important message, is that through volatile metabolite studies it is possible to 
distinguish S. aureus from different bacterial species and it is even possible to differentiate 
within S. aureus strains,, such as MRSA and MSSA.
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Abstract 
 
Staphylococcus aureus is responsible for a large spectrum of diseases, including SFP, due to its 
ability to produce SE. To prevent the development of SFP, effective food preservation methods 
are needed. HPP uses pressures, between 100 and 600 MPa, to inactivate pathogenic and 
spoilage microorganisms. In this study, HPP treatments (450 MPa and 600 MPa, both for 15 and 
30 min, at 20 °C) were applied in three different strains of S. aureus in the stationary growth 
phase and reduction effectiveness was assessed. A non-enterotoxic strain ATCC 6538 and two 
enterotoxic strains 2153 MA (with enterotoxin A) and 2065 MA (with enterotoxin A, G, I) were 
used. It was verified that the non-enterotoxic strain was the most resistant to HPP, not being 
completely inactivated within 30 min at 600 MPa. Additionally, it was demonstrated that HPP 
had no effect on virulence factors (enterotoxins, β-hemolysin, lipase, lecithinase, coagulase, 
thermonuclease, catalase), and also in mannitol fermentation capacity and methicillin 
susceptibility. HPP treatments also proved to be less effective in the strain with higher 
carotenoids content (non-enterotoxic strain). The results of this study show that S. aureus HPP 
barotolerance might be related not only to the presence of enterotoxins but also to carotenoids 
level, although these two factors may not be the only mechanisms responsible for the distinct 
sensitivity/resistance to HPP shown by different strains of S. aureus. 
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3.1. Introduction 
Staphylococcus aureus is a very versatile opportunistic human pathogen that causes a 
broad spectrum of diseases, ranging from superficial wound infections to septicemia, toxic-
shock syndrome and SFP, due to a wide variety of virulence factors, invasiveness capacity and 
antibiotic resistance (90). SFP appears due to the capability that S. aureus has to 
asymptomatically colonize healthy individuals who inadvertently contaminate foodstuff while 
manipulating it (325,326). In 2008, SFP represented 5.5% of foodborne poisoning outbreaks in 
the European Union, being S. aureus the fourth most common causal agent in bacterial food 
poisoning outbreaks (327,328). Most strains are able to produce one or more SE (18). Twenty 
one SE and SEl types have been described (58,329), although two more have been more recently 
proposed (330). The most common SE isolated from food are SEA, SEB, SEC and SED, with SEA 
being more frequently recovered from food poisoning outbreaks (329,331). SE are a family of 
serologically defined, low molecular-weight monomeric proteins (26―30 kDa) (59,84), soluble 
in water and saline solutions (90). SE are pH resistant, thermally stable and resistant to the 
activity of the digestive tract proteolytic enzymes (329), allowing them to retain their activity in 
the digestive tract (90). Hence, heat treatments used to eliminate S. aureus may not eliminate 
SE already formed (332). Ingesting low quantities (100―200 ng) of SE can cause intoxication 
(327). 
Almost all strains produce other virulence factors that grant them the ability to colonize 
and cause diseases in mammalian hosts. These proteins include hemolysins (alpha, beta, gamma 
and delta), thermonuclease, proteases, lipases, hyaluronidase, and collagenase (90,333). They 
also produce carotenoids (mainly staphyloxanthin) that are able to absorb excess energy from 
reactive oxygen species (ROS), protecting them against hydrogen peroxide, superoxide radical, 
hydroxyl radical, hypochloride and singulet oxygen and are also responsible to regulate 
membrane fluidity (170,171,334). MRSA strains are also a major concern since they are present 
in food products which can be transmitted to humans (335,336). 
HPP is an alternative food processing method that preserves the products features such 
as color, flavor, organoleptic properties and nutritional values (337,338). Food industry uses 
pressures between 100 and 600 MPa and short pressurization times (3―5 min) for the 
inactivation of pathogenic and spoilage microorganisms (169,326). The response of 
microorganisms to HPP depends on microbial species/strain, cell shape, growth phase, matrix, 
pressure magnitude, pressurization time and temperature (103,339). HPP damaging effects are 
mainly verified in lipid membranes, protein structure and function and ribosomes (92,338,339). 
Nonetheless, monomeric proteins can be quite stable to HPP, being dependent on each 
 84 
 
Chapter 3 
individual protein (99,340) and enzymatic reactions are differently affected (being either 
enhanced or inhibited) (106). 
S. aureus poses a major problem for HPP implementation because it is one of the most 
barotolerant nonsporulated foodborne pathogen (326). There are several studies which tested 
different strains of S. aureus in different combinations of pressure, time, temperature, matrix, 
different growth phases and with different carotenoid content (92,205,326,338,341). 
The main objective of this study was to evaluate the impact of HPP treatments on S. 
aureus virulence factors, and also in ability to ferment mannitol and susceptibility to methicillin. 
Furthermore, the effectiveness of HPP treatments (different pressures and different holding 
times) in the inactivation of enterotoxic and non-enterotoxic S. aureus was also evaluated. The 
relevance of studying HPP treatments in enterotoxic S. aureus strains and their virulence is due 
to the high importance of this species from the food safety point of view, even more because it 
is highly barotolerant to HPP. 
3.2. Materials and methods 
3.2.1. Cultivation and characterization of bacterial strains 
Three S. aureus strains were used: a non-enterotoxic strain ATCC 6538 and two 
enterotoxic strains, 2153 MA (with SEA) and 2065 MA (with SEA, SEG, SEI), isolated from food 
products and characterized in the Centre of Biotechnology and Fine Chemistry of the Faculty of 
Biotechnology of the Catholic University, Portugal. All strains are β-hemolysin, lipase, 
lecithinase, coagulase, thermonuclease and catalase positive. The strain 2153 MA was unable to 
ferment mannitol. All strains are methicillin sensitive and are able to produce pigmented 
colonies. The three strains were grown in BHI (Liofilchem, Italy) at 37 °C for 18 h at 170 rpm until 
stationary phase, corresponding to a concentration of approximately 108―109 colony forming 
units per mL (CFU mL-1). Cells were harvested by centrifugation (15,000 × g, 10 min), washed 
twice and ressuspended in the same volume of sterile phosphate buffered saline (PBS) (pH 7.0). 
Cell suspensions in PBS were used in HPP treatments. 
3.2.2. High pressure processing assays 
Cell suspensions were transferred with sterile glass Pasteur pipettes to 0.4 mL 
polyethylene tubes. For each strain, three independent samples were used and for each one, 
three sub-samples were prepared (n = 9) and three replicates per sub-sample were analyzed (n 
= 18). The tubes containing each sub-sample were placed in low permeability polyamide-
polyethylene bags (PA/PE-90, Albipack―Packaging Solutions, Portugal) with 70% ethanol, 
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thermosealed and pressurized. HPP conditions tested were 450 MPa/15 min, 450 MPa/30 min, 
600 MPa/15 min and 600 MPa/ 30 min at 20 °C in a hydrostatic press (High pressure system U33, 
Institute of High Pressure Physics, Poland) and the pressurization fluid was a mixture (60:40) of 
water and propylene glycol (DOWCAL™, Dow). Non-pressurized controls were also included for 
each strain in the different conditions. 
3.2.3. Enumeration of viable cells 
Pressurized and unpressurized samples were 10-fold serial diluted (10-1―10-8) in sterile 
Ringer Solution (Merck KGaA, Germany). One millilitre of each dilution was pour-plated in 
triplicate in PCAm (Liofilchem, Italy). After incubation (37 °C for 48 h) the number of colonies was 
counted in the most appropriate dilution (plates containing between 30 and 300 CFU). The 
survivor number was reported as log CFU ml-1 and values were used to determine high pressure 
reduction effectiveness (RE), using the equation 
RE = log N0 - log N, 
where N0 and N represent, respectively, the number of viable cells in the unpressurized 
suspensions and in the pressurized suspensions. 
3.2.4. Virulence factors, mannitol fermentation, methicillin susceptibility and 
carotenoids determination 
To assess if HPP treatments affected the virulence factors of the three strains, non-
pressurized controls and pressurized samples were tested for the presence/absence of virulence 
factors, choosing one typical colony of S. aureus from each sub-sample. Based on RE results, the 
pressure values were set at 500 MPa/15 min for 2153 MA (with SEA) and 2065 MA (with SEA, 
SEG, SEI) and 500 MPa/30 min for ATCC 6538, since these pressure treatments showed 
considerable RE, but viable cells were still possible to obtain in order to study the effect on 
virulence factors. The presence of SEA was determined using SET-RPLA Kit Toxin Detection Kit 
(Thermo Scientific, United Kingdom), according to the manufacturer's instructions, with positive 
results based in agglutination patterns (the presence of enterotoxins G and I were not tested 
since SET-RPLA Kit Toxin Detection Kit only detects the most common enterotoxins: SEA, SEB, 
SEC and SED). β-hemolysin was determined by streaking BA plates (Sheep Blood 7%; Liofilchem, 
Italy) and observing a clear/yellow zone surrounding S. aureus colonies. Lipase and lecithinase 
activities were determined by streaking BPA (Liofilchem, Italy). S. aureus colonies appear in black 
with clear zones surrounding them (lecithinase activity), and an opaque precipitation zone 
(lipase activity). Coagulase was tested using Pastorex Staph Plus (Bio-Rad, United States of 
America), with positive results shown by agglutination. Thermonuclease (TNAse) was 
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determined using D.N.A. Toluidine Blue Agar (Bio-Rad, United States of America), with positive 
results corresponding to a change in the color of halos, from blue to pink (342). Catalase 
production was evaluated using Catalase/Oxy Test (Liofilchem, Italy), with positive results shown 
by gas bubbles production. To determine the carotenoids content before pressurization, cell 
suspensions were collected in stationary phase of growth and optical density was adjusted to a 
value of 1. Carotenoids were extracted using the methodology described by Morikawa et al. 
(2001) (343) and quantified by measuring the absorbance at 465 nm. Mannitol fermentation 
was tested using MSA (Liofilchem, Italy), with positive results detected as color change (from 
pink to yellow). The susceptibility to methicillin was tested using the cefoxitin disk screen test, 
performed accordingly to the Clinical and Laboratory Standards Institute (CLSI), in which cultures 
with halos ≥22 mm are methicillin susceptible and cultures with halos ≤21 mm are methicillin 
resistant (344). 
3.2.5. Statistical analysis 
HPP inactivation and carotenoids content results statistical significance was verified by 
analysis of variance (ANOVA) and the post-hoc Bonferroni test, using SPSS 20.0 (IBM, New York, 
USA). Differences corresponding to ρ < 0.05 were considered significant. Statistical analysis was 
performed taking into account the three independent assays, each one with three sub-samples 
and each one with three replicates. 
3.3. Results 
3.3.1. Bacterial inactivation by HPP 
HPP treatment RE on S. aureus strains for all tested conditions is presented in Table 3.1. 
With increasing pressure and holding time an increase in RE was observed (decreasing CFU 
concentration), for all strains. For ATCC 6538 (Table 3.1), the RE was 2.3 log CFU ml-1 for 
suspensions treated at 450 MPa/15 min and the highest RE (5.1 log CFU.ml-1)was obtained at 
600 MPa/30 min. Bacterial inactivation was significantly different (ρ < 0.05) between the non-
pressurized suspension and the different conditions and between all conditions. The exception 
was between the treatments at 450 MPa/30 min and 600 MPa/15 min.  
Both, enterotoxic strains had a similar response to HPP (Table 3.1). RE values in the 
samples pressurized at 450 MPa/15 min were 4.1 log CFU.mL-1 for the strain 2153 MA and 4.8 
log CFU.mL-1 for the strain 2065 MA. The highest RE was observed at 600 MPa/30 min with 
values of 8.6 and 9.3 log CFU mL-1 for 2153 MA and 2065 MA, respectively. Bacterial inactivation 
was significantly different (p < 0.05) in both strains, in all tested conditions, not only between 
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the controls and tests but also between conditions. The exception was between 450 MPa/30 
min and 600 MPa/15 min which produced a similar RE (ρ > 0.05). 
Comparing all strains, the inactivation of ATCC 6538 was significantly lower (p < 0.05) in 
all treatments from the enterotoxic strains. For each HPP condition, the inactivation between 
the enterotoxic strains was similar (ρ > 0.05). 
Table 3.1 - Reduction Effectiveness along different HPP conditions in three Staphylococcus aureus 
strains: ATCC 6538 (without enterotoxins), 2153 MA (SEA) and 2065 MA (SEA, SEG and SEI). 
Strain Sample condition Log CFU.mL-1 
Reduction Effectiveness 
(log CFU.mL-1) 
ATCC 6538 
Suspension 9.17 ± 0.05 - 
450 MPa/15 min 6.85 ± 0.10 2.32 b,c,d 
450 MPa/30 min 5.65 ± 0.31 3.52 a,d 
600 MPa/15 min 5.81 ± 0.18 3.36 a,d 
600 MPa/30 min 4.06 ± 0.18 5.11 a,b,c 
2153 MA 
Suspension 8.59 ± 0.12 - 
450 MPa/15 min 4.46 ± 0.11 4.13 f,g,h 
450 MPa/30 min 2.40 ± 0.11 6.19 e,h 
600 MPa/15 min 2.38 ± 0.04 6.21 e,h 
600 MPa/30 min N.D. 8.59 e,f,g 
2065 MA 
Suspension 9.30 ± 0.04 - 
450 MPa/15 min 4.47 ± 0.08 4.83 j,k,l 
450 MPa/30 min 3.89 ± 0.04 5.41 i,l 
600 MPa/15 min 2.99 ± 0.33 6.31 i,l 
600 MPa/30 min N.D.  9.30 i,j,k 
N.D. – Not Detected (Below the limit of detection, 1 CFU mL-1) 
a Significantly different (ρ < 0.05) from ATCC 6538/450 MPa/15 min 
b Significantly different (ρ < 0.05) from ATCC 6538/450 MPa/30 min 
c Significantly different (ρ < 0.05) from ATCC 6538/600 MPa/15 min 
d Significantly different (ρ < 0.05) from ATCC 6538/600 MPa/30 min 
e Significantly different (p < 0.05) from 2153 MA/450 MPa/15 min 
f Significantly different (ρ < 0.05) from 2153 MA/450 MPa/30 min 
g Significantly different (ρ < 0.05) from 2153 MA/600 MPa/15 min 
h Significantly different (ρ < 0.05) from 2153 MA/600 MPa/30 min 
i Significantly different (ρ < 0.05) from 2065 MA/450 MPa/15 min 
j Significantly different (ρ < 0.05) from 2065 MA/450 MPa/30 min 
k Significantly different (ρ < 0.05) from 2065 MA/600 MPa/15 min 
l Significantly different (ρ < 0.05) from 2065 MA/600 MPa/30 min 
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3.3.2. HPP effect on the virulence factors, mannitol fermentation and methicillin 
sensitivity 
Virulence factors were tested in unpressurized (control cell suspensions) and pressurized 
samples (Table 3.2). The presence of SEA was detected in the two enterotoxic strains before and 
after HPP treatments. β-hemolysin, lipase, lecithinase, coagulase, thermonuclease, catalase, 
mannitol fermentation and methicillin susceptibility in the surviving cells were also not affected 
by pressurization.
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Table 3.2 - Effect of HPP on Staphylococcus aureus virulence factors, mannitol fermentation and methicillin resistance for the strains ATCC 6538 (without enterotoxins), 2153 MA (SEA) and 
2065 MA and (with SEA, SEG, and SEI). The signal “+” means “presence” and the signal “-” means absence. 
Strain Samples 
Virulence Factors  
Mannitol 
fermentation 
Methicillin 
sensitivity 
(mm) Enterotoxin A β-hemolysin Lipase Lecithinase Coagulase Thermonuclease Catalase 
ATCC 6538 
UPS 1a - + + + + + + + 34 
PS 1b - + + + + + + + 34 
UPS 2a - + + + + + + + 33 
PS 2b - + + + + + + + 33 
UPS 3a - + + + + + + + 32 
PS 3b - + + + + + + + 32 
2153 MA 
UPS 1a + + + + + + + - 27 
PS 1b + + + + + + + - 27 
UPS 2a + + + + + + + - 28 
PS 2b + + + + + + + - 28 
UPS 3a + + + + + + + - 28 
PS 3b + + + + + + + - 28 
2065 MA 
UPS 1a + + + + + + + + 29 
PS 1b + + + + + + + + 29 
UPS 2a + + + + + + + + 29 
PS 2b + + + + + + + + 29 
UPS 3a + + + + + + + + 30 
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PS 3b + + + + + + + + 30 
a UPS 1, UPS 2, UPS 3 – Unpressurized samples 1, 2 and 3. 
b PS 1, PS 2, PS 3 – Pressurized samples 1, 2 and 3. 
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Carotenoid content was only determined for the unpressurized samples. Absorbance was 
0.053 for ATCC 6538, 0.017 for 2153 MA and 0.036 for 2065 MA. Thus, carotenoid content was 
significantly different (ρ < 0.05) between strains and it was highest for the nonenterotoxic strain. 
3.4. Discussion 
One of the objectives of this study was to observe the behavior of the three S. aureus 
strains to different HPP treatments. Similarly to other studies, an increase in pressure and 
holding time of treatments caused higher S. aureus inactivation (177,205,326,345). 
Furthermore, O'Reilly et al. (2000) (345) and Fioretto et al. (2005) (177) reported identical 
inactivation for the non-enterotoxic strain (ATCC 6538). Differences in inactivation of different 
S. aureus strains by HPP, have also been described the studies of Alpas et al. (1999) (346) and 
Cebrián et al. (2010) (326). 
ATCC 6538 was not completely inactivated in the most severe HPP condition tested (600 
MPa/30 min) and was more barotolerant to the different treatments than the enterotoxic 
strains. Under the condition 600 MPa/30 min, the strains 2153 MA and 2065 MA were 
inactivated to the limit of detection (LOD) of the method (1 CFU.mL-1). In view of these results, 
differences between strains were not only related with the presence/absence of SE but also with 
the carotenoids content, which was higher for the most barotolerant strain and lower for the 
most barosensitive strains. Cebrián et al. (2010) (326) also explained the different barotolerant 
behavior of S. aureus strains to HPP based on carotenoids content, with strains with lower 
carotenoids content more susceptible to inactivation. Our results are in accordance with that 
study. Actually, the fact that carotenoids content is related with the resistance of S. aureus to 
several stress factors was reported in several studies which show that, mutant strains that are 
unable to produce carotenoids are more susceptible to those stress factors (171,172,347,348). 
So, it seems that in this study, for the tested strains, barosensitivity, lower carotenoids content 
and SE presence are related. Nonetheless, for the enterotoxic strains, the number of SE did not 
affect significantly (ρ > 0.05) their barosensitivity. The fact that barotolerance of several strains 
of S. aureus is dependent of more than one feature is not new. Although the exact reasons 
behind these differences are not yet understood, the σB factor is known to grant resistance to 
stress factors such as heat and pressure to S. aureus since this factor controls 251 genes and/or 
operons (188,201). 
The present research study focused mainly on the ability that surviving bacteria 
maintained the capability to produce virulence factors, their sensitivity to methicillin and to 
ferment mannitol. In light of the results obtained at the tested conditions, HPP had no effect in 
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the capability of surviving cells to produce SEA or any other virulence factors and maintained its 
biochemical characteristics. Since this detection, alongside the methicillin 
resistance/susceptibility were performed in the surviving cells, it would be expected that the 
bacteria, even if injured during HPP treatments, would be able to continue producing those 
virulence factors and other enzymes. Furthermore, along with the spherical shape, the high 
impermeability of S. aureus membrane seems to provide protection against 350 MPa pressure, 
as shown by the study of Wang et al. (2010) (349), in which cells maintained their general 
morphology. 
The effect of HPP on proteins is dependent of the type of protein and of the protein itself. 
For example, monomeric proteins are more stable to HPP than oligomeric proteins, with the first 
ones being able to withstand higher pressures (depending on each individual protein tolerance) 
whilst pressures of less than 300 MPa can cause dissociation into individual subunits in the last 
ones, leading to denaturation (340). Furthermore, at pressures between 400 and 800 MPa, 
monomeric proteins can unfold and aggregate although, reversible unfolding occurs for many 
proteins (350,351). If the effect of HPP was tested directly on SE, it would not been expected 
that SEA suffered many changes, since it is a small monomeric protein (99). This was observed 
in the study of Margosh et al. (2005) (159), where in HPP treatments between 0.1 and 800MPa 
for 30 min at 20 °C, staphylococcal SE suffered no change in their immuno-reactivity. It was also 
observed in the study of René-Trouillefou et al. (2010) (160), in which SEA solutions were 
submitted to 600 MPa/15 min at 20 °C, that there was no significant immunoreactivity 
difference between non-pressurized and pressurized SEA. Furthermore, it was observed that 
under 600 MPa/15 min at 20 °C spectral changes (fully reversible under decompression) 
occurred in SEA (160). 
Although the longer pressurization times and the matrix (PBS) used in this study are for 
research purposes and are not comparable to the ones used in food industry, they are selected 
as a the first step to study the effect of HPP technology in inactivation of enterotoxic and non-
enterotoxic S. aureus and evaluation of its impact on virulence factors. Further steps should 
include studies in foods prompt to be contaminated with S. aureus to check its HPP resistance 
behavior and, when HPP conditions are established, apply those conditions in food industry. 
3.5. Conclusions 
In conclusion, S. aureus enterotoxic strains with lower carotenoids content and SE were 
more easily inactivated by HPP treatments. Furthermore, the surviving cells have not lost their 
capability to produce SE and other factors/characteristics of virulence. The results of this study 
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allow to state that SE presence and carotenoids level are some of the distinctive features of each 
strain that might influence the barotolerance. In fact, these two features are dependent of the 
σB factor, which was already recognized to be responsible for differences in barotolerance 
between several strains of the same species. As these differences seem to be the result of more 
than one feature distinctive of each strain, more assays using several distinct strains are 
necessary in order to confirm the relationship between carotenoid production level and SE gene 
content. 
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Abstract 
In this work, the development of resistance and the recovery of growth after several 
consecutive cycles of high hydrostatic pressure (HPP) were for the first time evaluated in 
different strains of Staphylococcus aureus. Three strains of this important and highly resilient to 
HPP foodborne pathogen were used: a non-enterotoxic ATCC 6538 strain, treated with 600 MPa 
for 30 min at 20 °C, and two enterotoxic strains, 2153 MA (with enterotoxin A) and 2065 MA 
(with the enterotoxins A, G and I), treated with 600 MPa for 15 min at 20 °C. After the first 
treatment, surviving colonies were used to produce new bacterial cultures. This procedure was 
repeated nine times more for each bacterium or until total inactivation occurred. The 
inactivation profile of non-enterotoxic strain and the two enterotoxic strains did not change 
after consecutive cycles, but the toxic strain with three enterotoxins was completely inactivated 
after the fourth cycle. The three strains did not recover their viability after 14 days. The results 
indicate that HPP effectively inactivates non-enterotoxic and enterotoxic strains of S. aureus 
after a single treatment. The surviving bacteria did not develop resistance after 10 cycles of 
pressurization and did not recover their viability after 14 days of incubation.
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4.1. Introduction 
HPP treatment is an emerging food preservation method able to meet not only the 
increasing consumer demand for microbiologically safe foods, but also to produce foods with 
fresh-like appearance and with minimal modification of nutritional and organoleptic properties 
(110,337,338,352,353). HPP treatments of food are carried out with intense pressure 
(commercially ranging from 100 to 600 MPa) with or without heat, inactivating efficiently 
microorganisms and, consequently, extending food products shelf-life (128,169).  
The susceptibility of microorganisms to high hydrostatic pressure varies considerably 
depending on the pressure range applied, temperature and duration of the treatment (103,354–
356), but also depends on each microorganism characteristics, growth phase and suspending 
medium (205,338,346,356). It is generally assumed that Gram-positive bacteria and cells in the 
stationary growth phase are more resistant than Gram-negative and cells in the exponential 
growth phase (128). It has also been stated that bacterial protective effect against HPP may be 
given by carbohydrates, proteins, lipids and other constituents of the suspending medium or 
food (which, when caught up by the bacteria decrease their sensitivity to HPP) (338,357,358).  
HPP affects bacterial cellular processes such as protein and DNA synthesis, membrane-
associated processes, macromolecular quaternary structures (e.g., protein denaturation) and 
cellular membrane structure. Cell external structures are the primary sites that are damaged by 
pressure, altering cell permeability, transport systems, osmotic pressure and ability to preserve 
pH, resulting in leakage of cell contents (92,203,338,339,359,360). As the main targets of HPP 
are the external structures, microorganisms seem to have low chance to develop resistance. 
However, it has been shown that some cells can repair the sub-lethal damage induced by HPP, 
allowing them to proliferate once they have restored the injury. Injury recovery of Gram-positive 
(L. monocytogenes and S. aureus) and two Gram-negative (E. coli O157:H7 933 and S. enteritidis 
FDA) foodborne pathogens in HPP treated milk during storage was observed (202). Recovery of 
E. coli B in phosphate saline buffer after treatment with HPP was also reported (361).  
S. aureus was selected for being an opportunistic human pathogen that causes a broad 
spectrum of infections (362), being the fourth most common causal agent in bacterial food 
poisoning outbreaks (327,328). S. aureus has no particular nutritional and environmental 
requirement for growth and has also the ability to grow in a vast range of temperature, pH and 
NaCl concentration (18,363,364). Besides, some strains produce heatstable enterotoxins that 
are powerful gastrointestinal toxins, causing SFP (52,90,325,329,362). 
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S. aureus bacterial development of resistance and the growth recover after several cycles 
of HPP have not yet been evaluated. Hence, the aim of this study was to evaluate if enterotoxic 
and non-enterotoxic strains of S. aureus that survived a previous HPP treatment can develop 
resistance to repeated cycles and are able to recover their viability.  
4.2. Materials and methods 
4.2.1. Preparation of bacterial cultures 
Three S. aureus strains were used in this study: one non-enterotoxic strain (ATCC 6538) 
and two enterotoxic strains isolated from food (2153 MA, with SEA; and 2065 MA, with SEA, SEG 
and SEI). S. aureus cultures were grown in BHI (LIOFILCHEM, Italy) at 37 °C for 18 h at 170 rpm 
to achieve a concentration of approximately 108―109 colony forming units mL-1 (CFU mL-1) 
reaching the stationary phase. Cells were harvested by centrifugation (15,000 × g 10 min), 
washed twice and resuspended in the same volume of sterile phosphate buffer solution (PBS) 
(pH 7.0) in order to achieve concentrations of 108―109 CFU mL-1. 
4.2.2. High pressure processing assays 
Prior to HPP treatments, cell suspensions were transferred with sterile glass Pasteur 
pipettes to 0.4 mL polyethylene tubes. For each strain, three independent samples were used 
and for each one, three sub-samples were prepared (n = 9). The tubes containing each of the 3 
sub-replicates set were placed in low permeability polyamide-polyethylene bags (PA/PE-90, 
Albipack―Packaging Solutions, Portugal) sterilized distilled water which were then thermo-
sealed and pressurized. Based on the results achieved in CHAPTER 3, the pressurization 
conditions required to achieve a bacterial inactivation corresponding to ca. 5 to 6 log reductions 
(from ≈ 9 initial logs), ATCC 6538 strain was pressurized at 600 MPa for 30 min at 20 °C and the 
strains 2065 MA and 2153 MA were pressurized at 600 MPa for 15 min at 20 °C in a hydrostatic 
press (High pressure system U33, Institute of High Pressure Physics, Warsaw, Poland). The 
pressurization liquid was a mixture of 60% water and 40% propylene glycol (DOWCAL™, Dow). 
With such a procedure, it was intended to obtain a sizeable number of colonies, which were 
used to study the possible development of resistance and bacterial recovery. Non-pressurized 
controls were also included in the experiments. 
4.2.3. Enumeration of viable cells 
For each sub-sample treated and for untreated samples 10-fold serial dilutions (10-1―10-
8) were made in sterile PBS. One milliliter of each dilution was plated on PCAm (LIOFILCHEM, 
Italy) in duplicate. The plates were incubated at 37 °C for 48 h and the number of colonies was 
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counted in the most appropriate dilution (plates containing between 30 and 300 CFU) and the 
number of viable cells was expressed as log CFU.mL-1. The number of survivors was reported as 
log CFU mL-1. The RE of high pressure inactivation of the pathogen strains was calculated using 
the equation  
RE = log N0 - log N, 
where N0 represents the average number of viable cells in the untreated suspensions and N the 
number of viable cells in the pressurized suspensions. 
4.2.4. HPP resistance assays 
To verify the development of resistance to HPP, a new set of enterotoxic and non- 
enterotoxic bacterial cultures was produced from an isolated colony obtained after each cycle 
of exposure to HPP treatment. In order to obtain a bacterial inactivation corresponding to ca. 5 
log of reductions, the bacterial suspension was exposed to HPP in the same conditions of the 
aforementioned HPP assay. This allowed to test if the bacteria affected by HPP were able to 
develop resistance to HPP. After each cycle, survivor colonies were removed from PCAm and 
incubated in BHI at 37 °C for 22 h at 170 rpm. Unpressurized controls were also included in the 
experiments. This procedure was repeated for ten consecutive cycles. For each strain, and for 
each of the 10 cycles, three independent samples were used and for each sample three sub-
samples were done (n = 9). 
4.2.5. HPP viability recovery assay 
In order to evaluate if pressurized cells could recover viability after HPP treatments, 
enterotoxic and non-enterotoxic bacterial suspensions were subjected to HPP in the conditions 
described above. After the initial enumeration (48 h), the plates used to count viable cells were 
incubated for 14 days at 37 °C and the colonies were recounted after 5, 8, 11 and 14 days of 
incubation. This counting strategy was used after each pressurization cycle and the 
concentration of viable bacteria was determined. For each strain, three independent samples 
were counted, each one with three subsamples (n = 9). 
4.2.6. Statistical analysis 
HPP inactivation data from the resistance and recovery assays were statistically analyzed 
using analysis of variance (ANOVA) and the post-hoc Tukey test, with the SPSS 20.0 (IBM, New 
York, USA). Statistical significance was considered for ρ < 0.05. 
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4.3. Results 
4.3.1. HPP resistance assay 
The application of HPP treatment produced reductions in the counts of the three strains, 
being the magnitude dependent on each strain under study (ρ < 0.05). In each cycle, no 
significant differences among the 3 independent samples (ANOVA, ρ > 0.05) was observed for 
the three strains. Though, the efficiency of bacterial inactivation after the first treatment was 
almost the same (ρ > 0.05), the HPP treatment time was different for the non-enterotoxic strain 
and for the strain with one toxin (Fig. 1). After 30 min of treatment at 600 MPa, the RE of the 
non-enterotoxic strain was 4.5 log (out of 8.7 log) and, after 15 min at 600 MPa, the RE of the 
two enterotoxic strains was 4.7 log and 5.5 log (out of 8.3 and 9.2 log, respectively), for the strain 
with one toxin and the strain with three toxins, respectively (Figure 4.1). For this first cycle, for 
all tested strains, the results are in accordance to the ones obtained in past studies of the same 
group of authors (CHAPTER 3), in which RE values were approximately the same when only one 
cycle HPP treatment was applied. The number of surviving bacteria, after the second cycle for 
the non-enterotoxic strain (ATCC 6538) and after the first cycle for the enterotoxic bacterium 
with 1 toxin (2153 MA), was approximately the same. The efficiency of inactivation was not 
significantly different in the subsequent HPP cycles (ANOVA, ρ > 0.05) for these two strains (with 
exception for the seventh cycle for non-enterotoxic and sixth cycle for enterotoxic strains). The 
efficiency of inactivation for the strain with three toxins (2065 MA) was not constant during the 
4 consecutive treatments (Figure 4.1), increasing with the number of cycles and, after 4 cycles 
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of treatment, no surviving bacteria were detected. For this strain, the efficiency of inactivation 
was significantly different among the four consecutive HPP cycles (ANOVA, ρ < 0.05). 
Figure 4.1 - Counts of the three strains of 
Staphylococcus aureus under study (log CFU mL-1 ± 
SD) before and after pressurization over cycles. 
Treatment at 600 MPa for 30 min (strain ATCC 
6538) and 600 MPa for 15 min (strains 2065 MA and 
2153 MA). The dotted lines and squares are the 
counts before pressurization (N0) and the continuous 
line and diamonds are the counts after pressurization 
(N). Values represent the mean of three independent 
samples with three sub-replicates each and two 
replicates for each sub-replicate; error bars indicate 
the standard deviation of the three samples. The value 
zero means that no colonies were detected, which 
means that the counts were below the limit of 
detection of the method (<1 CFU. mL-1). 
 104 
 
Chapter 4 
4.3.2. HPP viability recovery assay 
The plates used to enumerate viable cells in the HPP resistance assays were counted past 
2 (initial enumeration), 5, 8, 11 and 14 days of incubation at 37 °C for each of the 10 cycles. 
Values of viable cells counts over different recovery times are shown in Table 1. Although, after 
the first cycle of partial HPP inactivation, the bacterial concentration of the non-enterotoxic 
strain and of the enterotoxic with one toxin strain were significantly reduced to 4.2 and 4.5 log, 
respectively (ANOVA, ρ < 0.05), and the survivor bacteria did not recover their viability during 
the following 14 days of incubation at 37 °C. The number of colonies counted after the first 2 
days of incubation was similar (ANOVA, ρ > 0.05) to that obtained after the 14 days. The same 
profile of variation was observed for the nine consecutive cycles of HPP treatment for these two 
strains (Table 4.1). For the strain with three toxins, although the number of colonies decreased 
between the consecutive cycles (ANOVA, ρ < 0.05), during the following 14 days of incubation 
at 37 °C the number of colonies did not vary significantly (ANOVA, ρ > 0.05) in each cycle. 
4.4. Discussion 
In general, the development of resistance to HPP by microorganisms should be considered 
as an unlikely event, because this is typically a multi-target process and cell external structures 
are the primary sites that are affected by pressure (92,203,339,365,366). In this study, the 
nonenterotoxic and the two enterotoxic strains, which present different susceptibility to HPP 
(CHAPTER 3), did not develop resistance to HPP treatments. Although in this study longer 
pressurization times were applied in comparison to the currently applied by the food industry 
(3―5 min), the levels of bacteria used in the experiments were also much higher (between 108 
and 109 CFU.mL-1) than those found in food [the range of S. aureus counts that can produce the 
amount of toxin able to induce staphylococcal food poisoning is between 103 and 105 CFU mL-1 
(367)]. Using lower bacterial concentrations, corresponding to those observed in food, will allow 
the use of lower pressure values and pressurization time to efficiently treat contaminated food 
(368). 
The results of the resistance assays showed that, after consecutive treatments none of the 
strains exhibit any evident signs of resistance. When the non-enterotoxic strain and the strain 
with 1 toxin, were subjected to ten consecutive HPP cycles, the fraction of survivor bacteria did 
not show considerable variation between cycles. After the first and the second treatments, 
respectively, for the strain with 1 toxin and for the non-enterotoxic strain no significant changes 
in the efficiency of inactivation were observed. For the strain with 3 toxins, substantial variations 
between the consecutive cycles were observed. The number of colonies decreased and, 
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consequently, the efficiency of inactivation increased, and bacteria were inactivated below the 
limit of detection (<1 CFU.mL-1) after the fourth treatment cycle (reduction of ≈ 9 log). Pressure 
can potentially lead to simultaneous damages on molecules of the external structures and also 
to the nucleic acid (DNA), avoiding the development of resistance to HPP. The bacteria would 
require multi-site mutations to become resistant, an event with significantly lower probability 
than single-target mutation which is often sufficient for conferring resistance. Up to now, the 
development of bacterial resistance to HPP after consecutive cycles of HPP treatment has not 
been reported for S. aureus.  
There are, however, some studies on bacterial growth after HPP treatment (202,360,366), 
which are, in fact, targeted for bacterial growth recovery and not for the development of 
resistance. Nonetheless, there is one study of Hauben et al. (1997) (359), in which barotolerant 
resistant mutants of E. coli MG1655 were selected and the survival of these mutants after HPP 
treatments was assessed. In this study, while the mutants were able to survive at increasing 
pressures as a result of the development of barotolerance, the viability of the wild type 
decreased, since it did not develop any resistance to pressure. Consequently, our finding is of 
particular interest, indicating that HPP treatment is a safe food method to control S. aureus 
growth, under the conditions tested. 
Although none of the three bacterial strains developed resistance to HPP after 
consecutive cycles of treatment, the efficiency of inactivation was significantly different for the 
three strains. The non-enterotoxic strain and the strain with one enterotoxin were not 
completely inactivated after the ten consecutive cycles, indicating that these two strains are 
more tolerant to HPP than the strain with three toxins. The results obtained for the first cycle 
are in agreement with those obtained in other studies using S. aureus collection strains and 
strains isolated from food, carried out in the range of 100 ― 600 MPa with or without heat, in 
which this bacterium was not completely inactivated by HPP treatments (205,326,338,369). In 
the pressurization conditions of this study, an average of 2.5―3.8 log of the non-enterotoxic 
strain and the strain with one enterotoxin survived for ten HPP cycles (corresponding to a RE of 
≈ 6.3 and 4.8 log cycles, respectively). 
The efficiency of inactivation slightly increased along repeated HPP cycles, with an 
average RE of 2.4 and 1.0 log, respectively, for non-enterotoxic strain and strain with one 
enterotoxin. The highest RE was observed after the first cycle for both strains (approximately 
4.5 log) but, for the non-enterotoxic strain, which was subjected to a longer time under pressure 
(30 min against 15 min for the other two strains) a higher RE between the first and the second 
cycles was also observed (6.7 log). However, after the second treatment the reduction for the 
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non-enterotoxic strain and strain with one enterotoxin was not significant, which indicates that 
these
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Table 4.1 - Counts of the three strains of Staphylococcus aureus under study (log CFU.ml-1 ± SD) after 2, 5, 8, 11 and 
14 days of incubation at 37 °C for each cycle (n = 9). Treatment at 600 MPa for 30 minutes (strain ATCC 6538) and 
600 MPa for 15 minutes (strains 2065 MA and 2153 MA). Values represent the mean of three independent samples 
with three sub-samples each and two replicates for each sub-sample; error bars indicate the standard deviation of the 
three samples. 
Strains Cycle N0a 2 5 8 11 14 
ATCC 6538 
1 8.73 ± 0.09 4.24 ± 0.21 4.26 ± 0.21 4.27 ± 0.21 4.27 ± 0.21 4.27 ± 0.21 
2 8.97 ± 0.09 2.30 ± 0.40 2.35 ± 0.36 2.37 ± 0.36 2.37 ± 0.36 2.37 ± 0.36 
3 8.86 ± 0.09 3.21 ± 0.44 3.24 ± 0.41 3.25 ± 0.41 3.25 ± 0.41 3.25 ± 0.41 
4 8.96 ± 0.23 2.33 ± 0.18 2.40 ± 0.16 2.40 ± 0.16 2.42 ± 0.16 2.42 ± 0.16 
5 8.87 ± 0.03 2.23 ± 0.01 2.47 ± 0.19 2.54 ± 0.26 2.55 ± 0.25 2.55 ± 0.25 
6 8.89 ± 0.10 2.26 ± 0.06 2.31 ± 0.12 2.34 ± 0.11 2.34 ± 0.11 2.34 ± 0.11 
7 8.76 ± 0.25 1.24 ± 0.25 1.28 ± 0.30 1.28 ± 0.30 1.28 ± 0.30 1.28 ± 0.30 
8 8.84 ± 0.19 2.66 ± 0.59 2.66 ± 0.59 2.66 ± 0.59 2.66 ± 0.59 2.66 ± 0.59 
9 8.91 ± 0.13 2.92 ± 0.13 2.92 ± 0.13 2.92 ± 0.13 2.92 ± 0.13 2.92 ± 0.13 
10 8.56 ± 0.32 1.71 ± 0.07 1.73 ± 0.05 1.73 ± 0.05 1.73 ± 0.05 1.73 ± 0.05 
2065 MA 
1 8.31 ± 0.01 2.84 ± 0.38 2.85 ± 0.37 2.85 ± 0.37 2.85 ± 0.37 2.85 ± 0.37 
2 8.58 ± 0.26 2.90 ± 0.46 2.90 ± 0.46 2.90 ± 0.46 2.90 ± 0.46 2.90 ± 0.46 
3 8.89 ± 0.18 2.26 ± 0.19 2.27 ± 0.18 2.29 ± 0.15 2.30 ± 0.15 2.30 ± 0.15 
4 8.95 ± 0.26 N.D.b N.D. b N.D. b N.D. b N.D. b 
5 - - - - - - 
6 - - - - - - 
7 - - - - - - 
8 - - - - - - 
9 - - - - - - 
10 - - - - - - 
2153 MA 
1 9.19 ± 0.22 4.54 ± 0.10 4.55 ± 0.10 4.55 ± 0.10 4.55 ± 0.10 4.55 ± 0.10 
2 8.09 ± 0.08 4.31 ± 0.38 4.33 ± 0.37 4.34 ± 0.37 4.34 ± 0.37 4.34 ± 0.37 
3 8.53 ± 0.69 4.23 ± 0.07 4.24 ± 0.07 4.24 ± 0.07 4.24 ± 0.07 4.25 ± 0.06 
4 8.52 ± 0.39 4.57± 0.07 4.58 ± 0.07 4.58 ± 0.07 4.58 ± 0.07 4.58 ± 0.07 
5 8.78 ± 0.07 4.48 ± 0.55 4.49 ± 0.54 4.50 ± 0.55 4.51 ± 0.53 4.52 ± 0.53 
6 8.87 ± 0.50 2.12 ± 0.60 2.20 ± 0.54 2.21 ± 0.55 2.21 ± 0.56 2.21 ± 0.56 
7 8.47 ± 0.16 3.53 ± 0.36 4.03 ± 0.40 4.05 ± 0.38 4.06 ± 0.37 4.06 ± 0.37 
8 8.46 ± 0.28 3.85 ± 0.48 3.87 ± 0.48 3.87 ± 0.48 3.87 ± 0.48 3.87 ± 0.48 
9 8.75 ± 0.32 3.79 ± 0.62 3.83 ± 0.58 3.84 ± 0.58 3.84 ± 0.58 3.84 ± 0.58 
10 8.39 ± 0.19 2.71 ± 0.33 3.26 ± 0.05 3.31 ± 0.02 3.32 ± 0.01 3.32 ± 0.01 
a N0, Before HHP. 
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b N.D. – Not Detected; below the limit of detection of the method (< 1 UFC mL-1). 
two strains, as the strain with three toxins, do not develop resistance against HPP. The bacteria 
that were not inactivated after the first 2 HPP cycles were not subsequently inactivated in the 
following cycles. The presence of viable but non-cultivable (VBNC) forms or the existence of 
dormant persistent cells, less sensitive to HPP treatment than their cultivable counterparts, 
might be an explanation for the results obtained (130,370–374). However, the discrimination 
between these two possibilities (non-cultivable forms or dormant persistent cells) cannot be 
done in light of the methods used, since no microscopy or molecular analyses were performed. 
Moreover, the different patterns of inactivation displayed by the three strains after consecutive 
HPP cycles might suggest differences in the mechanism of transmission of resistance to the 
inactivation induced by HPP treatments. 
The multi-target nature of HPP suggests also that the effect of treatment should have 
irreversible effects on the bacterial viability. As the three bacterial strains were treated to obtain 
a sizeable number of survivor colonies it was possible to evaluate if these survivor bacteria were 
viable after treatment but also if potential HPP injured bacteria were able to recover their 
viability. During 14 days of incubation in a non-specific medium after HPP treatment, the 
surviving bacteria were maintained in the necessary conditions to recover from the treatment. 
If new colonies would appear in the petri plates during the 14 days of incubation it would mean 
that the bacteria, previously not able to form colonies, after the “injury period” become able to 
recover from the treatment. However, none of the three bacterial strains were able to recover 
their viability in the 14 days post-treatment period. This indicates that inactivated bacterial cells 
cannot recover from the treatment effect. Using 600MPa for 15 or 30 min, respectively, for 
enterotoxic and non-enterotoxic strains, the enterotoxic strains with 3 toxins was inactivated to 
the limits of detection only after 4 consecutive cycles and did not recover within 14 days after 
each cycle but the other two strains were not completely inactivated after the ten consecutives 
cycles but after each cycle they do not recover the viability within the 14 days of incubation. This 
result indicates that, although one cycle of treatment is not enough to inactivate all the bacteria 
in the suspension, the bacteria inactivated after one cycle did not recover their viability.  
However, recovery of pathogenic and spoilage bacteria in different substrates after HPP 
treatment has been described for several species at 128―550 MPa and 20―50 °C (375–378). 
This recovery has been explained as the result of repairing of the bacterial injuries during food 
storage (361,375). Koseki et al. (2008) (378), showed that L. monocytogenes in milk recovers 
viability after 28 days of storage at 4 °C and 25 °C, but not at 37 °C, when a HPP treatment at 
550 MPa for min using combined with a mild-heat treatment (30―50 °C) was applied. Bozoglu 
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et al. (2004) (379), observed also that L. monocytogenes, S. aureus, E. coli O157:H7 and S. 
enteritidis treated at 350, 450 and 550 MPa at 45 °C for 10 min in milk and stored at 4, 22 and 
30 °C recovered after 1―15 days of HPP treatment. In both studies, the time of HPP processing 
was lower (5―10 min) than those used in our study (15―30 min) but in the two studies, higher 
temperatures were applied, thus not enabling straightforward comparison with the results not 
reported. However, in these other studies, bacteria recovered viability when foods were stored 
at 4 °C, 22 °C, 25 °C and 30 °C but not at 37 °C which was the temperature used in our studies 
during the recovery assays. More studies are necessary to elucidate the importance of 
temperature during the bacterial recovery assays in buffer solutions. Though, the differences 
between our results relatively to these two studies from the literature, can be, in part, explained 
by the protective effect of the food constituents.  
It is well demonstrated that several matrixes, such as milk, poultry meat, cream of chicken 
can have a baroprotective effect against HPP (380–384). For example Gervilla et al. (2000) (381), 
showed that several Pseudomonas fluorescens, E. coli, L. innocua, S. aureus and L. helveticus in 
ovine milk were more resilient to HPP than in buffer. Also Styles et al. (1991) (384), found that 
raw milk appeared to confer a protective effect to L. monocytogenes and V. parahaemolyticus 
against HPP treatment when compared with HPP treatment in PBS (361).  
In the present study the HPP treatment was also performed in PBS, with bacteria lacking 
the baroprotective effect of food matrices, which rendered those most probably more sensitive 
to HPP and, consequently their recovery was not observed during the 14 days of incubation. On 
the other hand, it has been shown that VBNC forms resulting from HPP treatments are not able 
to growth directly in specific media but they can grow directly in non-specific media or in specific 
media after a first passage in a non-specific medium (370). Nevertheless, in this study a non-
selective medium was used to evaluate bacterial viability after HPP treatment, differently from 
other studies in which specific growth medium, supplemented with different concentrations of 
NaCl, were used to recover injured bacterial cells and to assess the type of injuries inflicted on 
those cells (385). Furthermore, as S. aureus has no particular nutritional and environmental 
requirements to grow, being able to grow in a wide range of temperatures, pH and NaCl 
concentrations (18,363,364), the recovery in a selective medium would probably be similar. 
Further studies using a selective medium might be necessary in order to obtain a deeper helpful 
information about the types of mechanisms of recovery and if these mechanisms can be 
different for the enterotoxic and non-enterotoxic strains. 
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4.5. Conclusion 
In this study, it was demonstrated that HPP treatments (600 MPa for 30 min or 15 min, 
depending on the strain) effectively inactivate S. aureus (reduction of ≈ 5 log) after a single 
treatment. The bacteria that survived the treatments did not develop resistance after repeating 
cycles of HPP, considering the conditions tested and the inactivated bacteria do not recover their 
viability after 14 days of incubation. The next logical step is to perform studies using S. aureus 
inoculated in food to confirm the nonappearance of resistance and the absence of viability 
recover after consecutive cycles of HPP.
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Abstract 
Staphylococcal food poisoning is a disease that originates significant health and economic 
losses and is caused by Staphylococcus aureus strains able to produce enterotoxins. The aim of 
this work is to go further on the study of the volatile exometabolome of S. aureus using an 
advanced gas chromatographic technique. Enterotoxic and non-enterotoxic strains were 
assessed. The volatile exometabolome profile comprised 240 volatiles belonging to ten chemical 
families. This volatiles were mainly by-products of branched-chain amino acids and methionine 
degradation, pyruvate metabolism, diacetyl pathway, oxidative stress and carotenoid cleavage 
Metabolites released by the first two pathways were produced in higher contents by the 
enterotoxic strains. This study add further insights to S. aureus volatile exometabolome, and 
also shows that by applying it, it is possible to distinguish strains of S. aureus by the number of 
produced enterotoxins, which is especially important from the food safety point of view. 
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5.1. Introduction 
Foodborne diarrheal diseases are responsible for 550 million people to fall ill per year and result 
in 230 thousands deaths (386). Staphylococcus aureus is a Gram-positive pathogen, extremely 
adaptable and opportunistic, with no special nutritional or environmental requirements that is 
able to grow in a huge array of foodstuffs and surfaces (18). It can live as a commensal 
microorganism in humans and other animals, being responsible for a wide range of diseases and 
producing several virulence factors, such as SE which are responsible for SFP (387). S. aureus is 
mainly carried by humans asymptomatically, transferring this bacterium to foodstuff causing SFP 
outbreaks, mainly due to food workers and/or due to the lack of hygiene in locals where food is 
prepared (53). According to WHO, in 2014, the median SFP incidence in Australia together with 
Canada, France, Netherlands, New Zealand, England, Wales, and the United States of America 
was 77.3 per 100 000 inhabitants (386). 
From a health point of view, the symptoms of SFP are usually self-limiting and are solved on 
their own, or can be sporadically intense enough to cause hospitalization. Also, SFP may 
represent relevant economic losses for agro food industries among others, and elevated health 
costs (53,386). Thus, although SFP is not a high mortality foodborne disease, it is important 
enough due to the related morbidity and economic impact, requiring alternative methods of 
identification to the conventional ones in order to detect S. aureus enterotoxic strains in food, 
which might take several days. The detection of enterotoxic strains of S. aureus, using a pattern 
of biomarkers to indicate toxins presence, would be a convenient approach to monitor/control 
its presence. 
Microbial metabolomics is the study of the overall metabolites produced by microorganisms 
according to cellular state, response to an antibiotic or another chemical substance, response 
to different physical parameters or even differences between species and strains (224). Several 
studies of S. aureus volatile metabolome employing different methodologies were reported. The 
first one was performed in 1986, with the objective of finding differences in volatile profiles of 
four bacteria, including S. aureus, using gas chromatography with flame ionization (GC-FID) and 
one-dimensional gas chromatography-mass spectrometry (1D-GC-MS) (270). Afterwards, 
several metabolomics studies of S. aureus have been performed. They were mainly directed to 
clinical applications, i.e. to early detection of different species in different clinical specimens, 
distinction of MSSA from MRSA strains, the evaluation of growth conditions and detection of 
mastitis in cows, among others (282,297,302,303,388). A wide range of analytical methods was 
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used in these studies including  one dimensional gas and liquid chromatography, mass 
spectrometry (270,282,302,303,388) and NMR (297,388). Furthermore, there are already some 
applications using e-nose (299,300) and more advanced gas chromatographic methodology, 
such as comprehensive two-dimensional gas chromatography-time of flight mass spectrometry 
(GC×GC-ToFMS) (389), which have been reported.  
GC×GC-ToFMS, a high throughput and highly sensitive methodology, has proven to be a 
powerful tool for microbial metabolomics, specifically for the study of microbial volatile organic 
compounds (MVOCs) (257,315,390). There is only one study in which GC×GC-ToFMS was applied 
to compare of the fatty acids methyl esters from different strains of four foodborne bacterial 
species, including S. aureus strains ATCC 25923 and ATCC 6538, with results reporting separation 
of species and strains (389). To our knowledge, neither GC×GC-ToFMS, nor other high 
throughput methodologies, have been used to assess S. aureus volatile exometabolome and to 
discriminate between enterotoxic and non-enterotoxic strains. Although S. aureus metabolome 
is relatively well studied its non-volatile fraction is better known than the volatile. 
The information about the volatiles from S. aureus is fragmentary and only few analytes 
are commonly reported, which allow to infer that the growth conditions, strains, instrumental 
analysis, among others, may have impact on the reported volatiles. Consistently reported 
volatiles of S. aureus include: ethanol, 3-hydroxy-2-butanone, 2-propanone, acetic acid, 3-
methyl-1-butanol, 3-methylbutanoic acid, dimethyl disulfide, methanethiol, acetaldehyde and 
3-methylbutanal (270,282,297,302,303,388).  
Due to the importance of S. aureus enterotoxic strains as a source of SFP and to the lack 
of a detailed characterization of its volatile metabolome, the present study aims to add further 
insights to the volatile fraction of S. aureus exometabolome. To achieve this goal, fresh cultures 
of three strains (one non-enterotoxic and two enterotoxic) of S. aureus were in-depth studied 
using HS-SPME combined with GC×GC-ToFMS. Furthermore, resorting to hierarchical clustering, 
this study also examined whether enterotoxic strains can be distinguished from non-
enterotoxic. Finally, it was also intended to see if it was possible to find a pattern of biomarkers 
for S. aureus. 
5.2. Materials and methods 
Sampling, reporting of chemical analysis, and data relative to data pre-processing, pre-
treatment, processing, validation and interpretation were accomplished according to the MSI 
(272–274). Experimental procedure was performed accordingly to Figure 5.1, representing the 
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main stages for S. aureus exometabolome determination, which will be described in detail in the 
following sub-sections. 
5.2.1. Bacterial parameters 
5.2.1.1. Bacterial strains and growth conditions 
Three Staphylococcus aureus strains were used in this study: ATCC 6538, a collection 
strain, without SE, isolated from a human wound; 2153 MA (GenBank accession number 
MG675881) (SEA) and 2065 MA (GenBank accession number MG675880) (SEA, SEG, SEI), both 
enterotoxic, isolated from food samples and characterized in the Centre of Biotechnology and 
Fine Chemistry of the Faculty of Biotechnology of the Catholic University, Portugal. These strains 
are all β-hemolysin, lipase, lecithinase, coagulase, thermonuclease, catalase positive, able to do 
mannitol fermentation (except 2153 MA), and are methicillin sensitive. ATCC 6538 is the most 
baroresistant while the enterotoxic strains (2153 MA and 2065 MA) are barosensitive, and the 
carotenoid content follows the order: ATCC 6538>2065 MA>2153 MA (CHAPTER 3). 
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Figure 5.1 - Main stages for Staphylococcus aureus determination of exometabolome volatile profile: growth 
conditions, sample preparation, metabolites extraction, GC×GC analysis and data processing. Three independent assays 
were performed for each strain. 
All strains were cultured at 37 °C for 18 h at 170 rpm in 25 mL of non-buffered BHI 
(LIOFILCHEM, Italy), conditions adapted from ISO norm 6888-3:2003 (391) in 100 mL shaking 
flasks, in three independent assays (a total of 9 flasks, three for each strain). 
To determine viability, samples were 10-fold serial diluted (10-1 to 10-9) in sterile 1/4-
strength Ringer solution (Merck Millipore, Darmstadt, Germany). One milliliter of dilutions 10-5 
to 10-9 was pour-plated in triplicate in PCAm (LIOFILCHEM, Italy), and plates were incubated at 
37 °C for 48 h. The number of colonies were counted in the most appropriate dilution (plates 
containing between 30 and 300 CFU) and the number of viable cells was expressed as log 
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CFU.mL-1. Differences in cell viability between strains were statistically analyzed through ANOVA 
and the post-hoc Tukey test, with the SPSS 20.0. Statistical significance was considered for ρ < 
0.05. Viability was determined in order to compare the volatile patterns for all strains under 
study, thus expressing their content as area/cell concentration. 
5.2.1.2. Extracellular pH measurements 
At pre-determined incubation times (4, 8, 12 and 18 h), 1.5 mL of each sample was 
removed to a 2 mL microcentrifuge tube (Labbox Labware, Barcelona, Spain) and pH was 
assessed. Measurements were done using 2 types of pH strips (MColorpHast™, Merck Millipore, 
Darmstadt, Germany): in the ranges of 4.0―7.0 and 6.5―10.0, respectively. 
5.2.2. Staphylococcus aureus exometabolome determination by HS-SPME/GC×GC-
ToFMS 
After 18 h incubation, 20 mL of each sample (BHI cultured broth) were centrifuged at 
10000 rpm, at 4 °C for 15 min (centrifuge Heraeus Megafuge 16R, Thermo Scientific, United 
States). Next, 4 mL of supernatant were transferred via syringe with 0.22 μm filter pore (CA 
GyroDisc, Orange Scientific, Belgium) into 12 mL glass vials containing 0.8 g of NaCl (99.5%, 
Sigma-Aldrich, St. Louis, Mo., USA) and a cylindrical magnetic stirring bar of 12 x 4.5 mm (Labbox 
Labware, Barcelona, Spain). The vials were capped with a polytetrafluoroethylene septum and 
an aluminum cap (Chromacol Ltd., Herts, UK) and samples were stored at -80 °C until analysis. 
Also, in order to exclude the medium effect on the composition of the organic volatiles released 
from S. aureus, BHI medium was analyzed using the procedure described above for the samples.  
The SPME and GC×GC–ToFMS experimental parameters were previously defined (257). 
Both SPME holder for manual sampling and coating fiber were acquired from Supelco (Sigma-
Aldrich, Bellefonte, Pa., USA). The SPME device comprised a fused silica fiber coating, cross-
linked with 50/30 µm divinylbenzene/carboxen™/polydimethylsiloxane StableFlex™ (1 cm), 
including an extensive capacity of sorbing compounds with distinct physicochemical features.  
For analytes extraction, the vials with the defrosted samples (S. aureus cultures and BHI 
blank media) were placed in a thermostated water bath at 50.0± 0.1 °C and under constant 
agitation at 350 rpm. Then, the SPME fiber was inserted into the headspace for 30 min. Then, 
the SPME fiber with the sorbed analytes was manually inserted into the GC×GC–ToFMS injection 
port and exposed for 30 seconds allowing thermal desorption into heated inlet (250 °C), with 
the inlet lined with a 0.75 mm I.D. splitless glass liner, using splitless injection mode. The GC×GC–
ToFMS system, a LECO Pegasus 4D (LECO, St. Joseph, Mi., USA), contains an Agilent GC 7890A 
gas chromatograph (Agilent Technologies, Inc., Wilmington, De., USA), incorporating a dual 
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stage jet cryogenic modulator (licensed from Zoex), a secondary oven, and a mass spectrometer 
supplied with a ToF analyzer. In the first dimension (1D) an Equity-5 column (30 m × 0.32 mm 
I.D., 0.25 µm film thickness, Supelco, Inc., Bellefonte, Pa., USA) was used and a DB-FFAP column 
(0.79 m × 0.25 mm I.D., 0.25 µ m film thickness, J&W Scientific Inc., Folsom, Ca., USA) was used 
in the second dimension (2D). Helium was the carrier gas, at a constant flow rate of 2.50 mL/min. 
The primary oven temperature was programmed from 40 °C to 140 °C (10 °C/min-1; hold 1 min) 
and then to 200 °C (7 °C/min; hold 1 min). The secondary oven temperature program was 15°C 
offset above the primary oven. Both MS transfer line and MS source temperature were set at 
250 °C. The modulation time was 5 s and the modulator temperature was maintained at 20 °C 
offset above secondary oven, with hot and cold pulses through periods of 0.80 and 1.70 seconds, 
respectively. ToFMS was operated at a spectrum storage rate of 100 spectra/s. The mass 
spectrometer was operated in the EI mode at 70 eV and detector voltage of -1480 V, using a 
range of m/z 35–350. Total ion chromatograms (TIC) were processed using the automated data 
processing ChromaTOF software (LECO) at signal-to-noise threshold of 100. 
The data obtained were transferred into Guineu software (this software source code is 
published under GNU General Public License that can be downloaded from the internet 
(https://code.google.com/p/guineu/), and allows performing the score alignment based on first 
dimension retention time (1tR), on second dimension retention time (2tR), retention index (RI) 
value, spectra, and compound name.  
Compounds identification was performed by comparing the mass spectrum of each 
compound detected with those in mass spectral libraries, which included an in-house library of 
standards and commercial databases (Wiley 275 and US National Institute of Science and 
Technology (NIST) V. 2.0 – Mainlib and Replib). The identification was also supported by 
experimentally determined linear retention index (RI) values that were compared with values 
reported in the bibliography for chromatographic columns similar to the one used in the present 
work as the 1D column (Table A5.3, Annexes). A C8-C20 n-alkanes series was used for RI 
determination (the solvent n-hexane was used as C6 standard) comparing these values with 
reported ones in existing literature for chromatographic columns similar to 1D column above 
mentioned. The areas achieved were used to estimate the relative amount of each metabolite. 
The overall identified compounds presented similarity matches >800. To determine the relative 
content of each metabolite from each strain, area data from Deconvoluted Total Ion Current 
GC×GC were applied. 
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5.2.3. Statistical analysis 
From the 315 volatile organic compounds released from the S. aureus headspace (Table 
A5.3., Annexes), 240 were selected for statistical purposes (for an explanation please see 5.3.2), 
thus a full data matrix was constructed with 9 observations (three strains, in three independent 
assays) and 240 variables (volatiles) (Table B5.3, Annexes). The following strategy was used to 
extract relevant information from the S. aureus headspace volatiles: 
i. A heatmap hierarchical cluster, an unsupervised clustering analysis, was applied to evaluate 
the similarities among samples (i.e. strains) and, by using a chromatic scale, a graphical way 
of displaying the content of a metabolite is more intuitive. To achieve this, Euclidean 
distance measure and Ward clustering algorithm, were applied in chromatographic data 
previously normalized by CFU.mL-1 and autoscaled.  
ii. Then, Partial Least Squares Discriminant Analysis (PLS-DA) was applied using the same 
normalization criteria and VIP (Variable Importance in Projection) values were retrieved to 
identify the main volatiles that contribute for the distinction between the strains under study 
(clusters observed from the heatmap representation). Classification model complexity 
(number of latent variables) of the data set (Table B5.3, Annexes) was computed, as well as 
classification rate and Q2 (quality-of-fit criterion) were estimated by cross-validation.  
iii. A set of volatiles with VIP values higher than 1.5 was defined (Table A5.3, Annexes), and a 
heatmap hierarchical cluster visualization was constructed, using the chromatographic data 
previously normalized by CFU.mL-1 and autoscaled. 
iv. Calibration model weight randomization test (WRT) number of enterotoxins produced by 
S.aureus was calculated using Partial Least Square regression (PLS). A set of volatiles with 
VIP values above 1.5 obtained as described above were used for the calculations. The model 
was validated using leave one out validation. 
PLS-DA, VIP and heatmap hierarchical cluster visualization were conducted using 
MetaboAnalyst 3.0 (web interface). PLS was implemented with MATLAB, v. 7.12 (release 2011). 
5.3. Results and discussion 
5.3.1. Cell growth and extracellular pH 
Cell growth was similar (p > 0.05) for the three strains, with values of 9.15, 9.08 and 9.10 
log CFU.mL-1 for ATCC 6538, 2153 MA and 2065 MA, respectively (Figure 5.2 A), as reported 
before for the same strains and similar growth conditions (CHAPTER 3). 
The initial extracellular pH of 7.4 decreased after 8 h of incubation to 5.5 and 5.8 for the 
ATCC 6538 and enterotoxic strains, respectively (Figure 5.2 B). The decrease of the extracellular 
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pH during incubation time was expected, foremost because S. aureus is a facultative anaerobe 
and secondly because BHI was deliberately not buffered to mimic foodstuffs which are generally 
also not buffered. After 8 h of incubation onwards the pH remained relatively constant. These 
observations can be explained by changes in the exometabolome which will be discussed further 
ahead. 
 
Figure 5.2 - A) Cell viability of the three strains of Staphylococcus aureus under study, at 18 h of incubation (log 
CFU.mL-1 ± SD): ATCC 6538 (white), 2153 MA (light grey) and 2065 MA (dark grey). No significant differences 
were observed between strains. B) Extracellular pH values over 18 h incubation for the three strains: ATCC 6538 (black 
solid line with triangles), 2153 MA (light grey dashes with squares) and 2065 MA (dark dots with circles). 
5.3.2. Staphylococcus aureus volatile exometabolome profiling 
S. aureus cells were grown in BHI, a high nutrient non-selective broth medium with a pH 
of 7.4, which supports the growth and recovery of many bacteria, including S. aureus, from a 
variety of non-clinical and clinical specimens, such as food products. This “meaty” culture 
medium contains brain heart infusion and peptone, as nitrogen (proteins), vitamin and carbon 
sources, glucose as carbohydrate source, sodium chloride and disodium phosphate. The 
sterilization of BHI, like other culture media, is performed at 121 °C for 15 min in an autoclave, 
promoting the formation of unwanted compounds, such as Maillard reaction products, that are 
formed at temperatures higher than 100 °C and consists in the condensation of sugars with 
amino acids (AA) (392), both present in BHI. 
Approximately 1400 instrumental signals were detected using HS-SPME/GC×GC-ToFMS 
and, after the removal of column associated artefacts, 315 VOCs were retained (Table A5.3., 
Annexes), including acids, alcohols, aldehydes, esters, hydrocarbons, ketones, terpenes, 
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norisoprenoids, N-compounds, S-compounds. Pyrroles, pyridines, furan-like compounds, 
pyrazines and thiazoles were removed as they are most likely formed during culture medium 
sterilization (392,393). Further volatiles from the remaining families were excluded due to 
similar areas in both samples and blank controls, even though some of them were of metabolic 
significance. This was the case of 3-methyl-1-butanal and 2-phenylacetaldehyde, which can be 
either Strecker aldehydes (by-products of AAs reacting with α-dicarbonyl compounds), or 
products of leucine and phenylalanine metabolism, respectively (394). Other compounds such 
as propanoic acid, 2-methylpropanoic acid, 4-methyl-2-oxopentanoic acid, 2-
aminoacetophenone and methyl dihydrojasmonate, although associated with specific metabolic 
pathways, were also removed due to similar areas in samples and controls. Moreover, the 
volatiles indole and 3-methylindole, known to be products of tryptophan catabolism (due to the 
action of the enzyme tryptophanase) were excluded because S. aureus does not possess 
tryptophanase (323).  
 
Figure 5.3 - GC×GC-ToFMS total ion chromatogram contour plot of the Staphylococcus aureus ATCC 6538 culture 
headspace volatile components. Volatiles chemical families used for statistical analysis are represented by lines and 
clusters. The increase in volatility (low 1tR) is mainly related to the decrease in the number of carbons through the first 
dimension. On the other hand, an increase in the 2tR correlates to an increase in polarity through the second dimension. 
Subsequently, 240 volatiles (Table B5.3, Annexes) were used to build the dataset, which 
was composed by 10 chemical families as shown in the contour plot in Figure 5.3 and in Figure 
5.4: acids (0.8%), alcohols (13.3%), aldehydes (9.6%), esters (13.8%), hydrocarbons (21.3%), 
ketones (22.9%), terpenes (5.8%), norisoprenoids (1.3%), N-compounds (5.4%), and S-
compounds (5.8%). This dataset was considered the exometabolome of S. aureus, by the 
analytical procedure used in this work. 
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Figure 5.4 - Hierarchical clustered heatmap visualization of the three strains of Staphylococcus aureus cultures 
headspace volatiles, organized by chemical families: ATCC 6538, 2153 MA and 2065 MA. The chromatographic area 
of each metabolite was normalized by CFU.mL-1 followed by autoscaling. Each line corresponds to one metabolite and 
each column corresponds to each independent assay. 
None of the previous published studies for S. aureus was able to accomplish the putative 
identification of 240 volatiles at once. This confirms the high sensitivity and high throughput of 
HS-SPME/GCхGC-ToFMS in the detection of bacterial volatiles, previously demonstrated 
(257,315,390).  
In the present study it was possible to identify the main volatiles previously reported in 
the literature for S. aureus. These were: ethanol, 3-hydroxy-2-butanone, 2-propanone, acetic 
acid, 3-methyl-1-butanol, 3-methylbutanoic acid, dimethyl disulfide, methanethiol, 
acetaldehyde and 3-methylbutanal (270,282,297,302,303,388). This last volatile (Table A5.3, 
Annexes), although identified, was removed as previously explained. It is possible that after 
proper validation these volatiles can be used as biomarkers for S. aureus. Finding a specific 
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pattern of volatiles is of paramount importance for a quick and specific detection of S. aureus in 
food and clinical samples. 
Most of the previously mentioned volatiles were neither described as part of S. aureus 
exometabolome nor described to play an important role in its metabolism before. Some of these 
volatiles have their origin in BCAAs degradation, phenylalanine metabolism (either from 
degradation or from cyanoamino acid metabolism), degradation of methionine, carotenoid 
cleavage, mevalonate pathway (via geranyl diphosphate or via farnesyl diphosphate), or in the 
degradation of toluene and ethylbenzene. However some of the above mentioned volatiles are 
not yet associated with any pathway and no definite prove exist, as to their origin in S. aureus. 
Some of the volatiles detected play key roles in pH homeostasis while others are the result of 
oxidative stress, including lipid peroxidation. 
Observed stabilization of growth medium pH after 8 h of incubation was probably the 
outcome of the intrinsic acidification of the cells associated with ammonium production by 
arginine deiaminase (395). Although there is a high probability that all strains produced this 
volatile, it was absent from the chromatograms possibly due to its high volatility. Acetoin (3-
hydroxy-2-butanone) and 2,3-butanediol detected in the exometabolome of S. aureus are 
known to raise the internal pH of its cells. These volatiles, generated in the diacetyl pathway, 
contribute to pH homeostasis by decreasing the levels of pyruvate, thus avoiding the formation 
of acids (291). The content of these two volatiles is higher in ATCC 6538 (Table B5.3, Annexes). 
Conversion of pyruvate to acetoin as a mechanism of the pH homeostasis has been described 
for other bacterial species such as Lactobacillus plantarum and E. coli (362). 
A low extracellular pH can be responsible for oxidative stress in S. aureus (362). Several 
volatiles generated by oxidative stress were found: 1-butanol, hexanal, heptanal, octanal, 
nonanal, octane and nonane (396). Of these volatiles (Table B5.3, Annexes), the content of 
aldehydes was higher in 2153 MA, the content of 1-butanol and octane was higher in 2153 MA 
and equal to ATCC 6538, and nonane content was higher in 2065 MA. However, none of these 
volatiles have yet been described as oxidative stress markers in S. aureus.  
The strain 2153 MA also had the highest content of volatiles related to lipid peroxidation, 
namely hexanal, 2-heptenal, heptanal, octanal, nonanal, decanal, undecanal, dodecanal and 
tridecanal (396). Octane, another lipid peroxidation product (396), was detected in equal 
content for 2153 MA and ATCC 6538. Other lipid peroxidation products were detected with 
highest content in ATCC 6538 and/or 2065 MA: nonane (in 2065 MA), tetradecanal (in ATCC 
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6538) and pentadecanal (equal contents in both strains) (396). These results suggest that all 
strains suffered some degree of oxidative stress, especially 2153 MA (Table B5.3, Annexes). 
S. aureus contains seventeen types of carotenoids, including staphyloxanthin and γ-
carotene, which have an antioxidant role and are also responsible for the golden color of its cells 
(397). Oxidative stress causes carotenoid degradation via oxidation by non-specific enzymes, 
including lipoxygenases and peroxidases, which cleave non-specific double bonds, resulting in 
norisoprenoids (318,398). The norisoprenoid 6-methyl-5-hepten-2-one (Table B5.3, Annexes), 
already described for Staphylococcus spp., is the product of such sort of cleavage in γ-carotene 
(399). Contents of 6-methyl-5-hepten-2-one and geranylacetone (two out of three 
norisoprenoids detected) were higher in strain 2153 MA, suggesting the use of antioxidant role 
of carotenoids (which are found in the cellular membrane) as a protection against oxidative 
stress, mainly by this strain.  
Though methyl ketones were detected in S.aureus exometabolome in this work and are 
reported in the literature (248,270,278,282), there is no explanation for the presence of these 
compounds since S. aureus lacks fatty acids β-oxidation pathway (324) and, for many bacteria, 
methyl ketones are considered products of fatty acids β-oxidation. However, there is no proof 
that S. aureus and other species of Firmicutes own a different pathway with different enzymes 
and processes to use fatty acids (324). Thus, as this subject has not yet been studied intensively 
it is impossible to assert the origin of the methyl ketones detected in the current strains of S. 
aureus.  
5.3.3. Using the volatile exometabolome to distinguish strains 
A careful observation of Figure 5.4 (and of Table B5.3, Annexes), which is a hierarchical 
clustered heatmap containing the dataset of 240 volatiles, allows to examine the predominance 
of each chemical family by strain and the similarity between strains. Thus, it is possible to 
observe the presence of two main clusters, the first containing the 2065 MA strain and the 
second containing the strains ATCC 6538 and 2153 MA. Hence, 2065 MA achieved the highest 
content for the families of acids, alcohols, esters, ketones, N-compounds and terpenes and the 
lowest for the families of norisoprenoids and S-compounds. The stain ATCC 6538 had the highest 
content for the family of hydrocarbons and the lowest for the families of alcohols, aldehydes, 
ketones, and N-compounds and the strain 2153 MA showed highest content for the families of 
aldehydes, norisoprenoids and S-compounds and the lowest for the families of acids, esters, 
hydrocarbons and terpenes. 
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Specific volatiles from each family with highest content for each of the three strains were 
identified (Table B5.3, Annexes). Among acids, 3-methylbutanoic acid was the most abundant 
for all strains. The most prominent alcohol released from both ATCC 6532 and 2153 MA was 1-
dodecanol, while for 2065 MA it was 3-methyl-1-butanol. Benzaldehyde, 2-methyl-4-
phenylbutyric acid methyl ester, 3-ethyl-3-phenyl-1-pentene and phenylacetonitrile were the 
most abundant compounds for the families of aldehydes, esters, hydrocarbons and N-
compounds in all strains, respectively. For ATCC 6538 and 2153 MA the monoterpene with the 
highest content was tetrahydrogeraniol and for 2065 MA was dihydromyrcenol. The 
sesquiterpene with highest content for both ATCC 6538 and 2065 MA was β-caryophyllene while 
for 2153 MA was nerolidol. For ATCC 6538 and 2153 MA, the norisoprenoid with highest content 
was 6-methyl-5-hepten-2-one while for 2065 MA was geranylacetone. Finally, among S-
compounds, dimethyl disulfide had highest content in ATCC 6538 and 2065 MA whereas for 
2153 MA it was 3-(methylthio)-propanal. 
Table 5.1 - Sub-data set of volatiles with VIP (Variable Importance in Projection) and their values. Metabolic pathways 
from which each VIP putatively originated from is given. 
Peak 
number 
Volatiles VIP value Pathways Ref. 
164  2-Nonanone 2.11 - - 
234  Dimethyl trisulfide 2.06 Methionine degradation (318) 
237  Dimethyl tetrasulphide 2.03 Methionine degradation - 
7  3-Methylbutanol 2.00 Leucine degradation (303) 
63  3-Methyl-3-butenyl acetate 1.98 - - 
207  3-Methylbutanal oxime (isomer) 1.94 Leucine degradation (400) 
206  3-Methylbutanal oxime (isomer) 1.94 Leucine degradation (400) 
10 2-Methyl-3-hexanol 1.92 - - 
4  2-Methylpropanol 1.92 Valine degradation (394) 
29  2-Phenylethanol 1.90 Phenylalanine degradation (394) 
228  Methanethiol 1.90 Methionine degradation (394) 
208  Benzonitrile 1.87 Phenylalanine degradtion (394) 
181  1-Phenyl-1,2-propanedione 1.84 - - 
77  Methyl benzoate 1.82 
Phenylalanine or biphenyl or 
toluene degradation  
(401) 
183  4-Phenyl-2-butanone 1.75 - - 
236  6-(Methylthio)hexa-1,5-dien-3-ol 1.74 - - 
35  2−Methylpropanal 1.74 Valine degradation (394) 
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64 
 Methyl-2-hydroxy-4-
methylpentanoate 
1.74 
- 
- 
90  Butyl cyclopropanecarboxylate 1.74 - - 
153  2,3-Heptanedione 1.74 - - 
151  3-Hydroxy-2-pentanone 1.74 - - 
171  2-Tridecanone 1.73 - - 
231  Dimethyl disulfide 1.73 Methionine degradation (318) 
238  Dimethyl pentasulfide 1.69 Methionine degradation (318) 
176  2-Hexadecanone 1.69 -  
 
In order to examine the potential presence of groups (or clusters) among the strains a 
PLS-DA was applied and VIP values (Table 5.1) were assessed, and used to perform a hierarchical 
clustered heatmap (Figure 5.5 A). Twenty five volatiles with highest VIP values (above 1.73) were 
achieved. This sub-data set comprising alcohols, aldehydes, esters, ketones, N-compounds and 
S-compounds, allowed to see two main clusters: the first containing the 2065 MA strain (with 
three SE) and the second containing the strains 2153 MA (one SE) and ATCC 6538 (without SE). 
Most VIP volatiles were detected in allstrains, with differences between them mainly due to the 
contents of the chemical families released by each strain. Alcohols, aldehydes, esters, and N-
compounds were higher in the first cluster (2065 MA). In the second cluster, it was possible to 
observe that the strain ATCC 6538 had higher contents of S-compounds, while the strain 2153 
MA had intermediate contents of the VIP volatiles. Although this hierarchical clustered heatmap 
(Figure 5.5 A) is similar to the one achieved for the whole dataset (Figure 5.4), the Euclidian 
distance is different, being lower with the sub-data set of VIP, thus indicating a higher similarity 
between the strains than when using the whole dataset. In spite of the origin of almost half of 
the VIP volatiles is unidentified for S. aureus, the VIP volatiles with known origin belong to the 
metabolic pathways related to the degradation of BCAAs, phenylalanine and methionine and 
also cyanoamino acid metabolism. 
Metabolic pathways most active at the end of growth involving selected volatiles are 
shown in Figure 5.5 B with the aim to illustrate difference between enterotoxic and non-
enterotoxic strains. Volatiles originating from the degradation of BCAAs and the cyanoamino 
acid pathway (with origin at leucine which is a BCAA) have the highest content in the strain 2065 
MA and lowest the in the ATCC 6538. Volatiles resultant from methionine degradation have the 
highest content in ATCC 6538. Most of volatiles with unknown origin have higher content in 
2065 MA. Thus, taking into account that volatiles originating from BCAAs metabolism (either 
degradation or via cyanoamino acid pathway) such as 3-methylbutanol, isomers of 3-
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methylbutanal oxime, 2-methylpropanol and 2-methylpropanal, have highest content in the 
strain with more enterotoxins (2065 MA) and lowest in the strain without enterotoxins (ATCC 
6538), it is probable that those volatiles are part of biomarker pattern for strains with at least 
more than one SE. On the other hand, as volatiles originating from methionine degradation such 
as methanethiol, dimethyl disulfide, dimethyl trisulfide, dimethyl tetrasulfide and dimethyl 
pentasulfide, have the highest content in ATCC 6538 and the lowest in 2065 MA, it is possible 
that those volatiles are part of biomarker pattern for strains without or with only one SE. 
Furthermore, an exploratory study was done using the sub-set of 25 metabolites, which 
was used to construct a calibration model (y = 0.9866x + 0.0178, R2 = 0.9866) for prediction of 
number of enterotoxins. Satisfactory correlation coefficients (above 0.9 for both calibration and 
validation) and low prediction root-mean-square errors (0.1293 and 0.2250 number of toxins, 
for calibration and validation, respectively), suggests that this sub-set of volatiles is a good 
candidate for a pattern of biomarkers to identify enterotoxic strains of S. aureus and to estimate 
the number of SE that they produce. To see if this pattern: higher amounts of byproducts of the 
degradation of BCAAs higher and lower levels of degradation of methionine in the strain with 
three enterotoxins than in the other two; byproducts of the degradation of methionine higher 
and degradation of BCAAs lower in the strain without enterotoxins than in the other two; 
intermedium contents of both BCAAs and methionine degradation in the strain with one 
enterotoxin when compared with the other two strains; PLS was applied and showed a positive 
correlation (R2 = 0.9866) between the number of enterotoxins and the content of degradation 
products of BCAAs and methionine.  
The higher content of BCAAs degradation volatiles in the enterotoxic strains can be 
explained by the degradation of their enterotoxins (monomeric proteins). The degradation of 
proteins has already been described for S. aureus when it needs to raise the extracellular pH to 
consequently raise the internal pH, fact that was attributed to the upregulation of genes 
involved in the degradation of proteins, peptides and glycopeptides (291,362). The enterotoxic 
strains have in their SEs constitution 20% of BCAAs, with 46 residues and 81 residues of leucine, 
20 residues and 52 residues of isoleucine, and 26 and 50 residues of valine, for 2153 MA and 
2065 MA, respectively (127,402,403). This seems consistent with the content of volatiles 
released by the enterotoxic strains from BCAAs degradation. As ATCC 6538 lacks SE, it does not 
have these extra AAs, which explains the lower content of BCAAs degradation volatiles. Most 
volatiles were detected in all three strains with exception of methyl farnesoate, which was 
absent in 2065 MA, and dimethyl pentasulfide, which was absent in both enterotoxic strains. 
Furthermore, it is possible to examine the predominance of several chemical families in each 
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strain (Table B5.3, Annexes, seen in the Subtotal cells; and Figure 5.4). The predominant families 
were: hydrocarbons for ATCC 6538 (non-enterotoxic); aldehydes, norisoprenoids and S-
compounds for 2153 MA; acids, alcohols, esters, ketones, N-compounds and terpenes for 2065 
MA. 
Aromatic volatiles such as phenylacetonitrile, 2-phenylethanol or 5-methyl-2-phenyl-2-
hexenal and other volatiles derived from phenylalanine had, overall, higher content in the 
enterotoxic strains. However, some of these volatiles, such as methylbenzene, 1,3-
dimethylbenzene, naphthalene and biphenyl, might also be products of degradation of aromatic 
compounds present in the controls (culture medium).  
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Figure 5.5 - A) Hierarchical clustered heatmap visualization of the volatiles with VIP values (Variable importance in 
Projection from PLS-DA) higher than 1.5 from the three strains of Staphylococcus aureus cultures headspace volatiles, 
organized by chemical families: ATCC 6538, 2153 MA and 2065 MA. The chromatographic area of each metabolite 
was normalized by CFU.mL-1 followed by autoscaling. Each line corresponds to one metabolite and each column 
corresponds to each independent assay. B) Metabolic pathways related with the VIP volatiles and their relative content 
in three strains of Stapylococcus aureus under study: S1 - ATCC 6538; S2 - 2153 MA; and S3 - 2065 MA. Relative 
content of metabolite is illustrated on a red (high) to blue (low) scale.
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Fourteen volatile sulfur volatiles had the highest content in ATCC 6538 and thirteen had 
the highest content in the enterotoxic strains. Almost all volatile sulfur volatiles either originate 
from the AA methionine degradation, such as methanethiol and 3-(methylthio)-propanal 
(methional), or are derived from methanethiol, such as dimethyl disulfide, dimethyl trisulfide, 
dimethyl tetrasulphide, or are formed in the reaction of methanethiol with another metabolite, 
as for example methylthiolacetate, which is a product of methanethiol reaction with acetyl-CoA 
(404). ATCC 6538 has more S-compounds originating from the degradation of methionine, an 
AA extremely vulnerable to oxidative stress, than the enterotoxic strains, and this might mean 
that methionine sulfoxide reductases, responsible for the repair of oxidized staphylococcal 
proteins (405), can be less active in the ATCC 6538 strain. Some of the other volatile sulfur 
volatiles shown in Table B5.3 (Annexes) have been associated with bacteria while others have 
been described only for fungi.  
The differences between volatiles, mainly in content, in the three strains with origin in the 
degradation of AAs (leucine, isoleucine, valine, phenylalanine and methionine) can be the result 
of different contents of precursor biomolecules, including virulence factors. 
5.4. Conclusion 
Because enterotoxic strains of S. aureus are the causing agents of SFP, it is highly 
important to study the metabolome of S. aureus and to see if a distinction between non-
enterotoxic strains and enterotoxic strains is possible.  
It can be concluded that S. aureus volatile exometabolome is more complex (240 volatiles) 
than it was previously reported, consisting in 10 chemical families: acids, alcohols, aldehydes, 
esters, hydrocarbons, ketones, terpenes, norisoprenoids, N-compounds, and S-compounds, 
with volatiles originating in different metabolic pathways. Until now, no other study was able to 
detect and putatively identify as many volatiles as the current study for S. aureus. These volatiles 
may have origin from branched-chain amino acids and methionine degradation, pyruvate 
metabolism, diacetyl pathway, oxidative stress and carotenoid cleavage. 
By using PLS-DA it was possible to achieve twenty five VIP (2-nonanone, dimethyl 
trisulfide, dimethyl tetrasulphide, 3-methylbutanol, 3-methyl-3-butenyl acetate, two isomers of 
3-methyl-butyl aldoxime, 2-methylpropanol, 2-phenylethanol, methanethiol, benzonitrile, 1-
phenyl-1,2-propanedione, methyl benzoate, 4-phenyl-2-butanone, 6-(methylthio)hexa-1,5-
dien-3-ol, 2−methylpropanal, methyl 2-hydroxy-4-methylpentanoate, butyl 
cyclopropanecarboxylate, 2,3-heptanedione, 3-hydroxy-2-pentanone, 2-tridecanone, dimethyl 
disulfide, fimethyl pentasulfide and 2-hexadecanone) which were mainly responsible for the 
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distinction between the enterotoxic strain with three SE (2065 MA) and the strains with lower 
(2153 MA) or none (ATCC 6538) enterotoxins. Furthermore, PLS regression was used in these 
twenty five VIP and it was also possible to observe, that enterotoxic strain 2065 MA (three SE) 
produced higher contents of 3-methylbutanol, isomers of 3-methylbutanal oxime, 2-
methylpropanol and 2-methylpropanal and that the strains 2153 MA and ATCC 6538 (with one 
or none SE, respectively) produced higher contents of of methanethiol, dimethyl disulfide, 
dimethyl trisulfide, dimethyl tetrasulfide and dimethyl pentasulfide. Thus, by using PLS 
regression, tt was possible to associate the contents of the VIP obtained to the number of 
enterotoxins. Using these results, it is possible to see that the pathway of branched-chain amino 
acids is more active in the strain 2065 MA and that the pathway of methionine degradation is 
more active in the strains 2153 MA and ATCC 6538 Nonetheless, further studies need to be 
performed to confirm these findings. 
This is the first study of the volatile exometabolome of S. aureus using HS-SPME/GCxGC-
ToFMS showing the difference between enterotoxic and non-enterotoxic strains. Although the 
volatiles allowing its distinction must be validated, this is the beginning of a path which can be 
potentially applied in the food industry using simple and cheaper technologies. This would result 
in higher food safety for the consumer and a reduction of costs for the food industry and health 
services. More importantly, further works must be done to determine assure the pattern of 
biomarkers for S. aureus as a species and stains, such as using S. aureus in a mixture of foodborne 
microorganisms and also by using different culture media culture and food products. 
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General discussion 
In this work it was investigated the control and detection of different strains of S. aureus. 
Specifically, HPP was used as an approach for the inactivation of microorganisms, in particular 
as a way of controlling enterotoxic strains of S. aureus that can be spread by food. As a new 
approach to distinguish different strains, the volatile exometabolome of S. aureus was 
characterized. 
The choice of bacteria to work followed some criteria which included being: i) a foodborne 
pathogen (18,50,53,55); ii) of significance from the food safety point of view 
(18,50,53,55,60,61,91,94,327,331,406); iii) described as a challenge for HPP; (135,136,328); iv) 
considered a worldwide major health problem, such having the capability of causing a wide 
range of diseases easy to transfer, possessing a large number of virulence factors, adaptable to 
different sorts of environments and multi-resistant to antibiotics (8,329,330,406); 
HPP, as a fairly new food processing technique has already be applied all over the world 
in a variety of food products with success (99,103,110). Although several studies have already 
been done concerning HPP, only 57 were published between 1985 and 2014 for S. aureus. HPP 
is dependent of many factors and this work was focused on three: pressurization values, holding 
times and strains. Furthermore, as S. aureus is a barotolerant species (326), in this work was 
evaluated if the tested strains were able to develop resistance and if they were able to recover 
their viability after the treatments, as seen in other HPP studies (111,208).  
The results of this work are in line with results obtained for other works 
(177,205,326,345), showing that higher pressure values and higher holding times are more 
effective against the tested strains. HPP affected differently the tested strains, inactivating 
completely the two enterotoxic strains (2153 MA and 2065 MA) at 600 MPa for 30 min, but 
causing only a reduction of 5.11 log CFU.mL-1 in the non-enterotoxic strain (ATCC 6538). The 
explanation for this lies most certainly in the genotypic and phenotypic traits that are different 
in these strains, with σB factor likely conferring the barotolerance or barosensitivity to the 
strains, since this factor controls genes related with the production of carotenoids and also the 
production of SE (188,201). In fact, the most barosensitive strains not only had SE but also had 
lower carotenoid content and the barotolerant strain have not SE and had higher carotenoid 
content.  
The results of this study also showed that HPP has no effect on the virulence factors of 
none of the strains, even though the enterotoxic strains were more easily inactivated. The 
following step was to test if S. aureus was capable of developing resistance to HPP treatments. 
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The results showed a reduction in the survival for the ATCC 6538 and the 2153 MA (SEA) strains 
from the first to the second cycle. In the remaining cycles viability remained relatively constant. 
On the other hand, for the strain with three SE (2065 MA), the viability decreased over the HPP 
cycles until complete inactivation at the fourth cycle. Thus, the first strains were both 
barotolerant over the successive cycles while the latter was barosensitive. Although the 
probability for a bacterium to develop HPP resistance is low due to the fact that HPP treatment 
causes damages in several components of the cell, part of the population of the first two strains 
remain constantly barotolerant across the other 9 cycles. Independently of the strains and 
cycles, there was no recovery from HPP treatments with viability remaining the same.  
The fact that HPP inactivates S. aureus enterotoxic strains, along with the inability to 
create resistance to HPP treatments and to recover even after 14 days, shows that this food 
processing method has great potential concerning food safety. A positive outcome is that by 
applying HPP treatments in early stages of food processing, enterotoxic strains will be totally 
inactivated which will result in the absence of SE and consequently, SFP is avoided. 
In the second part of this work, the characterization of S. aureus volatile exometabolome 
was used in order to see if differences between enterotoxic and non-enterotoxic strains could 
be detected. Even though conventional methods are usually effective for the detection of S. 
aureus, with both conventional and molecular methods distinguishing S. aureus strains, they are 
contrariwise time consuming and, if molecular methods are used, it can exist an interference of 
food components with the activity of the polymerase enzyme. Thus, to detect differences 
between strains of S. aureus, microbial metabolomics, specifically the volatile exometabolome, 
was used. The use of the volatile exometabolome approach has the advantage of giving good 
results with the minimum sample manipulation. This procedure was used not only to have a 
clear picture of S. aureus volatile exometabolome, but also to see if it was possible, by this 
means, to detect if differences between enterotoxic and non-enterotoxic strains exist and if so, 
at what level. Furthermore, it was also intended to see, if possible, a pattern of biomarkers that 
could identify S. aureus. 
The use of the volatile exometabolome has already given positive proofs for the 
characterization, detection and identification of species and strains not only of S. aureus, but of 
other species as well and in many different matrices [from medium culture to blood, beer, and 
exhaled breath, among others (12,247,257,267,274,304–306)]. Comparing the results obtained 
in other studies for S. aureus volatile exometabolome, none was able to detect as many volatile 
compounds as in this study, probably because HS-SPME/GC×GC-ToFMS is a sensitive approach. 
The 240 volatiles identified in the volatile exometabolome of S. aureus belong to ten different 
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chemical families (acids, alcohols, aldehydes, esters, hydrocarbons, ketones, terpenes, 
norisoprenoids, N-compounds and S-compounds). Some of these volatiles play key roles in pH 
homeostasis [like 3-hydroxy-2-butanone and 2,3-butanediol which raise the internal pH of cells 
(291)] while others are the result of oxidative stress, caused by expected decrease of pH due to 
the growth of the bacteria in a non-buffered medium culture (362). Furthermore, many of the 
volatiles associated with oxidative stress were higher in the strain 2153 MA, indicating that this 
strain experienced higher levels of oxidative stress although still maintaining similar viability to 
the other two strains. On the other hand, the volatiles 3-hydroxy-2-butanone and 2,3-butanediol 
were higher in the ATCC 6538 strain, indicating that this strain coped with the lower external pH 
by diverting the pyruvate metabolism, thus avoiding the development of intracellular acids 
(291,362,407). 
Additionally, it was possible to detect differences in the volatile exometabolome 
compounds of the non-enterotoxic strain from the enterotoxic strains. By using PLS-DA, a 
supervised multivariate statistical analysis, twenty five VIP volatiles (Table 5.1) were extracted 
which were responsible for the distinction of the three strains into two main clusters: the first 
containing the strains ATCC 6538 and 2153 MA and the second containing solely the strain 2065 
MA. Hence, it was possible to see that the strain with higher SE number was less similar than 
the strains with one or none SE. Analyzing in detail the twenty five volatiles (Table 5.1), it was 
possible to see that, although these volatiles were present in all strains, their content was 
different according to each strain, and that the metabolic pathway in their genesis was different, 
i.e., the ATCC 6538 strain had higher contents of the volatiles derived from the degradation of 
methionine while the 2065 MA strain showed higher contents of the volatiles derived from the 
degradation of BCAA. The strain 2153 MA (only with one SE) had intermediate contents but 
more similar to the contents of the ATCC 6538 strain. When PLS regression was applied, a 
positive correlation (R2 = 0.9866) between the number of enterotoxins and the content of 
degradation products of BCAAs and methionine was observed. Thus, by using the volatile 
exometabolome, it was possible to distinguish strains by the number (or absence) of SE, 
clustering the strains by the content of the 25 VIP volatiles and the metabolic pathway in the 
origin of those volatiles. 
Furthermore, as a result from the analysis of the volatile exometabolome, it was also 
possible to see that in this study ten volatiles in common with other previous work that were 
highly described as volatiles of S. aureus were detected. Thus, these volatiles (ethanol, 3-
hydroxy-2-butanone, 2-propanone, acetic acid, 3-methyl-1-butanol, 3-methylbutanoic acid, 
dimethyl disulfide, methanethiol, acetaldehyde and 3-methylbutanal) can be considered as 
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good candidates to form a pattern of biomarkers of S. aureus. In fact, as with this work, this is 
the objective of many microbial metabolomics assays, which search for a pattern of biomarkers 
that characterize a species responsible for a specific disease in a non-invasive way, but in the 
present case it would be used to detect the presence of S. aureus in food. Ideally, in a near 
future, patterns of biomarkers could be used in portable and cheaper equipments that would 
allow the detection of microorganisms at the species level, or even strain, in food, clinical 
specimens and different environments. As consequence, contaminated food can be removed 
from shelves or rejected in food industry lines and infections can be treated earlier and with 
proper antibiotics. 
Limitations of the research 
Despite the novelty of the presented results in the CHAPTER 3, CHAPTER 4 and CHAPTER 
5, this work is not free of some limitations. 
The first concern was the use of PBS as the matrix in the HPP assays, since it is well known 
that the use of buffers causes the overestimation of HPP effects, since in general food matrices 
concede a protective effect to the bacteria being tested (361,386). Furthermore, longer holding 
times were used in this study in comparison to the currently applied by the food industry (3―5 
min) (169,326). However, the levels of bacteria used in the experiments were also much higher 
(between 108 and 109 CFU mL-1) than those found in food. Thus if lower levels of bacterial 
concentrations had been used in these studies, holding times could also be lower (368). Another 
limitation can be found in the studies of HPP in S. aureus virulence factors. These results should 
be confirmed by direct quantification of the virulence factors, particularly in the supernatant, 
obtained by centrifuging the samples after HPP treatments.  
Furthermore, concerning the general inactivation of S. aureus by HPP, it is impossible to 
state that there was a total inactivation based only in cultivation methods. Molecular methods 
should have been applied to detect the presence of VBNC forms that could still resist HPP 
treatments. 
Although it might not be considered a limitation the information acquired from the 
volatile exometabolome of S. aureus, enabled to gain some knowledge of how S. aureus cells 
behave during growth in a non-buffered medium culture, with the last becoming more acidic 
with the growth of the culture. Although it is impossible to establish a comparison with food, 
the use of non-buffered BHI, a complex meaty medium, gives a hint as how this bacteria might 
behave in meat food products. Using a buffered BHI could probably give different results, 
concerning both types and contents of volatiles, but this is only an hypothesis.  
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Finally, although the use of HS-SPME/GC×GC-ToFMS allows the extraction and 
identification of large quantities of volatiles, confirming the identity of those volatiles requires 
an extensive knowledge of mass spectrometry that is also time consuming. Furthermore, the 
exclusion of pyrazines or furans or halogenated compounds might not be totally correct since 
such compounds have already been described for some bacterial species (318). However this is 
controversial, since most of this compounds have their origin in the culture media and not in the 
bacterial metabolism (392,393). Nonetheless, for example, in the study of Rode et al. (2010) 
(291), an increase in the levels of pyrazine is described as a means to reduce the levels of organic 
acids and increasing the external pH of the media culture in which S. aureus is growing. 
Finally, an interesting finding that remains without explanation was the fact that the 
cluster attained in the volatile exometabolome, i.e., ATCC 6538 and 2153 MA versus 2065 MA, 
was similar to the results achieved in the HPP resistance assays, in which ATCC 6538 and 2153 
MA were not inactivated after ten consecutive cycles, while the strain 2065 MA was fully 
inactivated by the fourth cycle.  
Conclusions 
The main conclusions of the work developed in this thesis are: 
 S. aureus strains enterotoxic strains were more easily inactivated by HPP 
treatments 
 S. aureus strains with lower carotenoids content more easily inactivated by HPP 
treatments.  
 Cells surviving HPP treatment did not lose their ability to produce SE and other 
factors/characteristics of virulence.  
 HPP treatments effectively inactivate S. aureus (reduction of ≈ 5 log) after a single 
treatment.  
 The strains ATCC 6538 and 2153 MA with no SE and one SE, respectively, were 
able to endure ten consecutive cycles of HPP treatments, while the strain with three 
SE, 2065 MA, was completely inactivated by the fourth cycle. 
 None of the surviving cells were able to develop resistance even after repeating 
cycles of HPP. 
 HPP can be an efficient food processing treatment for S. aureus depending on the 
initial number of CFU. This is especially important for enterotoxic strains since 
HPP is unable to destroy SE. 
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 S. aureus volatile exometabolome is more complex (240 volatiles) than it was 
previously reported in other studies, most likely due to the use of HS-
SPME/GCxGC-ToFMS as an extraction and identification approach. 
 The main active pathways found in this work for S. aureus were: degradation of 
BCAAs, degradation of methionine, cyanoamino acid metabolism, pyruvate 
metabolism and diacetyl pathway, oxidative stress (including lipid peroxidation) 
and carotenoid cleavage. 
 Using the volatile exometabolome of the three strains of S. aureus it was possible 
to detect differences between the strain with most SE (2065 MA) from the two 
strains with none or one SE shown by the positive correlation (R2 = 0.9866) 
between the number of enterotoxins and the content of degradation products of 
BCAAs and methionine. 
 Finally, a possible pattern of biomarkers for S. aureus species, consisting of 10 
volatiles, previously reported in other studies, was also found in this work. 
Future work 
This study demonstrated the capability of HPP to control S. aureus, causing either full 
inactivation of enterotoxic strains or a reduction of the non-enterotoxic. Further work should be 
done in order to confirm if enterotoxic strains are indeed more susceptible to HPP inactivation, 
while studying if activity of the genes controlled by the σB factor. Additionally, experiments 
should be done in food products with different features that either protect the cells or enhance 
inactivation. The assay concerning the resistance and recovery should also be repeated 
detecting not only the VBNC, but also studying the molecular profile of the bacterial population 
present in the samples over the ten consecutive cycles (negative controls, i.e., suspensions 
without pressurization, and the pressurized suspensions), in order to understand the existence 
of barotolerant cells. Finally, the effect of HPP on virulence factors should be performed directly 
on the virulence factors and not on the virulence factors with origin in survivor cells. 
It is also needed much more work concerning the proposed volatile biomarkers of S. 
aureus. These ones will have to be validated in a series of assays. Such assays will include 
metabolite target analysis, in which ethanol, 3-hydroxy-2-butanone, 2-propanone, acetic acid, 
3-methyl-1-butanol, 3-methylbutanoic acid, dimethyl disulfide, methanethiol, acetaldehyde and 
3-methylbutanal will be searched using other strains with different backgrounds 
(environmental, food or clinical strains), with different characteristics (such as antibiotic 
resistance and sensitivity) in different media cultures. Afterwards, if these ten volatiles are 
present in all the tested conditions, assays including other microorganisms will also be important 
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to confirm the value of the selected potential biomarkers for S. aureus. The microorganisms 
chosen should belong to the same genus, but also to different phylum. Ideally, biomarkers for 
those microorganisms chosen should also be known which could be bypassed with an extensive 
research concerning the volatiles reported for the species which will be chosen. Such assay 
should mingle all tested species in one single medium culture and, afterwards, other media 
culture, food and clinical specimens would be tested. 
Moreover, in order to get an accurate picture of the volatile exometabolome of S. aureus, 
other conditions such as growth temperature, growth phase, presence of NaCl, 
presence/absence of oxygen, presence/absence of glucose, presence/absence of antibiotics 
should also be evaluated.  
Additionally, in order to get a wider picture of the volatile exometabolome of S. aureus 
and also still aiming for the volatile biomarkers, conditions such as growth temperature, growth 
phase, different NaCl concentrations, presence/absence of oxygen, presence/absence of 
glucose, presence/absence of antibiotics among many others factors should also be included in 
future works. Furthermore, the metabolic pathways of S. aureus should be studied in order to 
avoid the attribution of incorrect origins of its volatiles. Finally, because S. aureus strains are 
frequently multi-resistant, the study of its pathways would be primary to know how a 
determined antibiotic acts in a sensitive and in a resistant S. aureus cell. 
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Table A2.2 - Volatiles of Staphylococcus aureus detected and reported by different studies. Most volatiles reported were produced by this species. However, few of the reported were detected 
but not produced (for example, 2-propanone and butanal). 
Name (Color from Figure 2.3) Formula CAS Number Techniques Refs. Pathway 
Acids 
 Acetic acid  C2H4O2 64-19-7 GC-FID 
GC-FID 
GC-MS 
GC-MS 
SESI-MS 
SIFT-MS 
GC-MS 
GC-MS 
GC-MS 
SIFT-MS 
LC-MS 
(309) 
(310) 
(311) 
(282) 
(286) 
(292) 
(303) 
(279) 
(236) 
(283) 
(291) 
NA 
NA 
NA 
NA 
NA 
NA 
Pyruvate metabolism 
NA 
Pyruvate metabolism 
NA 
NA 
 Acetate C2H3O2 71-50-1 1H-NMR 
1H-NMR 
1H-NMR 
1H-NMR 
(297) 
(294) 
(284) 
(408) 
Glycolysis 
Pyruvate metabolism 
Glycolysis 
NA 
 Propanoic acid C3H6O2 79-09-4 GC-MS 
SIFT-MS 
(282) 
(283) 
NA 
NA 
 2-Methylpropanoate C4H7O2 - 
1H-NMR 
1H-NMR 
(294) 
(408) 
NA 
NA 
 2-Methylpropanoic acid C4H8O2 79-31-2 GC-MS 
GC-MS and GC/FPD 
(270) 
(304) 
NA 
NA 
 Butanoic acid C4H8O2 107-92-6 GC-MS 
GC-MS and GC/FPD 
SIFT-MS 
APCI-MS 
SIFT-MS 
(311) 
(304) 
(292) 
(409) 
(283) 
NA 
NA 
NA 
NA 
NA 
 2-hydroxybutanoic acid C4H8O3 600-15-7 1H-NMR (294) NA 
 192 
 
 
 2-Hydroxy-2-methylpropanoic acid C4H8O3 594-61-6 
1H-NMR (294) NA 
 2-Methylbutanoate C5H9O2 - GC-MS 
1H-NMR 
(311) 
(408) 
NA 
NA 
 3-Methylbutanoate C5H9O2 108-21-4 GC-MS
 
1H-NMR 
1H-NMR 
(311) 
(294) 
(408) 
NA 
NA 
NA 
 2-Methylbutanoic acid C5H10O2 116-53-0 GC-MS and GC/FPD 
1H-NMR 
(304) 
(297) 
NA 
NA 
 3-Methylbutanoic acid C5H10O2 503-74-2 GC-MS 
GC-FID 
GC-FID 
GC-MS and GC/FPD 
GC-MS 
GC-MS 
GC-MS 
GC-MS 
APCI-MS 
GC-MS 
GC-MS 
(270) 
(309) 
(310) 
(304) 
(282) 
(303) 
(240) 
(279) 
(409) 
(236) 
(291) 
NA 
NA 
NA 
NA 
NA 
Leucine metabolism 
NA 
NA 
NA 
Leucine metabolism 
NA 
 2-Hydroxy-3-methylbutanoic acid C5H10O3 4026-18-0 1H-NMR (294) NA 
 3-Hydroxy-3-methylbutanoic acid C5H10O3 625-08-1 1H-NMR (294) NA 
 4-methyl-2-oxopentanoic acid 
C6H10O2 816-66-0 1H-NMR (294) NA 
 Benzoic acid C7H6O2 65-85-0 GC-MS (282) NA 
 4-Methylhexanoic acid C7H14O2 1561-11-1 GC-MS and GC/FPD (304) NA 
2-(3-acetoxy-4,4,14-trimethylandrost-8-en-17-yl)-
propanoic acid a 
C27H42O4 - 
GC-MS (410) NA 
Alcohols 
 Methanol CH4O 67-56-1 SIFT-MS 
SIFT-MS 
(243) 
(283) 
NA 
NA 
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 Ethanol C2H6O 64-17-5 SIFT-MS 
SIFT-MS 
GC-MS 
SESI-MS 
1H-NMR 
SIFT-MS 
GC-MS 
MCC-IMS and GC-MS 
1H-NMR 
1H-NMR 
1H-NMR 
SIFT-MS 
GC-MS 
GC-MS 
GC-MS 
SIFT-MS 
LC-MS and GC-MS 
(302) 
(281) 
(282) 
(286) 
(297) 
(292) 
(303) 
(287) 
(294) 
(284) 
(295) 
(243) 
(279) 
(236) 
(308) 
(283) 
(291) 
NA 
NA 
NA 
NA 
NA 
NA 
Pyruvate metabolism 
NA 
Pyruvate metabolism 
Pyruvate metabolism 
Pyruvate metabolism 
NA 
NA 
Pyruvate metabolism 
NA 
NA 
NA 
 Ethane-1,2-diol 
C2H6O2 107-21-1 GC-MS (282) NA 
 1-Propanol C3H8O 71-23-8 GC-MS 
SIFT-MS 
SIFT-MS 
(282) 
(243) 
(283) 
NA 
NA 
NA 
 2-Propanol C3H8O 67-63-0 1H-NMR (294) NA 
 Glycerol C3H8O3 56-81-5 
1H-NMR (294) NA 
 1-Butanol C4H10O 71-36-3 GC-MS 
SESI-MS 
SIFT-MS 
GC-MS 
GC-MS 
GC-MS 
SIFT-MS 
(282) 
(286) 
(292) 
(303) 
(279) 
(236) 
(283) 
NA 
NA 
NA 
Pyruvate metabolism 
NA 
Pyruvate metabolism 
NA 
 2-Butanol C4H10O 78-92-2 GC-MS 
GC-MS 
(270) 
(303) 
NA 
NA 
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 2-Methyl-1-propanol C4H10O 78-83-1 GC-FID 
GC-MS 
GC-MS 
GC-MS 
(270) 
(303) 
(279) 
(236) 
NA 
NA 
NA 
NA 
 1,1-Butanediol C4H10O2 25265-75-2 
1H-NMR (295) Pyruvate metabolism 
 2,3-Butanediol C4H10O2 513-85-9 
1H-NMR 
1H-NMR 
1H-NMR 
(297) 
(284) 
(408) 
NA 
Pyruvate metabolism 
NA 
 2-Methylbut-3-en-2-ol C5H10O 115-18-4 GC-FID (270) NA 
 1-Pentanol 
C5H12O 71-41-0 SIFT-MS 
SIFT-MS 
(292) 
(283) 
NA 
NA 
 3-Methyl-1-butanol C5H12O 123-51-3 GC-FID 
GC-MS 
GC-MS 
SESI-MS 
GC-MS 
MCC-IMS and GC-MS 
GC-MS 
E-nose and GC-MS 
GC-MS 
GC-MS 
(270) 
(311) 
(282) 
(286) 
(303) 
(287) 
(240) 
(300) 
(279) 
(236) 
NA 
NA 
NA 
NA 
Leucine catabolism 
NA 
NA 
NA 
NA 
 Phenol C6H6O 108-95-2 SIFT-MS (283) NA 
 (E)-2-methylpent-2-en-1-ol 
C6H12O 1610-29-3 GC-FID (270) NA 
4-Methylphenol 
C7H8O 106-44-5 GC-MS 
SESI-MS 
(282) 
(286) 
NA 
 2-Methyl-3-hexanol C7H16O 617-29-8 GC-MS (282) NA 
 4-Methyl-1-hexanol C7H16O 818-49-5 GC-MS (282) NA 
 2-Phenylethanol 
C8H10O 60-12-8 GC-MS and GC/FPD (304) NA 
 2-Ethyl-1-hexanol 
C8H18O 104-76-7 E-nose and GC-MS (300) NA 
 2,4,7,9-tetramethyldec-5-yne-4,7-diol 
C14H26O2 126-86-3 GC-MS (282) NA 
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 Tetradecanol 
C14H30O 112-72-1 GC-MS (282) NA 
 2,6-Di-tert-butyl-4-methylphenol 
C15H24O 128-37-0 GC-MS (282) NA 
Aldehydes 
 Formaldehyde 
CH2O 50-00-0 SIFT-MS 
SIFT-MS 
SIFT-MS 
(292) 
(312) 
(283) 
NA 
NA 
NA 
 Acetaldehyde C2H4O 75-07-0 SIFT-MS 
SIFT-MS 
GC-MS 
GC-MS 
SIFT-MS 
GC-MS 
SIFT-MS 
GC-MS 
GC-MS 
(302) 
(281) 
(311) 
(282) 
(292) 
(303) 
(243) 
(279) 
(236) 
NA 
NA 
NA 
NA 
NA 
Pyruvate metabolism 
NA 
NA 
Pyruvate metabolism 
 Propanal C3H6O 123-38-6 GC-MS 
GC-MS 
GC-MS 
GC-MS 
SIFT-MS 
(282) 
(303) 
(279) 
(236) 
(283) 
NA 
NA 
NA 
NA 
NA 
 Propanedial C3H4O2 542-78-9 SIFT-MS (283) NA 
 Methacrolein C4H6O 78-85-3 GC-MS 
GC-MS 
GC-MS 
(303) 
(279) 
(236) 
NA 
NA 
NA 
 2-Butenal C4H6O 4170-30-3 SIFT-MS (283) NA 
 Butanal C4H8O 123-72-8 SIFT-MS (243) NA 
 2−Methylpropanal C4H8O 78-84-2 SIFT-MS 
GC-MS 
GC-MS 
GC-MS 
(292) 
(303) 
(279) 
(236) 
NA 
NA 
NA 
NA 
 196 
 
 
 (Z)-2-Methyl-2-butenal C5H8O 1115-11-3 GC-MS 
GC-MS 
GC-MS 
(303) 
(279) 
(236) 
NA 
NA 
NA 
 (E)-2-Methyl-2-butenal C5H8O 497-03-0 GC-MS 
GC-MS 
GC-MS 
(303) 
(279) 
(236) 
NA 
NA 
NA 
 3-Methyl-2-butenal C5H8O 107-86-8 GC-MS 
GC-MS 
GC-MS 
(303) 
(279) 
(236) 
NA 
NA 
NA 
 2-Ethylacrolein C5H8O 922-63-4 GC-MS 
GC-MS 
GC-MS 
(303) 
(279) 
(236) 
NA 
NA 
NA 
 2-Pentenal C5H8O 764-39-6 SIFT-MS (283) NA 
 Pentanal C5H10O 110-62-3 SIFT-MS 
SIFT-MS 
(243) 
(283) 
NA 
NA 
 2-Methylbutanal C5H10O 96-17-3 GC-MS 
GC-MS 
GC-MS 
SIFT-MS 
SIFT-MS 
GC-MS 
(270) 
(311) 
(282) 
(292) 
(312) 
(293) 
NA 
NA 
NA 
NA 
NA 
NA 
 3-Methylbutanal C5H10O 590-86-3 GC-MS 
GC-MS 
GC-MS 
MCC-IMS and GC-MS 
GC-MS 
GC-MS 
GC-MS 
GC-MS 
(311) 
(282) 
(303) 
(287) 
(240) 
(293) 
(279) 
(236) 
NA 
NA 
Leucine catabolism 
NA 
NA 
NA 
NA 
Leucine catabolism 
 2-Hexenal 
C6H10O 505-57-7 SIFT-MS (283) NA 
 Hexanal 
C6H12O 66-25-1 SIFT-MS 
GC-MS 
SIFT-MS 
(302) 
(308) 
(283) 
NA 
NA 
NA 
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 Benzaldehyde C7H6O 100-52-7 GC-MS 
GC-MS 
GC-MS 
GC-MS 
(282) 
(293) 
(279) 
(236) 
NA 
NA 
NA 
NA 
 2-Heptenal C7H12O 2463-63-0 SIFT-MS (283) NA 
 2-Octenal C8H14O 2363-89-5 SIFT-MS (283) NA 
 Octanal C8H16O 124-13-0 SIFT-MS (283) NA 
 Nonanal 
C9H18O 124-19-6 GC-MS 
SIFT-MS 
(282) 
(283) 
NA 
NA 
 Decanal C10H20O 112-31-2 GC-MS (282) NA 
Esters 
 Ethyl formate C3H6O2 109-94-4 GC-MS 
GC-MS 
GC-MS 
(303) 
(279) 
(236) 
NA 
NA 
NA 
 Ethyl acetate C4H8O2 141-78-6 GC-MS 
GC-MS 
GC-MS 
GC-MS 
(311) 
(303) 
(279) 
(236) 
NA 
NA 
NA 
NA 
 Methyl methacrylate C5H8O2 80-62-6 GC-MS 
GC-MS 
GC-MS 
(303) 
(279) 
(236) 
NA 
NA 
NA 
 Ethyl butanoate 
C6H12O2 105-54-4 GC-MS 
SIFT-MS 
(311) 
(292) 
NA 
NA 
 Butyl acetate C6H12O2 123-86-4 GC-MS 
GC-MS 
GC-MS 
GC-MS 
(303) 
(240) 
(279) 
(236) 
NA 
NA 
NA 
NA 
 Ethyl 2-methylbutanoate 
C7H14O2 7452-79-1 GC-MS 
GC-MS 
(311) 
(240) 
NA 
NA 
 Ethyl 3-methylbutanoate C7H14O2 108-64-5 GC-MS (311) NA 
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GC-MS 
GC-MS 
GC-MS 
(303) 
(279) 
(236) 
NA 
NA 
NA 
 3-Methylbutyl acetate 
C7H14O2 123-92-2 GC-MS 
GC-MS 
GC-MS 
GC-MS 
(303) 
(240) 
(279) 
(236) 
NA 
NA 
NA 
NA 
 Butyl butanoate 
C8H16O2 109-21-7 GC-MS (311) NA 
 Ethyl hexanoate 
C8H16O2 123-66-0 GC-MS (311) NA 
 Butyl 2-methylbutanoate 
C9H18O2 15706-73-7 GC-MS (240) NA 
 4-Isopropyl-1-methyl-3-oxocyclohexyl acetate C12H20O3 - GC-MS (282) NA 
 Decyl acetate 
C12H24O2 112-17-4 GC-MS (240) NA 
 Phenyl benzoate C13H10O2 93-99-2 GC-MS (282) NA 
 Isopropyl tetradecanoate 
C17H34O2 110-27-0 GC-MS (308) NA 
Furan-like compounds 
 3-Phenylfuran C10H8O 13679-41-9 GC-MS (282) NA 
Halogenated compounds 
 1,1,2,2-tetrachloroethane C2H2Cl4 79-34-5 GC-MS (293) NA 
 1,4-dichloroacetic acid C2H2Cl2O2 - GC-MS (293) NA 
 Trichloroacetic acid 
C2HCl3O2 76-03-9 GC-MS (293) NA 
 N,N-dimethylsulfamoyl chloride 
C2H6ClNO2S 13360-57-1 GC-MS (282) NA 
 2,4,6-Triphenyl-1,3,5-tripropylborazine 
C27H36B3N3 - GC-MS (282) NA 
Hydrocarbons 
 Methane CH4 74-82-8 SIFT-MS (283) NA 
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 Propane 
C3H8 74-98-6 GC-MS 
GC-MS 
GC-MS 
(303) 
(279) 
(236) 
NA 
NA 
NA 
 1,3-Butadiene C4H6 106-99-0 GC-MS 
GC-MS 
GC-MS 
(303) 
(279) 
(236) 
NA 
NA 
NA 
 2-Methylpropene 
C4H8 115-11-7 GC-MS 
GC-MS 
GC-MS 
(303) 
(279) 
(236) 
NA 
NA 
NA 
 (Z)-2-butene C4H8 590-18-1 GC-MS 
GC-MS 
GC-MS 
(303) 
(279) 
(236) 
NA 
NA 
NA 
 (E)-2-butene 
C4H8 624-64-6 GC-MS 
GC-MS 
GC-MS 
(303) 
(279) 
(236) 
NA 
NA 
NA 
 Butane C4H10 106-97-8 GC-MS 
GC-MS 
GC-MS 
(303) 
(279) 
(236) 
NA 
NA 
NA 
 1,4-Pentadiene 
C5H8 591-93-5 GC-MS (308) NA 
 Isoprene 
C5H8 78-79-5 SIFT-MS (283) NA 
 Pentane 
C5H12 109-66-0 SIFT-MS (283) NA 
 Benzene 
C6H6 71-43-2 GC-MS (282) NA 
 1-Heptene 
C7H14 592-76-7 GC-MS (282) NA 
 Styrene 
C8H8 100-42-5 GC-MS (282) NA 
 1,4-Dimethylbenzene 
C8H10 106-42-3 GC-MS (282) NA 
 2,3,3-trimethylpentane 
C8H16 560-21-4 GC-MS (293) NA 
 1-methyl-4-(1-methylethenyl)cyclohexane C10H18 6252-33-1 GC-MS (293) NA 
 2-Methylnaphthalene C11H10 91-57-6 GC-MS (308) NA 
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 Undecane C11H24 1120-21-4 GC-MS (308) NA 
 2,6,10,14-tetramethylhexadecane 
C20H42 638-36-8 GC-MS (282) NA 
Ketones 
 2-Propanone C3H6O 67-64-1 SIFT-MS 
SIFT-MS 
SIFT-MS 
SESI-MS 
1H-NMR 
SIFT-MS 
GC-MS 
GC-MS 
SIFT-MS 
(302) 
(281) 
(280) 
(286) 
(294) 
(243) 
(293) 
(308) 
(283) 
NA 
NA 
NA 
NA 
NA 
NA 
NA 
NA 
NA 
 1-Hydroxy-2-propanone 
C3H6O2 116-09-6 GC-MS and GC/FPD 
GC-MS 
GC-MS 
GC-MS 
(304) 
(303) 
(279) 
(236) 
NA 
NA 
NA 
NA 
 1,3-Dihydroxy-2-propanone 
C3H6O3 96-26-4 1H-NMR 
1H-NMR 
(294) 
(295) 
NA 
NA 
 2,3-Butadione 
C4H6O2 431-03-8 GC-MS 
GC-MS 
GC-MS 
GC-MS 
GC-MS 
GC-MS 
(311) 
(303) 
(293) 
(279) 
(236) 
(291) 
NA 
NA 
NA 
NA 
NA 
NA 
 2-Butanone 
C4H8O 78-93-3 GC-MS 
GC-MS 
GC-MS 
SIFT-MS 
(270) 
(311) 
(308) 
(283) 
NA 
NA 
NA 
NA 
 3-Hydroxy-2-butanone 
C4H8O2 513-86-0 GC-FID 
GC-MS 
GC-MS and GC/FPD 
1H-NMR 
(270) 
(311) 
(304) 
(297) 
NA 
NA 
NA 
NA 
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GC-MS 
1H-NMR 
1H-NMR 
1H-NMR 
GC-MS 
GC-MS 
GC-MS 
SIFT-MS 
(303) 
(284) 
(295) 
(408) 
(279) 
(236) 
(308) 
(283) 
Pyruvate metabolism 
Pyruvate metabolism 
Pyruvate metabolism 
NA 
NA 
Pyruvate metabolism 
NA 
NA 
 2-Pentanone 
C5H10O 107-87-9 GC-MS 
GC-MS 
SESI-MS 
SIFT-MS 
(270) 
(311) 
(286) 
(283) 
NA 
NA 
NA 
NA 
 2-Hexanone 
C6H12O 591-78-6 SIFT-MS (283) NA 
 2-Heptanone 
C7H14O 110-43-0 GC-MS 
GC-MS 
SIFT-MS 
(270) 
(311) 
(283) 
NA 
NA 
NA 
 5-Methyl-2-hexanone 
C7H14O 110-12-3 GC-MS (282) NA 
 2-Octanone 
C8H16O 111-13-7 SIFT-MS (283) NA 
 2-methylacetophenone 
C9H10O 577-16-2 SIFT-MS (283) NA 
 2-Nonanone 
C9H18O 821-55-6 GC-MS 
SESI-MS 
SIFT-MS 
(270) 
(286) 
(283) 
NA 
NA 
NA 
 3-Methyl-1-phenyl-1-butanone 
C11H14O 582-62-7 GC-MS (282) NA 
 1-(4-methylphenyl)-1-Pentanone 
C12H16O 1671-77-8 GC-MS (282) NA 
 2,10,10-Trimethyl-6-methylene-1-
oxaspiro[4.5]decan-7-one 
C13H20O2 - 
GC-MS (282) NA 
 (Z)-6,10-dimethyl-5,9-undecadien-2-one 
C13H22O 3879-26-3 GC-MS (282) NA 
 2-Tridecenone 
C13H24O - GC-MS (290) NA 
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N-Compounds 
 Ammonia 
H3N 7664-41-7 SIFT-MS 
SIFT-MS 
SIFT-MS 
SIFT-MS 
SIFT-MS 
LC-MS 
(281) 
(280) 
(312) 
(243) 
(283) 
(291) 
NA 
NA 
NA 
NA 
NA 
NA 
 Acetonitrile 
C2H3N 75-05-8 SESI-MS (286) NA 
 2-Aminoacetic acid 
C2H5NO2 56-40-6 GC-MS (282) NA 
 2-Hydrazinyl-2-oxoacetamide 
C2H5N3O2 515-96-8 GC-MS (282) NA 
 Trimethylamine 
C3H5N 75-50-3 SIFT-MS 
SIFT-MS 
(302) 
(292) 
NA 
NA 
 Pyrimidine 
C4H4N2 289-95-2 SESI-MS (286) NA 
 Pyrazine 
C4H4N2 290-37-9 GC-MS (291) NA 
 1H-Pyrrole 
C4H5N 109-97-7 GC-MS 
SIFT-MS 
(282) 
(292) 
NA 
NA 
 1,4,5,6-Tetrahydropyridazine 
C4H8N2 - GC-MS (282) NA 
 2-Aminobutanoic acid 
C4H9NO2 2835-81-6 1H-NMR (294) NA 
 Pyridine 
C5H5N 110-86-1 GC-MS (270) NA 
 N,N-Dimethyl-4-pyridinamine 
C7H10N 1122-58-3 GC-MS (282) NA 
 Indole 
C8H7N 120-72-9 GC-MS 
SIFT-MS 
SIFT-MS 
SIFT-MS 
(270) 
(302) 
(292) 
(243) 
NA 
NA 
NA 
NA 
 2-Aminoacetophenone 
C8H9NO 551-93-9 SIFT-MS 
SIFT-MS 
SIFT-MS 
SIFT-MS 
(302) 
(281) 
(292) 
(283) 
NA 
NA 
NA 
NA 
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 Quinoline 
C9H7N 91-22-5 GC-MS (282) NA 
S-Compounds 
 Hydrogen cyanide 
CHN 74-90-8 SIFT-MS (283) NA 
 Hydrogen sulfide 
H2S 7783-06-4 SIFT-MS 
SIFT-MS 
SIFT-MS 
SIFT-MS 
(302) 
(281) 
(292) 
(283) 
NA 
NA 
NA 
NA 
 Methanethiol 
CH4S 74-93-1 SIFT-MS 
SIFT-MS 
SIFT-MS 
SIFT-MS 
GC-MS 
IMR-MS 
GC-MS 
GC-MS 
SIFT-MS 
(302) 
(281) 
(292) 
(312) 
(303) 
(285) 
(279) 
(236) 
(283) 
NA 
NA 
NA 
NA 
NA 
NA 
NA 
NA 
NA 
 Methyl thiocyanate 
C2H3NS 556-64-9 SIFT-MS (283) NA 
 Dimethyl sulfide 
C2H6S 75-18-3 SIFT-MS 
SIFT-MS 
SIFT-MS 
(302) 
(281) 
(283) 
NA 
NA 
NA 
 Dimethyl disulfide 
C2H6S2 624-92-0 GC-MS 
GC-MS 
SIFT-MS 
SIFT-MS 
GC-MS 
GC-MS 
GC-MS 
GC-MS 
SIFT-MS 
(270) 
(290) 
(302) 
(281) 
(303) 
(293) 
(279) 
(236) 
(283) 
NA 
NA 
NA 
NA 
NA 
NA 
NA 
NA 
NA 
 Dimethyl trisulfide 
C2H6S3 3658-80-8 GC-MS 
SIFT-MS 
(293) 
(283) 
NA 
NA 
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 S-Methyl methanethiosulfonate 
C2H6O2S2 2949-92-0 GC-MS (282) NA 
 2-Methylsulfonylethanol 
C3H8O3S 15205-66-0 MCC-IMS and GC-MS (287) NA 
 Benzothiazole 
C7H5NS 95-16-9 GC-MS (282) NA 
 Methyl benzyl sulfide 
C8H10S 766-92-7 GC-MS (282) NA 
NA – Not addressed  
a absent from figure (just one volatile described) 
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Table A5.3 - Chromatographic data of the 315 analytes putatively identified from the three Staphyloccus aureus strains under study: ATCC 6538 (without enterotoxins), 2153 MA 
(with enterotoxin A) and 2065 MA (with enterotoxin A, G, I), using HS-SPME/GC×GC-ToFMS. Grey background colour lines represent volatiles used for statistical analysis. 
1tR (s)a 2tR (s)a Name Formula CAS Number 
RI 
calcb 
RI GCxGC litc Ref. 
  Acids      
  Aliphatics      
120 2.420 Acetic acid C2H4O2 64-19-7 658 602 (411) 
175 2.950 2-Methylpropanoic acid  C4H8O2 79-31-2 775 762 (412) 
250 2.790 3-Methylbutanoic acid C5H10O2 503-74-2 874 875 (413) 
355 1.190 4-Methyl-3-pentenoic acid C6H10O2 504-85-8 985 1011 (414) 
425 2.650 4-Methyl-2-oxopentanoic acid C6H10O3 816-66-0 1064 - (412) 
  Alcohols      
  Aliphatics      
70 0.460 Ethanol C2H6O 64-17-5 548 577 (415) 
100 0.610 2-Methyl-1-propanol C4H10O 78-83-1 612 602 (412) 
115 0.670 1-Butanol C4H10O 71-36-3 644 637 (412) 
145 0.740 3-Methyl-1-butanol C5H12O 123-51-3 707 731 (412) 
145 0.860 3-Methyl-3-buten-1-ol C5H10O 763-32-6 707 716 (416) 
180 0.970 3-Methyl-2-buten-1-ol C5H10O 556-82-1 781 778 (417) 
200 1.030 2,3-Butanediol C4H10O2 513-85-9 812 789 (411) 
270 1.010 2-Methyl-3-hexanol C7H16O 617-29-8 895 -  
345 0.790 1-Heptanol C7H16O 111-70-6 975 974 (418) 
350 0.770 1-Octen-3-ol C8H16O 3391-86-4 980 985 (418) 
360 0.760 6-Methyl-1-heptanol C8H18O 1653-40-3 990 -  
395 0.740 2-Ethyl-1-hexanol  C8H18O 104-76-7 1029 1031 (418) 
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400 0.790 4-Methyl-1-heptanol C8H18O 817-91-4 1034 -  
420 0.900 2,3-Octanediol C8H18O2 20653-90-1 1057 -  
435 0.770 1-Octanol C8H18O 111-87-5 1073 1071 (418) 
450 0.930  4-Methyl-1-hepten-4-ol C8H16O 1186-31-8 1090 -  
525 0.740 1-Nonanol C9H20O 143-08-8 1173 1179 (419) 
575 0.570 2-Methyl-2-nonanol C10H22O 10297-57-1 1230 -  
685 0.610 2,4-Undecadien-1-ol C11H22O 59376-58-8 1363 -  
735 0.690 2-Methyl-1-undecanol C12H26O 10522-26-6 1426 -  
775 0.730 1-Dodecanol C12H26O 112-53-8 1476 1480 (420) 
905 0.600 5,9-Dimethyl-1-decanol C12H26O 91482-38-1 1630 -  
950 0.730 1-Tetradecanol C14H30O 112-72-1 1683 1686 (420) 
  Aromatics      
415 2.260 Benzyl alcohol C7H8O 100-51-6 1053 1043 (412) 
455 1.730 2-Methoxyphenol C7H8O2 90-05-1 1096 1087 (421) 
460 3.670 4-Methylphenol C7H8O 106-44-5 1104 1077 (411) 
485 1.740 2-Phenylethanol C8H10O 60-12-8 1130 1132 (412) 
595 1.280 2-Phenylbutane-1-ol C10H14O 2035-94-1 1254 1261 (422) 
675 1.700 2-tert-Butyl-4-methylphenol C11H16O 2409-55-4 1352 1387 (423) 
705 1.050 2,4-Dimethyl-6-tert-butylphenol C12H18O 1879-09-0 1389 -  
735 1.590 3,5-Diisopropylphenol C12H18O 26886-05-5 1427 -  
805 1.380 2,4-Di-tert-butylphenol C14H22O 96-76-4 1513 1513 (424) 
1100 1.700 2,3-Dihydro-3-phenyl-1H-inden-1-ol C15H14O 79454-17-4 1861 -  
  Aldehydes      
  Aliphatics      
85 0.350 2−Methylpropanal C4H8O 78-84-2 580 554 (425) 
110 0.420 3-Methylbutanal C5H10O 590-86-3 632 643 (426) 
115 0.390 2−Methylbutanal C5H10O 96-17-3 643 635 (427) 
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180 0.680 3-Methyl-2-butenal C5H8O 107-86-8 780 783 (428) 
190 0.500 Hexanal C6H12O 66-25-1 801 801 (412) 
250 0.540 2-Methyl-2-hexenal C7H12O 28467-88-1 871 884 (429) 
275 0.520 Heptanal C7H14O 111-71-7 901 904 (430) 
325 0.650 2-Heptenal C7H12O 2463-63-0 953 962 (418) 
370 0.540 Octanal C8H16O 124-13-0 1001 1006 (418) 
465 0.530 Nonanal C9H18O 124-19-6 1106 1101 (418) 
550 0.540 Decanal C10H20O 112-31-2 1201 1207 (418) 
635 0.540 Undecanal C11H22O 112-44-7 1301 1307 (418) 
720 0.550 Dodecanal C12H24O 112-54-9 1407 1415 (412) 
800 0.570 Tridecanal C13H26O 10486-19-8 1507 1512 (427) 
890 0.580 Tetradecanal C14H28O 124-25-4 1612 1613 (427) 
975 0.590 Pentadecanal C15H30O 2765-11-9 1713 1711 (417) 
  Aromatics      
330 1.070 Benzaldehyde C7H6O 100-52-7 959 959 (412) 
410 1.100 2-Phenylacetaldehyde C8H8O 122-78-1 1046 1043 (426) 
410 1.230 2-Hydroxybenzaldehyde C7H6O2 90-02-8 1046 1041 (417) 
565 0.980 3,5-Dimethylbenzaldehyde C9H10O 5779-95-3 1219 -  
570 0.820 4-(1-Methylethyl)-benzaldehyde C10H12O 122-03-2 1225 1226 (431) 
640 0.830 4-tert-Butylbenzaldehyde C11H14O 939-97-9 1307 -  
755 0.810 2-Phenyl-4-pentenal C13H14O 24401-36-3 1451   
790 0.890 5-Methyl-2-phenyl-2-hexenal C13H16O 21834-92-4 1495 1486 (432) 
1020 1.110 3,5-di-tert-Butyl-4-hydroxybenzaldehyde C15H22O2 1620-98-0 1766 1774 (433) 
  Azoles      
150 0.870 Thiazole C3H3NS 288-47-1 718 735 (434) 
165 2.410 Pyrrole  C4H5N 109-97-7 752 751 (434) 
200 0.710 2-Methylthiazole C4H5NOS 3581-87-1 813 808 (434) 
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205 0.790 4-Methylthiazole C4H5NS 693-95-8 819 802 (434) 
385 1.240 2-Acetylthiazole C5H5NOS 24295-03-2 1018 1014 (435) 
470 1.010 2-Acetyl-4-methylthiazole C6H7NOS 7533-07-5 1112 1128 (436) 
480 1.050 2-Propionylthiazole C6H7NOS 43039-98-1 1123 1132 (434) 
515 0.900 2-Butanoylthiazole C7H9NOS - 1162 -  
575 1.310 Benzothiazole C7H5NS 95-16-9 1231 1223 (430) 
690 0.780 2,5,6-Trimethylbenzimidazole C10H12N2 3363-56-2 1370 -  
750 1.080 3-Methyl-5-phenyl-1H-pyrazole C10H10N2 3347-62-4 1445 -  
  Esters      
  Aliphatics      
135 0.420 Ethyl propanoate C5H10O2 105-37-3 685 684 (412) 
135 0.450 Methyl methacrylate C5H8O2 80-62-6 685 710 (437) 
175 0.440 Methyl isovalerate C6H12O2 556-24-1 769 765 (438) 
200 0.480 Butyl acetate C6H12O2 123-86-4 812 819 (412) 
230 0.430 Ethyl 2-methylbutanoate C7H14O2 7452-79-1 848 851 (412) 
260 0.540 3-Methyl-3-butenyl acetate C7H12O2 5205-07-2 883 881 (439) 
320 0.930 Methyl 2-hydroxy-4-methylpentanoate C7H14O3 40348-72-9 948 -  
370 0.410 Propyl 2,2-dimethylpropanoate C8H16O2 5129-35-1 1001 -  
380 0.540 tert-Butyl isopropyl carbonate C8H16O3 30221-21-7 1012 -  
555 0.730 Dimethyl 2,4-dimethylpentanedioate C9H16O4 2121-68-8 1207 -  
560 0.790 Dimethyl isopropylidenesuccinate C9H14O4 87384-00-7 1213 -  
585 0.660 Dimethyl 2-methylhexanedioate C9H16O4 19780-94-0 1242 -  
585 0.740 1-Ethyl 6-methyl hexanoate C9H16O4 18891-13-9 1242 -  
620 0.820 Dimethyl 2-(2-methylprop-2-enyl)propanedioate C9H14O4 50598-40-8 1283 -  
625 0.680 Dimethyl 2,2-dimethylpentanedioate C9H16O4 13051-32-6 1289 -  
645 0.620 Dimethyl 2,3-dimethyl hexanodioate C10H18O4 58219-48-0 1313 -  
675 0.780 1-Methylhexyl butanoate C11H22O2 39026-94-3 1351 -  
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690 0.730 2-Ethyl-3-hydroxyhexyl butyrate C12H24O3 18618-89-8 1370 -  
1020 0.920 Diethyl diallylmalonate C13H20O4 3195-24-2 1766 -  
  Aromatics      
455 0.890 Methyl benzoate C8H8O2 93-58-3 1095 1100 (437) 
530 0.950 Methyl phenylacetate C9H10O2 101-41-7 1179 -  
545 0.780 1-Phenylethyl acetate C10H12O2 93-92-5 1195 1192 (440) 
585 0.840 Ethyl phenylethanoate C10H12O2 101-97-3 1242 1244 (417) 
665 0.830 2-Benzylacrylic acid methyl ester C11H12O2 3070-71-1 1239 -  
665 0.870 Cinnamyl methanoate C10H10O2 104-65-4 1339 -  
730 0.800 2-Methyl-4-phenylbutyric acid methyl ester C12H16O2 - 1420 -  
765 0.870 5-Phenyl-2-pentenoic acid methyl ester C12H14O2 26429-97-0 1464 -  
795 0.830 Ethyl 5-phenyl-2-pentenoate C13H16O2 55282-95-6 1501 -  
855 0.870 Dimethyl phenylethyl carbinyl acetate C13H18O2 103-07-1 1572 -  
890 1.350 Phenyl benzoate C13H10O2 93-99-2 1613 -  
950 0.810 Hexyl 2-hydroxybenzoate C13H18O3 6259-76-3 1683 1683 (441) 
1055 0.760 2-Ethylhexyl 2-hydroxybenzoate C15H22O3 118-60-5 1807 1817 (442) 
  Cyclics      
515 0.660 Butyl cyclopropanecarboxylate C8H14O2 54947-39-6 1162 -  
930 0.940 Methyl dihydrojasmonate C13H22O3 24851-98-7 1660 1650 (443) 
  Furan-like compounds      
230 1.350 Furfural C5H4O2 98-01-1 849 840 (412) 
285 1.220 1-(2-Furanyl)-ethanone C6H6O2 1192-62-7 912 917 (412) 
360 0.480 2-Pentylfuran C9H14O 3777-69-3 990 994 (444) 
365 0.890 Benzofuran C8H6O 271-89-6 996 996 (412) 
380 1.020 1-(2-Furanyl)-1-propanone C7H8O2 3194-15-8 1012 1008 (445) 
455 0.790 1-(2,4-Dimethyl-furan-3-yl)-ethanone C8H10O2 32933-07-6 1095 -  
545 0.950 1,3-Dihydro isobenzofuran C8H8O 496-14-0 1196 -  
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560 0.960 Furfuryl methyl disulfide C6H8OS2 57500-00-2 1213 1226 (446) 
570 1.040 3-Phenylfuran C10H8O 13679-41-9 1225 1228 (432) 
  Furanones      
195 0.770 Dihydro-2-methyl-3(2H)-furanone C5H8O2 3188-00-9 807 804 (417) 
335 1.400 4-Methyldihydro-2(3H)-furanone C5H8O2 1679-49-8 965 -  
690 1.040 Dihydro-5-pentyl-2(3H)-furanone C9H16O2 104-61-0 1370 1360 (417) 
1010 0.990 Dihydro-2,2-dimethyl-5-phenyl-3(2H)-furanone C12H14O2 63678-00-2 1754 -  
  Hydrocarbons      
  Aliphatics      
70 0.300 2-Butene C4H8 107-01-7 548 411 (447) 
190 0.350 Octane C8H18 111-65-9 800 800 (430) 
275 0.360 Nonane C9H20 111-84-2 900 900 (430) 
375 0.360 2,2,4,6,6-Pentamethyl-3-heptene C12H24 123-48-8 1006 -  
475 0.370 3-Ethyl-2,7-dimethyl-octane C12H26 62183-55-5 1117 1180 (448) 
520 0.380 6-Methyl-3-undecene C12H24 74630-52-7 1167 -  
540 0.390 Dodecene C12H24 112-41-4 1189 1192 (430) 
615 0.370 4-Ethylundecane  C13H28 17312-59-3 1277 1281 (430) 
710 0.400 Tetradecene C14H28 1120-36-1 1394 1400 (430) 
760 0.400 2-Methyltetradecane C15H32 1560-95-8 1457 1467 (447) 
835 0.410 3-Ethyl-3-methyltridecane C16H34 - 1548 1544 (430) 
875 0.420 Hexadecane C16H34 544-76-3 1595 1600 (429) 
970 0.410 Heptadecane C17H36 629-78-7 1706 1700 (429) 
1045 0.430 Octadecane C18H38 593-45-3 1795 1800 (429) 
1150 0.420 Nonadecane C19H40 629-92-5 1919 1900 (429) 
1210 0.450 Eicosane C20H42 112-95-8 1994 1993 (429) 
  Aromatics      
165 0.470 Methylbenzene C7H8 108-88-3 748 776 (418) 
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245 0.500 1,3-Dimethylbenzene C8H10 108-38-3 865 878 (437) 
330 0.510 1-Ethyl-4-methylbenzene C9H12 622-96-8 958 970 (437) 
365 0.610 1-Propenylbenzene C9H10 637-50-3 995 1000 (449) 
390 0.570 1,2,3-Trimethylbenzene C9H12 526-73-8 1023 1022 (450) 
420 0.570 2-Phenyl-1-butene C10H12 2039-93-2 1056 -  
440 0.530 2-Ethyl-1,3-dimethylbenzene C10H14 2870-04-4 1078 1100 (437) 
535 0.920 Naphthalene C10H8 91-20-3 1184 1203 (437) 
630 0.870 1-Methylnaphthalene C11H10 90-12-0 1295 1299 (451) 
645 0.890 2-Methylnaphthalene C11H10 91-57-6 1314 1315 (451) 
655 0.590 5,6,7,8,9,10-Hexahydrobenzocyclooctene C12H16 1076-69-3 1326 -  
660 0.660 4-Phenyl-1-cyclohexene C12H14 4994-16-5 1332 1345 (452) 
695 0.950 Biphenyl C12H10 92-52-4 1376 1377 (453) 
730 0.900 1,4-Dimethylnaphthalene  C12H12 571-58-4 1420 1424 (453) 
740 0.900 Diphenylmethane C13H12 101-81-5 1432 -  
775 0.860 3-Ethyl-3-phenyl-1-pentene C13H18 19781-34-1 1476 -  
785 0.950 3-Methylbiphenyl C13H12 643-93-6 1489 1488 (453) 
785 1.050 Acenaphthene C12H10 83-32-9 1489 1489 (453) 
790 0.810 2,2'-Dimethylbiphenyl C14H14 605-39-0 1495 -  
795 0.790 1,1-Diethyl-1,2,3,4-tetrahydronaphthalene C14H20 2938-66-1 1501 -  
795 1.110 (1-Ethylhexyl)benzene C14H22 18335-15-4 1501 -  
810 0.920 1,1-Diphenyl-ethylene C14H12 530-48-3 1519 -  
835 0.830 2-Methyl-6-phenyl-1,6-heptadiene C14H18 51708-97-5 1613 -  
855 0.850 1,4-Diethyl-1,2,3,4-tetrahydronaphthalene C14H20 81356-57-2 1572 -  
880 0.790 (3-Methyl-1-methylenepentyl)benzene C13H18 74810-69-8 1601 -  
895 0.900 1,1-Diethylnaphthalene C14H20 74710-00-2 1619 -  
925 0.930 1,3-Diphenylpropane C15H16 1081-75-0 1654 1633 (454) 
935 0.530 3-Phenyldecane C16H26 4621-36-7 1665 -  
950 0.860 1,3-Diphenylbutane C16H18 1520-44-1 1683 -  
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975 0.890 1,2,3-Trimethyl-4-propenylnaphthalene  C16H18 26137-53-1 1713 -  
990 0.520 5-Phenyldodecane C18H30 2719-63-3 1730 1731 (455) 
1000 0.530 4-Phenyldodecane C18H30 2719-64-4 1742 -  
1005 0.950 9-Ethyl-9,10-dihydro-10-methyl-anthracene C17H18 36778-20-8 1748 -  
1020 0.540 3-Phenyldodecane C18H30 2400-00-2 1765 -  
1070 0.530 4-Phenyltridecane C19H32 4534-51-4 1824 -  
1175 0.980 (1,2-Dicyclopropyl-2-phenylethyl)benzene C20H22 110330-90-0 1951 -  
  Ketones      
  Aliphatics      
75 0.370 2-Propanone C3H6O 67-64-1 559 572 (456) 
90 0.410 2-Butanone C4H8O 78-93-3 590 601 (430) 
120 0.430 2-Pentanone C5H10O 107-87-9 654 682 (437) 
130 1.130 1-Hydroxy-2-propanone C3H6O2 116-09-6 676 662 (457) 
140 1.010 3-Hydroxy-2-butanone C4H8O2 513-86-0 707 697 (412) 
150 0.450 4-Methyl-2-pentanone C6H12O 108-10-1 717 733 (437) 
180 0.470 3-Hexanone C6H12O 589-38-8 780 783 (437) 
185 0.500 2-Hexanone C6H12O 591-78-6 791 795 (418) 
190 0.550 3-Hexen-2-one C6H10O 763-93-9 801 834 (422) 
195 0.990 3-Hydroxy-2-pentanone C5H10O2 3142-66-3 807 838 (446) 
200 1.030 2-Hydroxy-3-pentanone C5H10O2 5704-20-1 813 -  
220 0.520 2,3-Heptanedione C7H12O2 96-04-8 836 -  
235 0.510 5-Methyl-2-hexanone C7H14O 110-12-3 854 862 (423) 
250 0.480 4-Heptanone C7H14O 123-19-3 871 869 (417) 
265 0.500 3-Heptanone C7H14O 106-35-4 889 887 (430) 
265 0.520 2-Heptanone C7H14O 110-43-0 889 892 (444) 
290 0.510 5-Methyl-2-heptanone C8H16O 18217-12-4 916 971 (458) 
310 0.500 4-Methyl-2-heptanone C8H16O 6137-06-0 937 936 (437) 
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325 0.520 2-Methyl-6-heptanone C8H16O 928-68-7 953 962 (458) 
355 0.510 3-Octanone C8H16O 106-68-3 985 990 (418) 
360 0.540 2-Octanone C8H16O 111-13-7 990 994 (444) 
445 0.520 3-Nonanone C9H18O 925-78-0 1084 1091 (459) 
450 0.550 2-Nonanone C9H18O 821-55-6 1090 1093 (460) 
470 0.650 2,6-Dimethyl-2,5-heptadien-4-one C9H14O 504-20-1 1112 -  
500 0.760 2,5-Dimethyl-3,4-hexanedione C8H14O2 4388-87-8 1145 -  
540 0.540 2-Decanone C10H20O 693-54-9 1190 1194 (437) 
575 0.730 4-Methyl-3-octanone C9H18O 6137-15-1 1230 -  
610 0.510 5-Undecanone C11H22O 33083-83-9 1271 -  
625 0.550 2-Undecanone C11H22O 112-12-9 1289 1291 (444) 
790 0.570 2-Tridecanone C13H26O 593-08-8 1495 1498 (420) 
850 0.580 2-Tetradecanone C14H28O 2345-27-9 1565 1597 (461) 
875 0.590 3-Tetradecanone C14H28O 629-23-2 1595 -  
940 0.550 6-Tetradecanone C14H28O 6836-42-6 1671 -  
965 0.590 2-Pentadecanone C15H30O 2345-28-0 1701 1698 (462) 
1025 0.600 2-Hexadecanone C16H32O 18787-63-8 1771 1800 (461) 
1130 0.600 2-Heptadecanone C17H34O 2922-51-2 1895 1900 (417) 
  Aromatics      
430 1.050 1-Phenylethanone C8H8O 98-86-2 1068 1067 (418) 
485 1.040 1-Phenyl-2-propanone C9H10O 103-79-7 1129 1110 (463) 
520 1.120 1-(2-Hydroxyphenyl)-ethanone C8H8O2 118-93-4 1168 1167 (464) 
525 1.100 1-Phenyl-1,2-propanedione C9H8O2 579-07-7 1173 1186 (465) 
575 0.910 1-Phenyl-2-butanone C10H12O 1007-32-5 1231 -  
590 0.960 4-Phenyl- 2-butanone C10H12O 2550-26-7 1248 1218 (466) 
595 0.850 1-Phenyl-1-butanone C10H12O 495-40-9 1254 1253 (467) 
650 0.960 1-(4-Ethylphenyl)-ethanone C10H12O 937-30-4 1320 1274 (437) 
700 0.950 3-Methyl-1-phenyl-2-buten-1-one C11H12O 5650-07-7 1382 -  
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750 0.870 1-(4-tert-Butylphenyl)propan-2-one C13H18O 81561-77-5 1445 -  
915 1.460 Benzophenone C13H18O 119-61-9 1643 1621 (417) 
1065 1.070 3,5-di-tert-Butyl-4-hydroxyacetophenone C16H24O2 14035-33-7 1819 -  
1120 1.350 2,2-Dimethoxy-1,2-diphenyl-ethanone C16H16O3 24650-42-8 1884 1874 (468) 
  Cyclics      
275 0.730 Cyclohexanone C6H10O 1629-59-408-94-1 901 897 (437) 
470 0.780 3,4,4-Trimethyl-2-cyclopenten-1-one C8H12O 30434-65-2 1112 -  
480 0.780 3,5,5-Trimethyl-2-cyclohexen-1-one C9H14O 78-59-1 1123 1118 (417) 
490 0.710 4-Cyclopentylidene-2-butanone C9H14O 51004-21-8 1134 -  
770 0.620 2,6-di-Butyl-2,5-cyclohexadiene-1,4-dione C14H20O2 719-22-2 1470 1472 (469) 
770 0.940 2,6-di(t-Butyl)-4-hydroxy-4-methyl-2,5-cyclohexadien-1-one C15H24O2 10396-80-2 1470 1478 (470) 
  N-Compounds      
  Amines      
  Aliphatics      
140 0.540  N-methyleneethenamine C3H5N 38239-27-9 696 -  
  Aromatics      
335 0.600 Benzenamine C6H7N 62-53-3 964 971 (461) 
595 0.750 2,4,6-Trimethyl-benzenamine C9H13N 88-05-1 1254 1261 (461) 
655 0.560 4,5-Dimethyl-ortho-phenylenediamine C8H12N2 3171-45-7 1326 -  
655 0.730 4-Ethylphenethylamine C10H15N 64353-29-3 1326 -  
  Cyclics      
470 0.680 1-Methyl-1H-pyrrole-2-ethanamine C7H12N2 83732-75-6 1112 -  
  Amides      
  Aliphatics      
515 0.880 Dibutyramide C8H15NO2 4494-12-6 1162 -  
640 0.700 N,N-Dibutylformamide C9H19NO  761-65-9 1307 -  
  Aromatics      
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740 0.750  2-Phenylbutanamide C10H13NO 90-26-6 1432 -  
  Oximes      
240 1.420 3-Methylbutanal oxime (isomer) C5H11NO 5780-40-5 860 -  
260 1.480 3-Methylbutanal oxime (isomer) C5H11NO 5775-74-6 884 -  
  Pyridines      
360 0.640 2,4,6-Trimethylpyridine C8H11N 108-75-8 990 987 (461) 
400 1.030 1-(2-Pyridinyl)-ethanone C7H7NO 1122-62-9 1035 1057 (471) 
535 0.680 4-Pyrrolidinopyridine C9H12N2 2456-81-7 1184 -  
710 0.820 2-Butyrylpyridine C9H11NO 22971-32-0 1395 -  
900 1.050 4-(4-Dimethylaminophenyl)-pyridine C13H14N2 1137-80-0 1625 -  
  Pyrimidines      
765 1.360 2-Phenylpyrimidine  C10H8N2 7431-45-0 1464 -  
980 1.030 5-Ethyl-2-(4-ethylphenyl)pyrimidine C14H16N2 98495-10-4 1719 -  
  Others      
355 1.240 Benzonitrile C7H5N 100-47-0 986 988 (437) 
500 1.700 Phenylacetonitrile C8H7N 140-29-4 1146 1137 (421) 
645 1.890 2-Aminoacetophenone C8H9NO 551-93-9 1315 1315 (472) 
650 3.460 Indole C8H7N 120-72-9 1323 1320 (473) 
720 2.890 3-Methylindole C9H9N 83-34-1 1410 1410 (411) 
  Pyrazine      
150 0.770 Pyrazine C4H4N2 290-37-9 717 740 (474) 
210 0.750 Methylpyrazine C5H6N2 109-08-0 824 827 (434) 
285 0.730 2,5-Dimethylpyrazine C6H8N2 123-32-0 911 915 (434) 
290 0.730 Ethylpyrazine  C6H8N2 13925-00-3 917 920 (434) 
290 0.740 2,3-Dimethylpyrazine C6H8N2 5910-89-4 917 932 (475) 
305 0.900 Ethenylpyrazine C6H6N2 4177-16-6 933 954 (474) 
340 0.650 Isopropylpyrazine C7H10N2 9820-90-0 969 -  
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365 0.660 2-Ethyl-5-methylpyrazine C7H10N2 13360-64-0 995 1000 (432) 
370 0.680 Trimethylpyrazine C7H10N2 14667-55-1 1001 1014 (471) 
385 0.810 2-Ethenyl-5-methylpyrazine  C7H8N2 13925-08-1 1018 1034 (471) 
415 0.620 2-Methyl-3-isopropylpyrazine C8H12N2 15986-81-9 1051 -  
440 0.630 3-Ethyl-2,5-dimethyl-pyrazine C8H12N2 13360-65-1 1083 1088 (471) 
455 0.600 2-Ethyl-3,5-dimethyl-pyrazine C8H12N2 13925-07-0 1095 1084 (476) 
460 0.720 2-Methyl-5-(1-propenyl)-pyrazine  C8H10N2 18217-82-8 1101 1133 (477) 
465 0.550 2,5-Dimethyl-3-propylpyrazine C9H14N2 18433-97-1 1106 1131 (432) 
480 0.970 1-(6-Methyl-2-pyrazinyl)-1-ethanone C7H8N2O 22047-26-3 1123 1095 (478) 
500 0.610 2-Isobutyl-3-methylpyrazine C9H14N2 13925-06-9 1145 1144 (263) 
510 0.580 3,5-Diethyl-2-methyl-pyrazine C9H14N2 18138-05-1 1156 1172 (471) 
520 0.590 2,3-Dimethyl-5-propylpyrazine C9H14N2 32262-98-9 1167 1166 (475) 
525 0.790 1-(3,5-Dimethylpyrazinyl)-ethanone C8H10N2O 54300-08-2 1173 -  
530 0.650 2-Isoamylpyrazine C9H14N2 40790-22-5 1179 -  
535 0.530 2,3-Dimethyl-5-(1-methylpropyl)-pyrazine C10H16N2 32263-00-6 1184 -  
545 0.630 2-Pentyl-5-methylpyrazine C10H16N2 - 1195 -  
545 0.820 2-Methyl 5H-6,7-dihydrocyclopentapyrazine C8H10N2 - 1195 -  
550 0.570 2,5-Dimethyl-3-(2-methylpropyl)-pyrazine C10H16N2 32736-94-0 1201 1207 (476) 
570 0.560 2,5-Diethyl-3,6-dimethylpyrazine C10H16N2 - 1224 1225 (479) 
580 0.750 2,5-Dimethyl-3-(E-1-propenyl)pyrazine C9H12N2 55138-77-7 1236 -  
585 0.570 2,3,5-Trimethyl-6-propylpyrazine C10H16N2  92233-82-4 1242 1280 (471) 
590 0.620 2-Isoamyl-6-methylpyrazine C10H16N2 91010-41-2 1248 1248 (432) 
595 0.590 2-Butyl-3,5-dimethylpyrazine C10H16N2 50888-63-6 1254 -  
615 0.540 2-(2-Methylpropyl)-3-(1-methylethyl)pyrazine C11H18N2 - 1277 -  
635 0.560 2,6-Dimethyl-3(2-methyl-1-butyl)pyrazine C11H18N2 56617-70-0 1301 1307 (476) 
645 0.580 2,5-Dimethyl-3-(3-methylbutyl)-pyrazine C11H18N2 18433-98-2 1313 1319 (476) 
705 0.560 2,3,5-Trimethyl-6-isopentylpyrazine C12H20N2 10132-43-1 1388 1390 (476) 
710 0.630 2-Methyl-3-octylpyrazine C13H20N2 71700-39-5 1395 -  
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755 0.600 Hexyl-5-dimethyl-2,3-pyrazine C12H20N2 73570-19-1 1451 -  
  Terpenes      
  Monoterpenes      
305 0.380 α-Pinene C10H16 7785-26-4 932 932 (412) 
345 0.410 Sabinene C10H16 3387-41-5 974 1009 (480) 
375 0.420 γ-Terpinene C10H16 99-85-4 1006 1080 (481) 
395 0.440 Limonene C10H16 5989-54-8 1028 1028 (412) 
435 0.630 Dihydromyrcenol C10H20O 18479-58-8 1073 1076 (481) 
520 0.840 Isoborneol C10H18O 124-76-5 1168 1159 (482) 
525 0.720 Dihydro γ-terpineol C10H20O 21129-27-1 1173 1206 (481) 
540 0.780 α-Terpineol C10H18O 98-55-5 1190 1195 (412) 
545 0.700 Tetrahydrogeraniol C10H22O 106-21-8 1195 1196 (483) 
575 0.880 Nerol C10H18O 106-25-2 1230 1245 (481) 
670 0.580 4-Terpinenyl acetate C12H20O2 4821-04-9 1345 1300 (484) 
  Sesquiterpenes      
760 0.650 β-Caryophyllene C15H24 87-44-5 1457 1423 (485) 
850 0.720 Nerolidol C15H26O 7212-44-4 1566 1573 (412) 
1035 0.680 Methyl farnesoate C16H26O2 3675-00-1 1783 1789 (442) 
  Norisoprenoids      
355 0.610 6-Methyl-5-hepten-2-one C8H14O 110-93-0 985 990 (418) 
755 0.640 Geranylacetone C13H22O 3796-70-1 1451 1455 (486) 
780 0.630 α-iso-Methyl ionone C14H22O 127-51-5 1482 1481 (487) 
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a Retention times for first (1tR) and second (2tR) dimensions in seconds. 
b RI,Retention Index obtained through the modulated chromatogram. 
c RI, Retention Index reported in the literature for Equity-5 column or equivalents. 
  S-Compounds      
  Aliphatics      
70 0.320 Methanethiol CH4S 74-93-1 548 464 (488) 
70 2.650 Mercaptoacetic acid C2H4OS 68-11-1 553 -  
80 0.320 Carbon disulfide CS2 75-15-0 569 544 (489) 
125 0.520 Methylthiolacetate C3H6OS 1534-08-3 664 699 (490) 
150 0.530 Dimethyl disulfide C2H6S2 624-92-0 717 719 (412) 
225 0.870 Methylthio-2-propanone C4H8OS 14109-72-9 842 863 (423) 
280 1.040 3-(methylthio)-propanal C4H8OS 3268-49-3 906 904 (411) 
340 0.710 Dimethyl trisulfide C2H6S3 3658-80-8 969 967 (430) 
340 0.730 2-Methylsulfinylethanol C3H8O2S 21281-74-3 969 -  
445 1.230 5-Methyl-2-thiophenecarboxaldehyde C6H6OS 13679-70-4 1085 1135 (434) 
455 1.350 2-Acetylthiophene C6H6OS 88-15-3 1096 1092 (445) 
485 1.310 3-Methyl-2-thiophenecarboxaldehyde C6H6OS 5834-16-2 1129 1133 (434) 
510 1.050 2-Acetyl-5-methylthiophene C7H8OS 13679-74-8 1157 1157 (445) 
540 0.830 6-(Methylthio)hexa-1,5-dien-3-ol C7H12OS - 1190 -  
540 0.880 2,6-Dimethyl-4-thiopyrone C7H8OS 1004-37-1 1190 1193 (491) 
540 1.120 2-Propionylthiophene C7H8OS 13679-75-9 1190 1188 (492) 
545 1.000 Dimethyl formylthiophene C7H7OS - 1196 -  
565 0.850 Dimethyl tetrasulphide C2H6S4 5756-24-1 1219 1234 (459) 
765 0.570 Dimethyl pentasulfide C2H6S5 7330-31-6 1463 -  
825 0.530 1-Dodecanethiol C12H26S 112-55-0 1536 -  
860 0.730 2-Methyl-2-undecanethiol C12H16S 10059-13-9 1577 -  
910 0.520 Dodecyl methyl sulfide C13H28S 3698-89-3 1636 -  
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Table B5.3 - Volatiles used for statistics processing identified by HS-SPME/GC×GC-ToFMS in three Staphylococcus aureus strains under study: ATCC 6538 (without enterotoxins; light grey), 
2153 MA (with enterotoxin A; medium grey) and 2065 MA (with enterotoxin A, G, I; dark grey). 
Compound Name CAS Number 
ATCC 6538 (x102) 2153 MA (x102) 2065 MA (x102) 
Rep1 Rep2 Rep3 Rep1 Rep2 Rep3 Rep1 Rep2 Rep3 
 
Acids 
          
 
Aliphatics 
          
1 Acetic acid 64-19-7 4.42 4.84 0.18 0.1 0.06 0.07 0.07 0.09 2.68 
2 3-Methylbutanoic acid 503-74-2 4.19 13.47 3.09 13.67 6.14 4.1 16.86 17.76 23.24 
 
Subtotal (GC Peak Area) 10.06 8.05 20.23 
 
Subtotal (%) 8.11 6.42 12.30 
 
Alcohols 
          
 Aliphatics           
3 Ethanol 64-17-5 1.29 0.04 0.14 1.9 0.23 0.21 0.42 0.21 1.53 
4 2-Methyl-1-propanol 78-83-1 0.09 0.08 0.06 0.21 0.16 0.17 1.11 0.94 1.27 
5 1-Butanol 71-36-3 0.04 0.03 0.02 0.03 0.03 0.03 0.02 0.02 0.02 
6 3-methyl-1-butanol 123-51-3 3.06 3.08 1.74 6.09 4.7 4.72 14.05 16.49 14.91 
7 3-Methyl-3-buten-1-ol 763-32-6 0.2 0.16 0.22 0.15 0.23 0.15 0.13 7.66 0.12 
8 3-Methyl-2-buten-1-ol 556-82-1 0.09 0.07 0.07 0.05 0.08 0.07 0.07 0.07 0.08 
9 2,3-Butanediol 513-85-9 0.04 0.05 0.1 0.01 0.02 0.01 0.02 0.02 0.02 
10 2-Methyl-3-hexanol 617-29-8 0.06 0.06 0.07 0.04 0.05 0.04 0.03 0.04 0.04 
11 1-Heptanol 111-70-6 0.14 0.04 0.02 0.05 0.15 0.04 0.08 0.04 0.02 
12 1-Octen-3-ol 3391-86-4 0.13 0.06 0.07 0.13 0.1 0.1 0.14 0.11 0.13 
13 6-Methyl-1-heptanol 1653-40-3 0.51 0.16 0.07 0.36 0.23 0.04 0.18 0.12 0.07 
14 2-Ethyl-1-hexanol  104-76-7 5.14 2.07 2.05 3.68 2.61 2.53 3.07 3.08 2.65 
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15 4-Methyl-1-heptanol 817-91-4 0.6 0.09 0.07 0.9 0.33 0.04 12.29 1.07 0.06 
16 2,3-Octanediol 20653-90-1 0.03 0.01 0.02 0.01 0.01 0.02 0.07 0.05 0.04 
17 1-Octanol 111-87-5 1.77 0.23 0.19 0.56 0.62 0.4 0.65 0.36 0.4 
18  4-Methyl-1-hepten-4-ol 1186-31-8 0.65 0.55 0.49 0.38 0.57 0.62 0.86 0.98 0.92 
19 1-Nonanol 143-08-8 0.49 0.04 1.03 0.57 0.53 0.48 0.36 0.17 0.22 
20 2-Methyl-2-nonanol 10297-57-1 0.46 0.33 0.34 0.48 0.4 0.39 0.32 0.41 0.43 
21 2,4-Undecadien-1-ol 59376-58-8 0.08 0.11 0.08 0.13 0.08 0.09 0.07 0.08 0.05 
22 2-Methyl-1-undecanol 10522-26-6 0.61 0.01 0.35 0.05 0.04 0.53 0.05 0.02 0.04 
23 1-Dodecanol 112-53-8 8.94 7.49 4.13 7.42 4.1 4.23 4.62 7.67 4.07 
24 5,9-Dimethyl-1-decanol 91482-38-1 0.04 0.03 0.02 0.03 0.03 0.02 0.04 0.03 0.04 
25 1-Tetradecanol 112-72-1 0.61 0.77 0.68 0.42 0.1 0.33 1.27 0.8 2.46 
 Aromatics           
26 Benzyl alcohol 100-51-6 0.87 0.79 0.78 1.38 1.83 1.55 1 1.06 1.03 
27 2-Methoxyphenol 90-05-1 0.46 0.06 0.04 0.21 0.32 0.03 0.34 0.11 0.07 
28 4-Methylphenol 106-44-5 1.8 1.62 1.55 1.81 2.21 2.11 1.64 2.22 1.95 
29 2-Phenylethanol 60-12-8 0.15 0.05 0.04 0.11 0.13 0.15 0.6 0.53 0.48 
30 2-tert-Butyl-4-methylphenol 2409-55-4 0.9 0.87 0.49 0.88 0.34 0.58 0.51 0.95 0.64 
31 2,4-Dimethyl-6-tert-butylphenol 1879-09-0 0.07 0.04 0.03 0.05 0.03 0.04 0.05 0.05 0.05 
32 3,5-Diisopropylphenol 26886-05-5 0.41 0.33 0.22 0.33 0.15 0.25 0.29 0.4 0.29 
33 2,4-Di-tert-butylphenol 96-76-4 4.85 5.19 5.2 3.61 3.23 4.56 4.55 4.9 4.27 
34 2,3-Dihydro-3-phenyl-1H-inden-1-ol 79454-17-4 0.13 0.06 0.01 0.04 0.07 0.04 0.05 0.06 0.05 
 
Subtotal (GC Peak Area) 26.49 26.77 46.01 
 
Subtotal (%) 21.36 21.35 27.98 
 
Aldehydes 
          
 Aliphatics           
35 2−Methylpropanal 78-84-2 0.29 0.27 0.13 0.26 0.34 0.25 0.42 0.42 0.58 
36 2−Methylbutanal 96-17-3 0.69 0.88 0.42 0.85 0.84 0.36 0.53 1.32 1.72 
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37 3-Methyl-2-butenal 107-86-8 0.08 0.06 0 0.01 0.12 0.09 0.15 0.81 0.18 
38 Hexanal 66-25-1 0.1 0.05 0.04 0.1 0.14 0.14 0.1 0.07 0.08 
39 2-Methyl-2-hexenal 28467-88-1 0.02 0.06 0.06 0.03 0.07 0.05 0.03 0.02 0.03 
40 Heptanal 111-71-7 0.12 0 0.04 0.11 0.16 0.08 0.11 0.02 0 
41 2-Heptenal 2463-63-0 0.04 0.03 0.03 0.03 0.05 0.03 0.01 0.04 0.04 
42 Octanal 124-13-0 0.17 0.1 0.06 0.31 0.51 0.19 0.23 0.18 0.06 
43 Nonanal 124-19-6 1.24 0.1 0.08 2.42 2.65 1.05 1.08 0.48 0.32 
44 Decanal 112-31-2 0.43 0.11 0.26 0.9 0.87 0.44 0.42 0.33 0.42 
45 Undecanal 112-44-7 0.15 0.05 0.07 0.31 0.04 0.37 0.1 0.09 0.14 
46 Dodecanal 112-54-9 0.29 0.11 0.06 1.07 0.53 0.55 0.19 0.17 0.11 
47 Tridecanal 10486-19-8 0.03 0.02 0.04 0.05 0.04 0.04 0.02 0.02 0.03 
48 Tetradecanal 124-25-4 0.13 0.05 0.03 0.06 0.06 0.03 0.04 0.04 0.03 
49 Pentadecanal 2765-11-9 0.02 0.02 0.01 0.01 0.01 0.01 0.03 0.02 0.02 
 Aromatics           
50 Benzaldehyde 100-52-7 5.11 4.46 3.64 8.41 10.48 10.76 6.69 7.07 7.07 
51 2-Hydroxybenzaldehyde 90-02-8 0.15 0.1 0.08 0.17 0.16 0.22 0.12 0.2 0.2 
52 3,5-Dimethylbenzaldehyde 5779-95-3 1.59 0.78 0.32 1.09 0.93 0.56 0.69 0.59 0.42 
53 4-(1-Methylethyl)-benzaldehyde 122-03-2 0.14 0.02 0.01 0.15 0.06 0.02 0.07 0.05 0.01 
54 4-tert-Butylbenzaldehyde 939-97-9 0.16 0.02 0.04 0.11 0.06 0.03 0.14 0.18 0.07 
55 2-phenyl-4-pentenal  24401-36-3 0.27 0.1 0.09 0.38 0.06 0.11 0.22 0.26 0.12 
56 5-Methyl-2-phenyl-2-hexenal 21834-92-4 0.4 0.26 0.24 0.15 0.2 0.18 1.78 0.77 0.85 
57 3,5-di-tert-Butyl-4-hydroxybenzaldehyde 1620-98-0 0.47 0.07 0.05 0.06 0.19 0.07 0.34 0.09 0.08 
 
Subtotal (GC Peak Area) 7.84 16.4 11.92 
 
Subtotal (%) 6.32 13.08 7.25 
 
Esters 
          
 Aliphatics           
58 Ethyl propanoate 105-37-3 0.15 0.08 0.02 0.05 0.06 0.05 0.04 0.04 0.05 
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59 Methyl methacrylate 80-62-6 0.06 0.15 0.06 0.05 0.05 0.06 0.04 0.06 0.05 
60 Methyl isovalerate 556-24-1 0.24 0.54 0.48 0.36 0.43 0.29 0.39 0.38 0.49 
61 Butyl acetate 123-86-4 0.21 0.16 0.12 0.11 0.08 0.15 0.14 0.14 0.19 
62 Ethyl 2-methylbutanoate 7452-79-1 0.2 0.17 0.06 0.35 0.3 0.47 0.28 0.21 0.34 
63 3-Methyl-3-butenyl acetate 5205-07-2 0.02 0.02 0.02 0.03 0.03 0.03 0.05 0.04 0.05 
64 Methyl 2-hydroxy-4-methylpentanoate 40348-72-9 0.06 0.04 0.06 0.02 0.04 0.03 0.49 0.35 0.34 
65 Propyl 2,2-dimethylpropanoate 5129-35-1 0.01 0.46 0.48 0.27 0.26 0.27 0.37 0.36 0.41 
66 tert-Butyl isopropyl carbonate 30221-21-7 0.41 0.26 0.23 0.19 0.24 0.17 0.23 0.36 0.3 
67 Dimethyl 2,4-dimethylpentanedioate 2121-68-8 13.37 4.4 0.47 9.67 4.67 1.01 6.74 7.84 1.04 
68 Dimethyl isopropylidenesuccinate 87384-00-7 1.31 0.24 0.04 0.87 0.44 0.02 0.54 0.53 0.01 
69 Dimethyl 2-methylhexanedioate 19780-94-0 0.49 0.59 0.07 3.37 1.32 0.9 0.42 1.12 0.08 
70 1-Ethyl 6-methyl hexanoate 18891-13-9 3.42 0.67 0.16 2.27 1.67 0.22 2.28 1.42 0.15 
71 Dimethyl 2-(2-methylprop-2-enyl)propanedioate 50598-40-8 0.36 0.08 0.02 0.27 0.15 0.1 0.27 0.18 0.03 
72 Dimethyl 2,2-dimethylpentanedioate 13051-32-6 0.67 0.27 0.1 0.62 0.2 0.07 0.33 0.54 0.1 
73 Dimethyl 2,3-dimethyl hexanodioate 58219-48-0 0.43 0.31 0.13 0.42 0.21 0.08 4.91 0.71 0.09 
74 1-Methylhexyl butanoate 39026-94-3 0.76 0.25 0.21 0.38 0.52 0.24 0.56 0.32 0.29 
75 2-Ethyl-3-hydroxyhexyl butyrate 18618-89-8 1.3 0.63 0.34 0.93 0.91 0.54 1.27 0.89 0.65 
76 Diethyl diallylmalonate 3195-24-2 0.18 0.05 0.01 0.07 0.11 0.03 0.11 0.06 0.01 
 Aromatics           
77 Methyl benzoate 93-58-3 0.62 0.56 0.92 0.23 0.28 0.25 0.19 0.18 0.19 
78 Methyl phenylacetate 101-41-7 0.11 0.12 0.17 0.15 0.15 0.08 0.13 0.16 0.13 
79 1-Phenylethyl acetate 93-92-5 0.04 0.03 0.02 0.03 0.09 0.02 0.05 0.05 0.03 
80 Ethyl phenylethanoate 101-97-3 0.23 0.04 0 0.14 0.1 0.07 0.1 0.09 0.08 
81 2-Benzylacrylic acid methyl ester 3070-71-1 2.62 1.32 0.4 2.37 0.78 0.67 1.46 1.7 0.62 
82 Cinnamyl methanoate 104-65-4 0.06 0.08 0.03 0.1 0.06 0.02 0.08 0.11 0.06 
83 2-Methyl-4-phenylbutyric acid methyl ester - 16.36 9.59 6.49 12.71 5.99 8.19 8.99 13.39 8.37 
84 5-Phenyl-2-pentenoic acid methyl ester 26429-97-0 0.07 0.09 0.04 0.01 0.03 0.01 0.1 0.12 0.09 
85 Ethyl 5-phenyl-2-pentenoate 55282-95-6 2.5 2.15 0.71 1.71 0.29 1.28 1.33 2.05 1.96 
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86 Dimethyl phenylethyl carbinyl acetate 103-07-1 0.04 0.06 0.03 0.03 0.02 0.02 0.01 0.03 0.01 
87 Phenyl benzoate 93-99-2 0.04 0.02 0 0.03 0.01 0 0.03 0.04 0 
88 Hexyl 2-hydroxybenzoate 6259-76-3 0.01 0.01 0.01 0.01 0 0.01 0.01 0.01 0.01 
89 2-Ethylhexyl 2-hydroxybenzoate 118-60-5 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.02 
 Cyclics           
90 Butyl cyclopropanecarboxylate 54947-39-6 0.04 0.01 0.02 0.03 0.03 0.02 0.55 0.28 0.36 
 
Subtotal (GC Peak Area) 27.26 24.26 27.62 
 
Subtotal (%) 21.98 19.35 16.80 
 
Hydrocarbons 
          
 Aliphatics           
91 2-Butene 107-01-7 0.07 0.04 0.04 0.04 0.02 0.05 0.04 0.05 0.05 
92 Octane 111-65-9 0.08 0.03 0.04 0.04 0.08 0.03 0.05 0.03 0.03 
93 Nonane 111-84-2 0.04 0.02 0.03 0.04 0.06 0.03 0.14 0.07 0.08 
94 2,2,4,6,6-Pentamethyl-3-heptene 123-48-8 1.11 1.24 0.55 0.8 1.52 0.32 0.98 1.49 0.1 
95 3-Ethyl-2,7-dimethyl-octane 62183-55-5 0.24 0.12 0.06 0.03 0.2 0.05 0.03 0.16 0.24 
96 6-Methyl-3-undecene 74630-52-7 0.12 0.11 0.04 0.09 0.06 0.03 0.04 0.08 0.1 
97 Dodecene 112-41-4 0.48 0.2 0.12 0.59 0.39 0.31 0.27 0.29 0.23 
98 4-Ethylundecane  17312-59-3 0.04 0.02 0.02 0.05 0.11 0.04 0.02 0.04 0.04 
99 Tetradecene 1120-36-1 0.21 0.06 0.1 0.26 0.28 0.12 0.08 0.11 0.22 
100 2-Methyltetradecane 1560-95-8 0.02 0.01 0.02 0.02 0.04 0.01 0.01 0.01 0.01 
101 3-Ethyl-3-methyltridecane - 0.09 0.05 0.03 0.05 0.02 0.02 0.03 0.02 0.01 
102 Hexadecane 544-76-3 0.11 0.09 0.05 0.08 0.19 0.09 0.05 0.04 0.06 
103 Heptadecane 629-78-7 0.12 0.08 0.21 0.03 0.12 0.03 0.03 0.01 0.04 
104 Octadecane 593-45-3 0.05 0.04 0.03 0.03 0.03 0.03 0.02 0.02 0.04 
105 Nonadecane 629-92-5 0.02 0.01 0.02 0.02 0.01 0.02 0.02 0.01 0.03 
106 Eicosane 112-95-8 0.06 0.01 0.04 0.06 0.01 0.01 0.01 0.01 0.05 
 Aromatics           
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107 Methylbenzene 108-88-3 1.78 2.88 2.49 1.11 1.52 0.83 1.22 2.02 2.05 
108 1,3-Dimethylbenzene 108-38-3 0.31 0.12 0.11 0.18 0.23 0.09 0.12 0.19 0.16 
109 1-Ethyl-4-methylbenzene 622-96-8 0.11 0.11 0.06 0.12 0.1 0.07 0.08 0.16 0.13 
110 1,2,3-Trimethylbenzene 526-73-8 0.13 0.08 0.05 0.18 0.09 0.08 0.06 0.13 0.07 
111 2-Phenyl-1-butene 2039-93-2 0.07 0.03 0.03 0.14 0.09 0.05 0.04 0.02 0.03 
112 2-Ethyl-1,3-dimethylbenzene 2870-04-4 0.04 0.04 0.02 0.04 0.04 0.01 0.02 0.02 0.02 
113 Naphthalene 91-20-3 0.68 0.38 0.23 0.87 0.55 0.41 0.36 0.39 0.22 
114 1-Methylnaphthalene 90-12-0 0.1 0.08 0.05 0.12 0.08 0.08 0.07 0.06 0.06 
115 2-Methylnaphthalene 91-57-6 0.08 0.06 0.04 0.1 0.03 0.07 0.07 0.07 0.06 
116 5,6,7,8,9,10-Hexahydrobenzocyclooctene 1076-69-3 0.18 0.08 0.08 0.19 0.07 0.13 0.01 0.08 0.11 
117 4-Phenyl-1-cyclohexene 4994-16-5 0.02 0.01 0.01 0.03 0.01 0.02 0.01 0.01 0.01 
118 Biphenyl 92-52-4 0.03 0.02 0.03 0.03 0.02 0.03 0.02 0.03 0.02 
119 1,4-Dimethylnaphthalene  571-58-4 0.03 0.02 0.03 0.09 0.03 0.05 0.01 0.02 0.01 
120 Diphenylmethane 101-81-5 0.02 0.02 0.02 0.05 0.01 0.03 0.01 0.01 0.01 
121 3-Ethyl-3-phenyl-1-pentene 19781-34-1 7.77 6.69 2.9 6.25 1.98 4.16 3.96 7.71 5.07 
122 3-Methylbiphenyl 643-93-6 0.02 0.02 0.02 0.08 0.04 0.09 0.01 0.03 0.02 
123 Acenaphthene 83-32-9 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 
124 2,2'-Dimethylbiphenyl 605-39-0 0.19 0.13 0.06 0.09 0.02 0.08 0.04 0.04 0.05 
125 1,1-Diethyl-1,2,3,4-tetrahydronaphthalene 2938-66-1 0.93 0.67 0.38 0.68 0.47 0.49 0.52 0.6 0.41 
126 (1-Ethylhexyl)benzene 18335-15-4 0.14 0.12 0.11 0.1 0.09 0.12 0.4 0.24 0.22 
127 1,1-Diphenyl-ethylene 530-48-3 0.19 0.19 0.13 0.09 0.09 0.18 0.1 0.11 0.12 
128 2-Methyl-6-phenyl-1,6-heptadiene 51708-97-5 0.75 0.51 0.34 0.49 0.55 0.4 0.41 0.6 0.48 
129 1,4-Diethyl-1,2,3,4-tetrahydronaphthalene 81356-57-2 0.12 0.04 0.05 0.05 0.01 0.06 0.06 0.07 0.06 
130 (3-Methyl-1-methylenepentyl)benzene 74810-69-8 5.1 2.32 1.73 2 2.6 1.78 3.25 2.26 1.96 
131 1,1-Diethylnaphthalene 74710-00-2 0.09 0.07 0.22 0.06 0.03 0.07 0.05 0.07 0.06 
132 1,3-Diphenylpropane 1081-75-0 0.13 0.11 0.12 0.16 0.08 0.17 0.07 0.08 0.07 
133 3-Phenyldecane 4621-36-7 0.13 0.06 0.06 0.12 0.14 0.07 0.04 0.04 0.05 
134 1,3-Diphenylbutane 1520-44-1 0.07 0.07 0.02 0.08 0.05 0.05 0.03 0.03 0.03 
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135 1,2,3-Trimethyl-4-propenylnaphthalene  26137-53-1 3.25 1.79 2.1 1.33 1.51 1.5 1.6 1.06 1.51 
136 5-Phenyldodecane 2719-63-3 0.18 0.06 0.07 0.1 0.17 0.05 0.05 0.05 0.07 
137 4-Phenyldodecane 2719-64-4 0.07 0.03 0.02 0.04 0.06 0.02 0.02 0.02 0.02 
138 9-Ethyl-9,10-dihydro-10-methyl-anthracene 36778-20-8 0.13 0.1 0.02 0.08 0.09 0.11 0.05 0.08 0.01 
139 3-Phenyldodecane 2400-00-2 0.07 0.03 0.03 0.05 0.07 0.03 0.02 0.02 0.02 
140 4-Phenyltridecane 4534-51-4 0.07 0.03 0.02 0.03 0.06 0.02 0.04 0.01 0.02 
141 (1,2-Dicyclopropyl-2-phenylethyl)benzene 110330-90-0 0.73 0.04 0.03 0.05 0.39 0.05 0.58 0.07 0.05 
 
Subtotal (GC Peak Area) 19.61 14.86 16.23 
 
Subtotal (%) 15.81 11.85 9.87 
 
Ketones 
          
 Aliphatics           
142 2-Propanone 67-64-1 2.48 1.92 1.85 2.68 2.34 2.2 2.08 2.12 2.31 
143 2-Butanone 78-93-3 2.63 2.17 1.91 2.1 2.57 2.43 2.72 2.39 2.56 
144 2-Pentanone 107-87-9 0.14 0.18 0.1 0.18 0.18 0.15 0.09 0.11 0.15 
145 1-Hydroxy-2-propanone 116-09-6 0.34 0.66 0.75 0.49 0.42 0.52 0.47 0.99 1.04 
146 3-Hydroxy-2-butanone 513-86-0 0.21 0.18 0.22 0.09 0.09 0.09 0.2 0.16 0.11 
147 4-Methyl-2-pentanone 108-10-1 0.3 0.29 0.18 0.12 0.19 0.18 0.13 0.13 0.29 
148 3-Hexanone 589-38-8 0.02 0.02 0.02 0.02 0.02 0.03 0.03 0.02 0.03 
149 2-Hexanone 591-78-6 0.09 0.08 0.08 0.08 0.1 0.1 0.1 0.1 0.1 
150 3-Hexen-2-one 763-93-9 0.03 0.03 0.02 0.02 0.04 0.03 0.02 0.02 0.03 
151 3-Hydroxy-2-pentanone 3142-66-3 0.16 0.19 0.29 0.04 0.07 0.03 0.03 0.05 0.04 
152 2-Hydroxy-3-pentanone 5704-20-1 0.04 0.05 0.09 0.01 0.02 0.01 0.02 0.02 0.02 
153 2,3-Heptanedione 96-04-8 0.02 0.01 0.02 0.01 0.01 0.02 0.1 0.07 0.08 
154 5-Methyl-2-hexanone 110-12-3 0.2 0.14 0.17 0.18 0.15 0.3 0.27 0.24 0.29 
155 4-Heptanone 123-19-3 0.02 0.06 0.05 0.05 0.05 0.06 0.06 0.05 0.06 
156 3-Heptanone 106-35-4 0.06 0.04 0.04 0.04 0.05 0.04 0.06 0.04 0.06 
157 2-Heptanone 110-43-0 0.9 0.81 0.72 0.74 0.94 1.07 0.98 1.07 1.25 
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158 5-Methyl-2-heptanone 18217-12-4 0.02 0.01 0.01 0.02 0.03 0.02 0.01 0.05 0.02 
159 4-Methyl-2-heptanone 6137-06-0 0.16 0.18 0.11 0.94 0.14 0.16 0.05 0.16 0.18 
160 2-Methyl-6-heptanone 928-68-7 0.41 0.35 0.35 0.36 0.4 0.44 1.95 0.67 0.57 
161 3-Octanone 106-68-3 0.25 0.15 0.17 0.23 0.22 0.23 0.13 0.14 0.15 
162 2-Octanone 111-13-7 0.32 0.23 0.15 0.35 0.28 1.17 2 0.43 0.44 
163 3-Nonanone 925-78-0 0.01 0.01 0 0.01 0.01 0.01 0.01 0.01 0.01 
164 2-Nonanone 821-55-6 0.14 0.12 0.11 0.22 0.22 0.21 0.3 0.32 0.28 
165 2,6-Dimethyl-2,5-heptadien-4-one 504-20-1 0.07 0.03 0.04 0.03 0.03 0.05 0.06 0.08 0.11 
166 2,5-Dimethyl-3,4-hexanedione 4388-87-8 0.56 0.48 0.57 0.56 0.58 0.52 0.58 0.88 0.62 
167 2-Decanone 693-54-9 0.16 0.08 0.03 0.15 0.11 0.08 0.13 0.12 0.11 
168 4-Methyl-3-octanone  6137-15-1 0.65 0.48 0.41 0.51 0.57 0.45 0.53 0.68 0.51 
169 5-Undecanone 33083-83-9 0.04 0.02 0.02 0.05 0.05 0.07 0.04 0.02 0.02 
170 2-Undecanone 112-12-9 0.57 0.23 0.22 0.23 0.13 0.14 0.34 0.21 0.17 
171 2-Tridecanone  593-08-8 0.07 0.06 0.07 0.07 0.05 0.08 0.03 0.03 0.03 
172 2-Tetradecanone 2345-27-9 0.06 0.15 0.2 0.25 0.26 0.31 0.03 0.07 0.07 
173 3-Tetradecanone 629-23-2 0.03 0.03 0.06 0.04 0.03 0.07 0.03 0.01 0.02 
174 6-Tetradecanone 6836-42-6 0.03 0.05 0.05 0.03 0.02 0.03 0.01 0.02 0.03 
175 2-Pentadecanone 2345-28-0 0.03 0.03 0.05 0.03 0.03 0.04 0.01 0.02 0.03 
176 2-Hexadecanone 18787-63-8 0.08 0.12 0.16 0.08 0.15 0.08 0.02 0.03 0.03 
177 2-Heptadecanone 2922-51-2 0.02 0.02 0.02 0.02 0.03 0.03 0.01 0.01 0.02 
 Aromatics           
178 1-Phenylethanone 98-86-2 7.52 5.83 5.15 6.76 9.26 6.38 8.04 7.53 6.13 
179 1-Phenyl-2-propanone 103-79-7 0.61 0.51 0.4 0.55 0.75 0.8 0.62 0.75 1 
180 1-(2-Hydroxyphenyl)-ethanone 118-93-4 0.03 0.02 0.03 0.03 0.05 0.02 0.03 0.03 0.04 
181 1-Phenyl-1,2-propanedione 579-07-7 0.18 0.07 0.06 0.12 0.15 0.15 0.39 0.46 0.32 
182 1-Phenyl-2-butanone 1007-32-5 0.09 0.07 0.12 0.1 0.1 0.11 0.11 0.1 0.16 
183 4-Phenyl-2-butanone 2550-26-7 0.26 0.05 0.16 0.39 0.42 0.4 0.4 0.45 0.4 
184 1-Phenyl-1-butanone 495-40-9 0.61 0.24 0.11 0.47 0.39 0.12 0.42 0.3 0.13 
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185 1-(4-Ethylphenyl)-ethanone 937-30-4 0.02 0.02 0.01 0.01 0.01 0.01 0.02 0.02 0 
186 3-Methyl-1-phenyl-2-buten-1-one 5650-07-7 0.04 0.01 0.02 0.06 0.02 0.02 0.04 0.09 0.03 
187 1-(4-tert-Butylphenyl)propan-2-one 81561-77-5 0.13 0.07 0.13 0.01 0.05 0.04 0.1 0.12 0.06 
188 Benzophenone 119-61-9 0.23 0.18 0.21 0.14 0.27 0.24 0.23 0.23 0.25 
189 3,5-di-tert-Butyl-4-hydroxyacetophenone 14035-33-7 0.01 0.01 0 0.01 0.01 0.01 0.02 0.01 0.01 
190 2,2-Dimethoxy-1,2-diphenyl-ethanone 24650-42-8 0.03 0.02 0.02 0.03 0.04 0.03 0.01 0.02 0.02 
 Cyclics           
191 Cyclohexanone 108-94-1 0.36 0.08 0.04 0.02 0.07 0.07 0.04 0.03 0.03 
192 3,4,4-Trimethyl-2-cyclopenten-1-one 30434-65-2 0.08 0.07 0.02 0.01 0.13 0.03 0.01 0.13 0.06 
193 3,5,5-Trimethyl-2-cyclohexen-1-one 78-59-1 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 
194 4-Cyclopentylidene-2-butanone 51004-21-8 0.04 0 0 0.02 0.02 0.02 0.02 0.01 0 
195 2,6-di-Butyl-2,5-cyclohexadiene-1,4-dione 719-22-2 0.75 0.12 0.59 0.56 0.6 0.4 0.71 0.49 0.34 
196 2,6-di(t-Butyl)-4-hydroxy-4-methyl-2,5-
cyclohexadien-1-one 
10396-80-2 9.01 0.84 0.61 1.35 3.33 0.86 3.72 1.77 0.86 
 
Subtotal (GC Peak Area) 22.07 23.04 24.78 
 
Subtotal (%) 17.79 18.38 15.07 
 
N-Compounds 
          
 Amines           
 Aliphatics           
197  N-methyleneethenamine 38239-27-9 0.09 0.08 0.07 0.05 0.08 0.08 0.07 0.07 0.07 
 Aromatics           
198 Benzenamine 62-53-3 0.01 0.01 0 0.38 0.01 0.01 0.01 0.02 0.01 
199 2,4,6-Trimethyl-benzenamine 88-05-1 0.13 0.04 0.04 0.07 0.06 0.07 0.05 0.06 0.06 
200 4,5-Dimethyl-ortho-phenylenediamine 3171-45-7 0.08 0.4 0.04 0.05 0.07 0.09 0.2 2.69 0.09 
201 4-Ethylphenethylamine 64353-29-3 0.07 0.05 0.08 0.12 0.06 0.1 0.11 0.13 0.1 
 Cyclics           
202 1-Methyl-1H-pyrrole-2-ethanamine 83732-75-6 0.06 0.05 0.04 0.05 0.07 0.07 0.06 0.06 0.07 
 Amides           
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 Aliphatics           
203 Dibutyramide 4494-12-6 0.11 0.1 0.08 0.08 0.1 0.12 0.13 0.16 0.14 
204 N,N-Dibutylformamide  761-65-9 0.1 0.02 0.01 0.04 0.02 0.01 0.13 0.09 0.02 
 Aromatics           
205  2-Phenylbutanamide 90-26-6 0.28 0.21 0.19 0.15 0.18 0.35 0.58 0.42 0.57 
 Oximes           
206 3-Methylbutanal oxime (isomer) 5780-40-5 0.16 0.18 0.15 0.2 0.25 0.2 0.28 0.26 0.34 
207 3-Methylbutanal oxime (isomer) 5775-74-6 0.1 0.11 0.1 0.14 0.15 0.12 0.17 0.18 0.23 
 Others           
208 Benzonitrile 100-47-0 0.41 0.35 0.35 0.41 0.49 0.49 0.48 0.56 0.54 
209 Phenylacetonitrile 140-29-4 1.17 1.06 1.03 1.15 1.29 1.37 1.2 1.63 1.35 
 
Subtotal (GC Peak Area) 2.54 2.93 4.46 
 
Subtotal (%) 2.05 2.34 2.71 
 
Terpens 
          
 Monoterpens           
210 α-Pinene 7785-26-4 0.08 0.09 0.05 0.08 0.13 0.06 0.06 0.08 0.08 
211 Sabinene 3387-41-5 0.02 0.02 0.01 0.02 0.02 0.01 0.01 0.02 0.02 
212 γ-Terpinene 99-85-4 0.06 0.03 0.01 0.05 0.04 0.01 0.02 0.02 0.05 
213 Limonene 5989-54-8 0.06 0.11 0.07 0.15 0.08 0.07 0.13 0.12 0.12 
214 Dihydromyrcenol 18479-58-8 0.59 0.24 0.16 0.53 0.25 0.17 0.63 0.25 1.76 
215 Isoborneol 124-76-5 0.05 0.03 0.04 0.03 0.03 0.05 0.04 0.06 0.04 
216 Dihydro γ-Terpineol 21129-27-1 0.48 0.36 0.08 0.54 0.19 0.15 0.28 0.41 0.14 
217 α-Terpineol 98-55-5 0.73 0.25 0.08 0.5 0.24 0.13 0.33 0.5 0.13 
218 Tetrahydrogeraniol 106-21-8 0.81 0.82 0.12 0.76 0.21 0.11 0.39 0.71 0.22 
219 Nerol 106-25-2 0.17 0.09 0.19 0.34 0.36 0.28 0.27 0.36 0.23 
220 4-Terpinenyl acetate 4821-04-9 0.13 0.08 0.04 0.12 0.03 0.09 0.05 0.12 0.09 
 Sesquiterpens           
 233 
 
 
221 β-Caryophyllene 87-44-5 0.39 0.31 0.02 0.04 0.04 0.25 0.38 0.16 0.12 
222 Nerolidol 7212-44-4 0.24 0.13 0.16 0.18 0.24 0.19 0.23 0.11 0.24 
223 Methyl farnesoate 3675-00-1 0 0.02 0.02 0.02 0.03 0.03 0 0 0 
 
Subtotal (GC Peak Area) 2.48 2.28 8.98 
 
Subtotal (%) 2.00 1.82 5.47 
 
Norisoprenoids 
          
224 6-Methyl-5-hepten-2-one 110-93-0 0.52 0.17 0.4 1.14 0.59 0.35 0.19 0.19 0.27 
225 Geranylacetone 3796-70-1 0.13 0.23 0.16 0.38 0.29 0.26 0.25 0.3 0.28 
226 α-iso-Methyl ionone 127-51-5 0.05 0.01 0.01 0.01 0.04 0.01 0.04 0.01 0.02 
 
Subtotal (GC Peak Area) 0.56 1.02 0.52 
 
Subtotal (%) 0.45 0.81 0.32 
 
S-Compounds 
          
 Aliphatics           
227 Methanethiol 74-93-1 0.58 0.48 0.39 0.42 0.33 0.4 0.23 0.24 0.27 
228 Carbon disulfide 75-15-0 0.24 0.24 0.24 0.29 0.22 0.22 0.15 0.17 0.16 
229 Methylthiolacetate 1534-08-3 0.45 0.31 0.27 0.38 0.34 0.45 0.14 0.09 0.15 
230 Dimethyl disulfide 624-92-0 1.55 1.17 1.19 1.11 0.88 1.29 0.89 0.72 0.83 
231 Methylthio-2-propanone 14109-72-9 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 
232 3-(methylthio)-propanal 3268-49-3 0.1 0.12 0.08 0.08 0.22 3.37 1.79 0.11 0.27 
233 Dimethyl trisulfide 3658-80-8 1.29 1.06 1.13 0.84 0.62 0.8 0.47 0.44 0.43 
234 2-Methylsulfinylethanol 21281-74-3 0.12 0.07 0.06 0.1 0.07 0.03 0.07 0.11 0.1 
235 6-(Methylthio)hexa-1,5-dien-3-ol - 0.01 0.02 0.02 0.01 0.02 0.02 0.03 0.03 0.04 
236 Dimethyl tetrasulphide 5756-24-1 0.43 0.46 0.53 0.33 0.22 0.31 0.21 0.14 0.15 
237 Dimethyl pentasulfide 7330-31-6 0.02 0.01 0.01 0 0 0 0 0 0 
238 1-Dodecanethiol 112-55-0 0.29 0.17 0.02 0.07 0.1 0.02 0.15 0.4 0.54 
239 2-Methyl-2-undecanethiol 10059-13-9 0.33 0.16 0.1 0.12 0.07 0.15 0.14 0.21 0.21 
 234 
 
 
240 Dodecyl methyl sulfide 3698-89-3 0.57 0.45 0.39 1.46 0.71 0.91 0.14 0.18 0.12 
 
Subtotal (GC Peak Area) 5.06 5.68 3.53 
  Subtotal (%) 4.08 4.53 2.15 
 235 
 
 
 
 
